[{"card":{"key":"af8052cb-491f-4612-a43e-59af37db04be","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2021","description":"Revisiting the biosimilars market with Sean McGowan and Michelle Jesse from AmerisourceBergen’s biosimilars team, along with Brad Tallamy, Senior Director of Government Affairs at AmerisourceBergen. In part one of a two-part series on insulin biosimilars, we’ll talk about what these new drugs could mean for the category.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insulin-model-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-insulin-biosimilars-1","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Podcast: Insulin biosimilars part 1"},"categories":["biosimilars","affordability","policy"],"segments":[],"timestamp":637624053510000000,"title":"podcast: insulin biosimilars part 1"},{"card":{"key":"a62aca4d-87f5-4fe5-bd3a-e0e0f4fe8273","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2021","description":"We’re discussing insulin biosimilars with Sean McGowan and Michelle Jesse from AmerisourceBergen’s biosimilars team, along with Brad Tallamy, Senior Director of Government Affairs at AmerisourceBergen. In part two of a two-part series on insulin biosimilars, we’ll talk about how pharmacies can prepare to dispense biosimilars once these products receive interchangeability status.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insulin-consultation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-insulin-biosimilars-2","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Podcast: Insulin biosimilars part 2"},"categories":["biosimilars","affordability","policy","pharmacy operations"],"segments":[],"timestamp":637660341000000000,"title":"podcast: insulin biosimilars part 2"},{"card":{"key":"e8fde5bf-8e85-4d95-84ca-803f403de4fe","authorName":"Matt Sarnes, PharmD; Brian Ansay","authorCompany":"Biopharma Services","date":"May 2021","description":"AmerisourceBergen recently hosted its first-ever manufacturer summit dedicated to commercialization strategy and market access. In this episode of the AmerisourceBergen Insights podcast, hear highlights from the event. ","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/audience.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-may-2021","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: ThinkLive Commercialization 2021"},"categories":["affordability","commercialization","innovation","market access","medication adherence","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637564950000000000,"title":"podcast: thinklive commercialization 2021"},{"card":{"key":"7c3a70fd-f41b-48b7-aab9-87d69a919466","authorName":"Sean McGowan; Steve Miller; David Senior","authorCompany":"AmerisourceBergen","date":"October 2020","description":"In the inaugural episode of the AmerisourceBergen Insights podcast, we’re looking at the biosimilars market. Sean McGowan, Senior Director of Biosimilars at AmerisourceBergen, will be joined by David Senior and Steve Miller about the policy and reimbursement issues that impact our customers and the overall growth of biosimilars. These three experts will discuss how different policy issues can slow market growth, with actionable guidance for providers on how to confront reimbursement-related challenges. ","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/microphone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-oct-2020","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Health Systems","headline":"Biosimilars: Patents, policy, and reimbursement"},"categories":["biosimilars","policy","regulatory","reimbursement"],"segments":["health systems","manufacturers","physician practices"],"timestamp":637387830000000000,"title":"biosimilars: patents, policy, and reimbursement"},{"card":{"key":"1e6ad45c-b174-4b9e-aa0a-0d81336070c7","authorName":"Lara Knudsen","authorCompany":"AmerisourceBergen","date":"July 2020","description":"There's an unprecedented opportunity to start serving pets in your pharmacy. Here's how to put pet health into practice and provide more comprehensive care to the people in your community who have companion animals at home.","img":{"alt":"A person petting the underside of a cat's chin","src":"-/media/assets/gnp/images/gnp-insights-caring-for-every-member-of-the-family.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/caring-for-every-member-of-the-family","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Caring for Every Member of the Family, Including the Ones with Four Legs"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637302553200000000,"title":"caring for every member of the family, including the ones with four legs"},{"card":{"key":"01da0cbd-834f-4da8-a213-7a084ada7e2a","authorName":"Good Neighbor Pharmacy","authorCompany":null,"date":"February 2020","description":"The basics of Collaborative Practice Agreements and how they can help eliminate some of the biggest challenges faced by independent pharmacy owners today. ","img":{"alt":"","src":"-/media/assets/gnp/icons/gnpconnect.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/gnp-connect-podcast-collaborative-practice-agreements-101","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"GNP Connect Podcast: Collaborative Practice Agreements 101"},"categories":["patient care","pharmacy operations","pharmacy ownership","good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":637163208000000000,"title":"gnp connect podcast: collaborative practice agreements 101"},{"card":{"key":"efe46bbc-0db8-4ff0-bb32-4773ba0d608a","authorName":"Tim Jones; Beth Lea","authorCompany":"AmerisourceBergen","date":"August 2021","description":"What are DIR fees and GER and BER recoupments? How do they impact pharmacy profitability?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacy-payment.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-pharmacies-should-know-about-dir-fees-and-ger-and-ber-recoupments","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What pharmacies should know about DIRs, GERs, and BERs"},"categories":["business performance","cash flow management","dir fees","financial management","good neighbor pharmacy","managed care","reimbursement"],"segments":["pharmacies"],"timestamp":637649102710000000,"title":"what pharmacies should know about dirs, gers, and bers"},{"card":{"key":"4fff1242-de63-4ab4-aa8a-f9a055aa208f","authorName":"Marc Johnson","authorCompany":"AmerisourceBergen","date":"April 2020","description":"Long-term care isn't slowing down. Here's how your pharmacy can keep up as demands for LTC pharmacy grow.","img":{"alt":"","src":"-/media/assets/lash/images/pagedesign_patient_caregiver.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/six-steps-to-growing-a-long-term-care-pharmacy-business","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Six Steps to Growing a Long-Term Care Pharmacy Business"},"categories":["long term care","pharmacy operations"],"segments":["pharmacies"],"timestamp":637214533200000000,"title":"six steps to growing a long-term care pharmacy business"},{"card":{"key":"eabd1e2d-a504-44c4-b981-db78dffdbbae","authorName":"Don Via","authorCompany":"Good Neighbor Pharmacy","date":"June 2020","description":"While there's no magic formula for finding the appropriate pharmacy staffing levels, there are subtle shifts you can make that will have a big impact on your bottom line.","img":{"alt":"Two pharmacists filling prescriptions in a pharmacy","src":"-/media/assets/gnp/images/gnp-insights-changes-you-can-make-to-your-staffing.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/three-small-staffing-changes-that-can-boost-your-pharmacys-profits","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Three Small Staffing Changes That Can Boost Your Pharmacy's Profits"},"categories":["business performance"],"segments":["pharmacies"],"timestamp":637291344000000000,"title":"three small staffing changes that can boost your pharmacy's profits"},{"card":{"key":"41fa84a4-6a21-4413-bbc4-36f4fad641bc","authorName":"Cathy Humphrey","authorCompany":"Good Neighbor Pharmacy","date":"March 2020","description":"By consistently engaging with local families, you’ll multiply the number of patients under your care and ways to profitably meet their needs.","img":{"alt":"Two pharmacists help a mother and her daughter","src":"-/media/assets/gnp/images/gnp-insights-attracting-families.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/attracting-families-to-your-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Attracting Families to Your Pharmacy: How to Wow Parents While Wooing Their Little Ones"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637191122400000000,"title":"attracting families to your pharmacy: how to wow parents while wooing their little ones"},{"card":{"key":"d63ff856-20a7-43e0-bf39-43c56a293184","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"October 2018","description":"Now is the time to encourage patients to receive an annual flu shot. Start engaging patients in a conversation about the importance of this vaccine and keep your community healthy during this flu season.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/reminding-patients-of-the-importance-of-annual-flu-vaccines","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Keeping Communities Well: Reminding Patients of the Importance of an Annual Flu Vaccine"},"categories":["immunizations","patient care"],"segments":["pharmacies"],"timestamp":636742666720000000,"title":"keeping communities well: reminding patients of the importance of an annual flu vaccine"},{"card":{"key":"846915a6-e29f-4565-bead-1c29718435e4","authorName":"Scott Welle","authorCompany":"AmerisourceBergen","date":"September 2019","description":"A well-prepared plan does more than make your case to secure pharmacy financing. It also better positions you to capitalize on changing market conditions throughout your pharmacy’s business lifecycle.","img":{"alt":"Two men with laptops writing a business plan together","src":"-/media/assets/gnp/images/gnp-insights-business-plan.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/business-plan","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"The Ins and Outs of an Independent Pharmacy Business Plan"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637032844800000000,"title":"the ins and outs of an independent pharmacy business plan"},{"card":{"key":"a2f32daf-13aa-4d86-a7bf-4d621efa6370","authorName":"John Pross ","authorCompany":"AmerisourceBergen","date":"July 2020","description":"Passing down a pharmacy legacy usually works out well for both parties when there’s already an existing relationship between the buyer and seller since the groundwork for a smooth transition has already been laid.","img":{"alt":"A father with his arm around his son as they walk and talk","src":"-/media/assets/gnp/images/gnp-insights-sell-to-someone-you-know.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-sell-your-pharmacy-to-someone-you-know","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Ensuring Success for Your Successor: How to Sell Your Pharmacy to Someone You Know"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637314761400000000,"title":"ensuring success for your successor: how to sell your pharmacy to someone you know"},{"card":{"key":"e3bb15c7-da60-487e-a5ea-7321a995e8bd","authorName":"Carla Frehn; Jason Montgomery","authorCompany":"AmerisourceBergen ","date":"March 2021","description":"How should pharmacies prepare to administer the COVID-19 vaccine in their communities? Our Good Neighbor Pharmacy team shares tips for a safe and stress-free experience.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/covid_car.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/six-tips-for-pharmacies-administering-the-covid-19-vaccine","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Six tips for pharmacies administering the COVID-19 vaccine"},"categories":["good neighbor pharmacy","immunizations","covid-19","in-store experience","marketing","patient care","patient safety","pharmacy operations"],"segments":["pharmacies"],"timestamp":637510805900000000,"title":"six tips for pharmacies administering the covid-19 vaccine"},{"card":{"key":"c92e0926-996d-4681-bb80-10975d5f57f2","authorName":"Kelley De La Fuente","authorCompany":"Good Neighbor Pharmacy","date":"June 2019","description":"Differentiation, supported by in-store branding and staff expertise, helps independent pharmacies pave a path toward long-term profitability.","img":{"alt":"A pharmacist educating a patient on vitamin supplements","src":"-/media/assets/gnp/images/gnp-insights-how-to-construct-a-one-of-a-kind-front-end-shopping-experience.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/one-of-a-kind-front-end-shopping-experience","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Construct a One-of-a-Kind Front-End Shopping Experience"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":636960187200000000,"title":"how to construct a one-of-a-kind front-end shopping experience"},{"card":{"key":"d12bd907-f3ea-4cb6-aff9-113f3a634535","authorName":"Adelina Ardelean","authorCompany":"Good Neighbor Pharmacy","date":"August 2020","description":"Flu season always has a tendency to make patients feel confused and concerned, but the coronavirus is casting an even darker shadow on the months ahead. Although keeping patients healthy through flu season this year will be challenging, you have a unique chance to educate your community, deliver convenient flu shots and develop deeper relationships with your patients that will long outlast the COVID-19 pandemic.","img":{"alt":"A woman wearing a face mask reading a text message from her pharmacist on her phone","src":"-/media/assets/gnp/images/gnp-insights-helping-patients-navigate-flu-season-part-1.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/helping-patients-navigate-flu-season-while-contending-with-covid-19-part-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Helping Patients Navigate Flu Season While Contending with COVID-19, Part 1"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637344957000000000,"title":"helping patients navigate flu season while contending with covid-19, part 1"},{"card":{"key":"e09b4727-98c3-4fab-bc6f-80effd07245c","authorName":"Curtis Ernst, RPh","authorCompany":"Good Neighbor Pharmacy","date":"April 2020","description":"Properly developing your pharmacy staff is the secret to enhancing patient experience and improving health outcomes, as it empowers them to be proactive while freeing up pharmacists to practice at the top of their license.","img":{"alt":"A customer laughing joyfully as a pharmacist helps her find the medication she needs","src":"-/media/assets/gnp/images/gnp-insights-patient-satisfaction.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/patient-satisfaction-starts-with-your-staff","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Patient Satisfaction Starts with Your Staff"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637236814200000000,"title":"patient satisfaction starts with your staff"},{"card":{"key":"3ea7e60e-709b-4bcd-9274-eafc2c9b47e3","authorName":"John Pross ","authorCompany":"AmerisourceBergen","date":"February 2020","description":"Short-term and long-term pharmacy goals will help shape your strategy for buying the right pharmacy—one that should be able to evolve through optimization and the addition of new patient care services customized to community needs.","img":{"alt":"Distance markers laid out on a driving range with golf balls strewn across the grass","src":"-/media/assets/gnp/images/gnp-insights-how-to-identify-the-right-goals.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-identify-the-right-goals-when-acquiring-a-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Identify the Right Goals When Acquiring a Pharmacy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637181629200000000,"title":"how to identify the right goals when acquiring a pharmacy"},{"card":{"key":"574d7c60-5937-4e61-8489-b768cec6e6a8","authorName":"Mark Ciarlone, PharmD","authorCompany":"Good Neighbor Pharmacy","date":"August 2019","description":"Get guidance on how to make sure you’re focusing your attention on the right areas of your business.","img":{"alt":"Audio mixing board","src":"-/media/assets/gnp/images/gnp-insights-pharmacy-optimization.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/pharmacy-optimization","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Pharmacy Optimization: Knowing Where to Start Is Half the Battle"},"categories":["business performance"],"segments":["pharmacies"],"timestamp":637024159200000000,"title":"pharmacy optimization: knowing where to start is half the battle"},{"card":{"key":"ed073efe-86bc-4914-ab5b-03ad63c0998b","authorName":"John Pross ","authorCompany":"AmerisourceBergen","date":"November 2019","description":"Great deals happen for good buyers. Here’s how to work through the pharmacy search process to capture an ideal opportunity.","img":{"alt":"Rooftop binoculars looking out over a city","src":"-/media/assets/gnp/images/gnp-insights-searching-for-a-pharmacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/where-to-start-when-searching-for-a-pharmacy-to-buy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Where to Start When Searching for a Pharmacy to Buy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637098387000000000,"title":"where to start when searching for a pharmacy to buy"},{"card":{"key":"7083fea3-75f4-4bb1-9f2d-4b1c5f4a9e9c","authorName":"Braheim Knight, RPh","authorCompany":"Good Neighbor Pharmacy","date":"August 2020","description":"Flu season is going to make a difficult situation even more complex, but independent pharmacies are up to the task. Having already risen to the challenges of the COVID-19 pandemic, your ability to adapt your business operations and offer new services at the drop of a hat are the keys to keeping your patients healthy through flu season.","img":{"alt":"A pharmacist giving a patient a flu shot","src":"-/media/assets/gnp/images/gnp-insights-helping-patients-navigate-flu-season-part-2.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/helping-patients-navigate-flu-season-while-contending-with-covid-19-part-2","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Helping Patients Navigate Flu Season While Contending with COVID-19, Part 2"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637344993000000000,"title":"helping patients navigate flu season while contending with covid-19, part 2"},{"card":{"key":"f4565e63-9ef6-46b3-9680-895a1cdbb67c","authorName":"Tim Jones","authorCompany":"AmerisourceBergen","date":"September 2020","description":"Although participating in a preferred cost-share network may be promoted as a necessity, most independent pharmacies in standard cost-share networks are retaining patients and preserving prescription profitability.","img":{"alt":"A man writing notes on a notepad behind a scale","src":"-/media/assets/gnp/images/gnp-insights-preferred-vs-standard-networks.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/picking-the-cost-share-networks-that-fit-your-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Preferred vs. Standard: Picking the Cost-Share Networks That Fit Your Pharmacy"},"categories":["managed care"],"segments":["pharmacies"],"timestamp":637365439800000000,"title":"preferred vs. standard: picking the cost-share networks that fit your pharmacy"},{"card":{"key":"769f327f-78e2-4d45-8d5d-52d0e898f8b6","authorName":"Bill LaRose, RPh","authorCompany":"AmerisourceBergen","date":"June 2019","description":"Although there's no standard formula you can use when it comes to determining the value of an independent pharmacy, there are several guidelines you can follow that will help you narrow down an accurate opinion of the pharmacy’s worth.","img":{"alt":"Marking up financial documents with calculations while conducting a pharmacy valuation","src":"-/media/assets/gnp/images/gnp-insights-realistic-valuation.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-goes-into-a-realistic-pharmacy-valuation","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What Goes into a Realistic Pharmacy Valuation?"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":636970663200000000,"title":"what goes into a realistic pharmacy valuation?"},{"card":{"key":"6aafe7ce-a21d-4ac7-ab06-fb6db40cc1ab","authorName":"Scott Welle","authorCompany":"AmerisourceBergen","date":"August 2019","description":"Preserving the legacy of an independent pharmacy after an ownership transition requires an adept buyer to lead the charge in maintaining strong relationships with patients and prescribers, motivating staff members, having financial discipline and continuing to improve upon the best management practices that the previous owner may have spent decades developing.","img":{"alt":"A quarterback handing off a football to a running back","src":"-/media/assets/gnp/images/gnp-insights-characteristics-of-a-pharmacist-who-can-carry-on-a-legacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/characteristics-of-a-pharmacist-who-can-carry-on-a-legacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Characteristics of a Pharmacist Who Can Carry on a Legacy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637006184400000000,"title":"characteristics of a pharmacist who can carry on a legacy"},{"card":{"key":"3fdf8477-efa1-471e-918f-2a7bc740bc2a","authorName":"Beth Mitchell","authorCompany":"AmerisourceBergen","date":"June 2020","description":"Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.","img":{"alt":"A pharmacist hosts a virtual meeting with an elected official on her tablet","src":"-/media/assets/gnp/images/gnp-insights-elected-officials.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-engage-with-elected-officials-when-you-cant-meet-face-to-face","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Engage with Elected Officials When You Can't Meet Face to Face"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637279995600000000,"title":"how to engage with elected officials when you can't meet face to face"},{"card":{"key":"3a412867-1c92-427f-908d-fba13c57b727","authorName":"Phyllis Houston, MSOL","authorCompany":"AmerisourceBergen","date":"January 2020","description":"Independent community pharmacies remain essential to adherence because they see patients so frequently and have a unique ability to influence outcomes.","img":{"alt":"A pharmacist ringing up a prescription at a cash register","src":"-/media/assets/gnp/images/gnp-insights-star-ratings.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-star-ratings-really-mean-to-your-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What Star Ratings Really Mean to Your Pharmacy"},"categories":["business performance"],"segments":["pharmacies"],"timestamp":637139211000000000,"title":"what star ratings really mean to your pharmacy"},{"card":{"key":"802c3fd7-20cc-4ad0-9bb8-19ee0ce2b746","authorName":"Cass Schaedig","authorCompany":"","date":"May 2022","description":"There are many aspects to the success of offering buy-and-bill services","img":{"alt":"","src":"-/media/assets/intrinsiqanalytics/images/ab-hh-hs-doctor-medication-1_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/navigating-buy-and-bill","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Navigating buy-and-bill: What every practice should monitor and how data analytics can help"},"categories":["analytics","practice management"],"segments":["physician practices"],"timestamp":637892532000000000,"title":"navigating buy-and-bill: what every practice should monitor and how data analytics can help"},{"card":{"key":"0635f42f-7350-467c-a49a-de7bb98077bc","authorName":"Andy Clarey","authorCompany":"AmerisourceBergen","date":"February 2020","description":"Shoppers should never come to a screeching halt before they get to the checkout counter. By maintaining and nurturing your front end, you can keep customers moving along, enhance the overall patient experience and position your pharmacy as the go-to resource for health and wellness in your community.","img":{"alt":"A yellow and black striped speed bump on asphalt","src":"-/media/assets/gnp/images/gnp-insights-smoothing-out-the-speedbumps.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/smoothing-out-speed-bumps-in-your-pharmacy-front-end","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Smoothing Out Speed Bumps in Your Pharmacy Front End"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637164895800000000,"title":"smoothing out speed bumps in your pharmacy front end"},{"card":{"key":"8b210f7c-5dc9-43a0-9b25-5b879fa7d37e","authorName":"John Dodd ; Kristy McGowan","authorCompany":"ION Solutions","date":"July 2020","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/lab-tech-in-protective-gear-checks-patient-in-car.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/getting-your-practice-future-ready","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The now normal, part 2: Getting your practice future-ready"},"categories":["financial management","practice management","patient safety"],"segments":["physician practices"],"timestamp":637292289490000000,"title":"the now normal, part 2: getting your practice future-ready"},{"card":{"key":"cd5bb042-84f2-4580-b4e9-aaa4e9b9c0f1","authorName":"Rita Norton","authorCompany":"","date":"March 2022","description":"Developments in potential reform for DIR fees, the pending Medicaid copay assistance benefit rule, and the effects of white bagging legislation. ","img":{"alt":"doctor at computer","src":"-/media/assets/besse/images/general/doctor-financial.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/government-affairs-q-and-a-with-rita-norton","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Q&A: Legislative updates and healthcare advocacy report"},"categories":["practice management","regulatory","advocacy"],"segments":["physician practices"],"timestamp":637824408200000000,"title":"q&a: legislative updates and healthcare advocacy report"},{"card":{"key":"2ea5462f-5d36-4517-ab93-c3dc21502f31","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2020","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/group-physicians-wearing-masks.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-road-ahead-for-community-practices-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: The road ahead for community practices "},"categories":["advocacy","covid-19","practice management"],"segments":["physician practices"],"timestamp":637260480000000000,"title":"roundtable: the road ahead for community practices "},{"card":{"key":"ffbc504a-7e6b-4ff3-9060-4b8a246879ea","authorName":"Scott Bradford","authorCompany":"AmerisourceBergen","date":"August 2020","description":"You can improve your cash flow and add dollars back to your bottom line simply by selecting the appropriate program to handle your unsold pharmaceutical products and then processing your unsaleable pharmaceutical returns on a consistent basis.","img":{"alt":"Someone using a broom to sweep dollar bills into a dust pan","src":"-/media/assets/gnp/images/gnp-insights-recouping-your-losses-on-unsaleable-pharmaceuticals.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/recouping-your-losses-on-unsaleable-pharmaceuticals","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Manage Your Margin: Recouping Your Losses on Unsaleable Pharmaceuticals"},"categories":["in-store experience"],"segments":["pharmacies"],"timestamp":637330130400000000,"title":"manage your margin: recouping your losses on unsaleable pharmaceuticals"},{"card":{"key":"7f7408f1-4301-4417-bd15-ea5608ecff11","authorName":"Tanya Mericle; John Duffy","authorCompany":"AmerisourceBergen","date":"March 2022","description":"Learn how pharmacies can adapt their front end to meet the needs of patients.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacy_curbside.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-create-a-more-community-driven-pharmacy-front-end","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to create a more community-driven pharmacy front end"},"categories":["business performance","covid-19","data","good neighbor pharmacy","in-store experience","marketing"],"segments":["pharmacies"],"timestamp":637823606450000000,"title":"how to create a more community-driven pharmacy front end"},{"card":{"key":"9e793e1f-86fc-4c0c-ae53-ee33534b35b8","authorName":"Christie Smith; Kristy McGowan","authorCompany":"","date":"March 2021","description":"","img":{"alt":"Black female doctor looks at iPad","src":"-/media/assets/besse/images/general/black-female-doctor-looks-at-ipad.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/healthcare-payer-trends-in-2021","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Healthcare payer trends in 2021"},"categories":["affordability","dir fees","reimbursement"],"segments":["physician practices"],"timestamp":637509165180000000,"title":"healthcare payer trends in 2021"},{"card":{"key":"e01b4e88-e1c1-4ff9-8902-aa2dbe81918b","authorName":"David Hardman, MBA 340B ACE; Jason Atlas, RPh, MBA, 340B ACE","authorCompany":"AmerisourceBergen","date":"August 2021","description":"As a pharmacy owner, are you struggling with which parts of your 340B pharmacy services agreement (PSA) to negotiate and/or exclude? You’re not alone. PSAs can vary by both 340B covered entity and third-party administrator (TPA) capabilities, but looking at five key areas can help you navigate your PSA with ease and negotiate the best terms for your pharmacy. ","img":{"alt":"","src":"-/media/assets/amerisourcebergen/pharmacy/gettyimages-1135377678_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/understanding-your-340b-contract-pharmacy-agreement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Understanding your 340B contract pharmacy agreement: Five areas worth negotiating"},"categories":["340b","pharmacy operations"],"segments":["pharmacies"],"timestamp":637659505960000000,"title":"understanding your 340b contract pharmacy agreement: five areas worth negotiating"},{"card":{"key":"561a78d6-8290-433f-b65b-eb192d1c4782","authorName":"Peter Kounelis","authorCompany":"AmerisourceBergen","date":"July 2019","description":"Working together, you and your PSAO can mitigate or avoid PBMs’ bias toward commoditization.","img":{"alt":"Umbrella","src":"-/media/assets/gnp/images/gnp-insights-how-to-respond-to-pharmacy-reimbursement-threats.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-respond-to-pharmacy-reimbursement-threats","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Respond to Pharmacy Reimbursement Threats"},"categories":["managed care"],"segments":["pharmacies"],"timestamp":636979290600000000,"title":"how to respond to pharmacy reimbursement threats"},{"card":{"key":"7c0d490e-43dd-4805-bfd8-eed372275bc3","authorName":"Michael (Mick) Besse; Lisa Harrison","authorCompany":"","date":"July 2020","description":"","img":{"alt":"Masked patient and masked nurse in conversation","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/masked-patient-and-masked-nurse-in-conversation.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-vital-role-of-community-practices-in-delivering-care-through-a-pandemic","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The Vital Role of Community Practices in Delivering Care Through a Pandemic"},"categories":["covid-19","financial management","practice management"],"segments":["physician practices"],"timestamp":637292046120000000,"title":"the vital role of community practices in delivering care through a pandemic"},{"card":{"key":"faa01a65-f954-4716-9ec8-2bbeb45ba2a7","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"The decision to purchase a pharmacy is a big one. Once that decision is made, there are a few key steps to finding the right pharmacy and closing a deal. ","img":{"alt":"Pharmacy Counter Consult","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacycounterconsultrep1116053.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/ready-to-buy","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Ready to Buy? How to Find Your First Pharmacy "},"categories":["pharmacy ownership","pharmacy ownership","financial management","pharmacy operations"],"segments":["pharmacies"],"timestamp":636603670240000000,"title":"ready to buy? how to find your first pharmacy "},{"card":{"key":"bd28dae2-46bf-4035-8528-eb9277e338b4","authorName":"Sasha Juenemann","authorCompany":"Good Neighbor Pharmacy","date":"May 2020","description":"You have many different options on how to promote your pharmacy, but finding a successful balance that suits your community will ensure your current and prospective patients are fully aware of all your store has to offer.","img":{"alt":"A person reviewing a variety of colorful charts set out on a rustic table","src":"-/media/assets/gnp/images/gnp-insights-marketing-budget.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-make-the-most-of-your-pharmacy-marketing-budget","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to Make the Most of Your Pharmacy’s Marketing Budget"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637256012400000000,"title":"how to make the most of your pharmacy’s marketing budget"},{"card":{"key":"5af37440-1afa-4442-af91-5cfd6f9e04b8","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2021","description":"Blue Sky Specialty Pharmacy has found its footing in a hypercompetitive market thanks to a culture that puts people first, from patients and staff to the providers who bring them business.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/blue_sky.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/pulling-a-passion-for-patients-into-specialty-pharmacy-marketing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Pulling a passion for patients into specialty pharmacy marketing"},"categories":["innovation","patient care","our role in healthcare","specialty pharmacy"],"segments":["pharmacies"],"timestamp":637674105880000000,"title":"pulling a passion for patients into specialty pharmacy marketing"},{"card":{"key":"4aab409a-a604-4e77-bbcd-4d4c8fa5fd16","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2020","description":"LTC pharmacies can position themselves to meet growing patient needs by focusing on a few key areas. The time to start is right now.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/pharmacy/product_oral_presc_bottle_005.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/the-growing-ltc-industry","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Infographic: The growing LTC industry"},"categories":["long term care","advocacy","technology"],"segments":["pharmacies"],"timestamp":637290558000000000,"title":"infographic: the growing ltc industry"},{"card":{"key":"975b4591-f713-4697-9dfb-2467e433d362","authorName":"Scott Welle","authorCompany":"AmerisourceBergen","date":"March 2020","description":"Independent pharmacy owners who sell their store for a premium—at the ideal time and on their own terms—are the ones who measure and monitor the health of their business on an ongoing basis and take corrective action where warranted before making a final decision to divest.","img":{"alt":"The months of a calendar blowing in the wind","src":"-/media/assets/gnp/images/gnp-insights-when-is-the-right-time-to-sell-my-pharmacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/when-is-the-right-time-to-sell-my-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"When Is the Right Time to Sell My Pharmacy?"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":637203033600000000,"title":"when is the right time to sell my pharmacy?"},{"card":{"key":"d03b2603-d223-4be4-ad0c-edafa04b762f","authorName":"Jim McCaslin; Tanya Mericle","authorCompany":"AmerisourceBergen","date":"April 2022","description":"As highly accessible and trusted experts on medication usage, independent pharmacies are ideally positioned to positively influence medication adherence. Learn how you can get patients on an adherent path.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/asian-woman-on-smartphone-at-home.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/getting-through-to-non-adherent-patients","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Getting through to non-adherent patients"},"categories":["data","good neighbor pharmacy","medication adherence","patient care","star ratings"],"segments":["pharmacies"],"timestamp":637846911560000000,"title":"getting through to non-adherent patients"},{"card":{"key":"d1265fbc-8e12-4e62-8754-44ef092b65be","authorName":"Alana Vaughn; John Dodd ","authorCompany":"ION Solutions","date":"July 2020","description":"","img":{"alt":"Doctor talking to patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor-talking-to-patient.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/proactive-communications-for-practice-success","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The now normal, part 3: Proactive communications for practice success"},"categories":["marketing","patient safety","practice management"],"segments":["physician practices"],"timestamp":637297220170000000,"title":"the now normal, part 3: proactive communications for practice success"},{"card":{"key":"dc9576a1-77d0-4135-ad89-f94e920d8ce8","authorName":"Good Neighbor Pharmacy","authorCompany":null,"date":"May 2021","description":"Navigating reimbursement for the COVID-19 vaccine doesn't have to feel overwhelming. Good Neighbor Pharmacy offers an overview of the process and tips for submitting claims for COVID-19 vaccine reimbursement.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/covid19/vaccine_magenta-gloves.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/getting-reimbursed-for-the-covid-19-vaccine","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Getting reimbursed for the COVID-19 vaccine: What pharmacies need to know"},"categories":["covid-19","good neighbor pharmacy","immunizations","pharmacy operations","reimbursement"],"segments":["pharmacies"],"timestamp":637562614950000000,"title":"getting reimbursed for the covid-19 vaccine: what pharmacies need to know"},{"card":{"key":"4d2d6881-ad9c-4fd4-b1e5-49bbeff1afb6","authorName":"Brian Nightengale","authorCompany":"AmerisourceBergen","date":"December 2018","description":"The high-touch, high-quality, personalized care independent pharmacies provide creates a unique value proposition in a healthcare market where more chronically ill patients need accessible care. As payers are prioritizing improved patient outcomes and a reduction in overall healthcare costs, they need to also consider new reimbursement models for these pharmacy services, a framework under which independent pharmacies are uniquely positioned to excel. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/delivering-care-beyond-prescriptions-a-marketplace-opportunity-for-independent-pharmacies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Delivering Care Beyond Prescriptions: A Marketplace Opportunity for Independent Pharmacies"},"categories":["good neighbor pharmacy","patient care","reimbursement"],"segments":["pharmacies"],"timestamp":636794522340000000,"title":"delivering care beyond prescriptions: a marketplace opportunity for independent pharmacies"},{"card":{"key":"f426beff-f5d9-4c56-bd59-728c52a4e6a0","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"January 2015","description":"An executive Q&A on how Medication Therapy Management can impact Star Ratings.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/star-ratings-mtm-and-independent-pharmacy","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Star Ratings, MTM and Independent Pharmacy"},"categories":["star ratings","medication therapy management"],"segments":["pharmacies"],"timestamp":635574478200000000,"title":"star ratings, mtm and independent pharmacy"},{"card":{"key":"dd4a54c6-6989-4596-9aef-66be2c70c820","authorName":"Cindy Dunn; Cass Schaedig; Brad Tallamy","authorCompany":"","date":"September 2021","description":"Practices should prepare for reductions to Medicare payments beginning January 1, 2021","img":{"alt":"","src":"-/media/assets/intrinsiq/images/istock-1129810557.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/how-specialty-practices-can-prepare-for-coming-changes-to-reimbursement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How specialty practices can prepare for coming changes to reimbursement"},"categories":["practice management","cash flow management","business performance"],"segments":["physician practices"],"timestamp":637667085610000000,"title":"how specialty practices can prepare for coming changes to reimbursement"},{"card":{"key":"b80129ca-5b97-4916-8ef6-f25926494d08","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2018","description":"Independent pharmacists share what it means to be independent and why independent pharmacy is worth protecting. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/guardians-of-the-pharmacy-vol-2","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Guardians of the Pharmacy Vol. 2"},"categories":["pharmacy ownership","pharmacy ownership"],"segments":["pharmacies"],"timestamp":636554307190000000,"title":"guardians of the pharmacy vol. 2"},{"card":{"key":"916937fb-89c8-4389-a13f-a84dea320a9d","authorName":"Carla Frehn","authorCompany":"AmerisourceBergen ","date":"September 2019","description":"Is it time to evolve your advertising strategy? Find out how traditional advertising stacks up against targeted digital marketing as we explore the effectiveness and cost of broadcast against digital.","img":{"alt":"Infographic comparing targeted digital advertising to traditional broadcast advertising","src":"-/media/assets/gnp/images/gnp-insights-advertising-effectiveness.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/advertising-effectiveness","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Advertising Effectiveness: Targeted Digital vs. Traditional Broadcast"},"categories":["marketing"],"segments":["pharmacies"],"timestamp":637054496400000000,"title":"advertising effectiveness: targeted digital vs. traditional broadcast"},{"card":{"key":"240580cc-fea1-4fbc-a99d-8a2b63fd7998","authorName":"Mark Pilkington, MS, RPh","authorCompany":"AmerisourceBergen","date":"May 2020","description":"A successful partnership between a hospice agency and an independent community pharmacy optimizes care for enrolled patients while opening new pharmacy revenue streams.","img":{"alt":"A female nurse handing medication to a woman laying in a hospital bed","src":"-/media/assets/gnp/images/gnp-insights-pharmacy-hospice-connection.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/the-pharmacy-hospice-connection","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"The Pharmacy Hospice Connection: Delivering Care to the Patients Who Need It Most"},"categories":["managed care"],"segments":["pharmacies"],"timestamp":637263715800000000,"title":"the pharmacy hospice connection: delivering care to the patients who need it most"},{"card":{"key":"fd2a8f26-ca91-4944-b248-737228fbcc2d","authorName":"Michael Amante","authorCompany":"AmerisourceBergen","date":"August 2021","description":"Healthcare distributors must understand the large retail pharmacy to successfully serve these customers and their patients. Learn what to look for in a distribution partner.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_aframe_loading_roanoke_2012_001.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/four-things-large-retail-pharmacies-should-look-for-in-a-distribution-partner","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Four things large retail pharmacies should look for in a distribution partner"},"categories":["business performance","distribution","innovation","inventory management","large retail pharmacy","patient care","pharmacy operations","product access"],"segments":["pharmacies"],"timestamp":637642994420000000,"title":"four things large retail pharmacies should look for in a distribution partner"},{"card":{"key":"1129f1a5-018e-4ae1-a76b-89090e5614dc","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2022","description":"In honor of Women’s History Month, we are highlighting four female pharmacists and sharing their insights about their pharmacy careers.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/women-in-pharmacy/women-in-pharmacy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/celebrating-women-in-pharmacy-march-2022","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Celebrating women in pharmacy"},"categories":["good neighbor pharmacy","pharmacy transformation","pharmacy ownership"],"segments":["pharmacies"],"timestamp":637818348130000000,"title":"celebrating women in pharmacy"},{"card":{"key":"a967e47b-3914-4260-9b6a-b2ef1e5f5e8a","authorName":"Mark Ciarlone, PharmD; Kelley De La Fuente; Don Via","authorCompany":"Good Neighbor Pharmacy","date":"June 2021","description":"Good Neighbor Pharmacy business coaches share real-world ways of making care more accessible and overcoming health disparities at the pharmacy.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/latino-women-smiling-and-laughing-in-mural-alley.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/health-equity-making-personalized-care-accessible-to-minority-groups","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Health equity: Making personalized care accessible to minority groups"},"categories":["covid-19","good neighbor pharmacy","health equity","immunizations","in-store experience","patient care"],"segments":["pharmacies"],"timestamp":637598907290000000,"title":"health equity: making personalized care accessible to minority groups"},{"card":{"key":"85e49dea-4b45-4648-8c02-46ca68ccfc04","authorName":"Michael Amante","authorCompany":"AmerisourceBergen","date":"July 2020","description":"Executive Q&A: What is the role of Strategic Solutions at AmerisourceBergen? Learn how this team helps us cultivate a deep understanding of our pharmacy customers.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_conv_belt_roanoke_020.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/driving-deeper-customer-relationships","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Driving deeper customer relationships"},"categories":["large retail pharmacy","distribution"],"segments":["pharmacies"],"timestamp":637317394770000000,"title":"driving deeper customer relationships"},{"card":{"key":"2d3ab1f3-7d4f-4b46-9c2b-ebf5e4cb20f4","authorName":" Phyllis Houston, MSOL ","authorCompany":"AmerisourceBergen","date":"April 2019","description":"Pharmacists can build stronger patient relationships, increase medication adherence and build lasting brand loyalty by initiating routine phone calls to share information. Done well, an automated outbound communication system can send messages on behalf of the pharmacist in a personal and authentic way. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/three-easily-avoidable-mistakes-pharmacists-make-when-communicating-with-patients","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Three Easily Avoidable Mistakes Pharmacists Make When Communicating with Patients"},"categories":["marketing","good neighbor pharmacy","pharmacy operations","medication adherence"],"segments":["pharmacies"],"timestamp":636897434570000000,"title":"three easily avoidable mistakes pharmacists make when communicating with patients"},{"card":{"key":"05cd4364-2321-4248-99a0-431af1b8f13b","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Why a PSAO should be dedicated to helping independent pharmacies thrive today, while actively advocating for their future.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/pharmacy/gettyimages-1070962948_jpg.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/investing-in-independent-pharmacy","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Executive Q&A: Investing in independent pharmacy"},"categories":["advocacy","business performance","dir fees","good neighbor pharmacy","managed care","reimbursement"],"segments":["pharmacies"],"timestamp":637776044330000000,"title":"executive q&a: investing in independent pharmacy"},{"card":{"key":"4ab4094c-f977-4991-8c3d-ae9c3cdf08ca","authorName":"Mark Pilkington, MS, RPh","authorCompany":"AmerisourceBergen","date":"April 2021","description":"Independent pharmacies may find themselves at a disadvantage when competing against PBMs for hospice business. Learn how a partner like Hospice Pharmacy Connect can put independents on a level playing field.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharmacist-female-pulling-product.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/why-your-direct-hospice-business-might-not-withstand-pbm-poaching","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Why your pharmacy's direct hospice business might not withstand PBM poaching"},"categories":["marketing","patient care","pharmacy operations"],"segments":["pharmacies"],"timestamp":637548061430000000,"title":"why your pharmacy's direct hospice business might not withstand pbm poaching"},{"card":{"key":"2f4da9b4-0527-4c3b-85bf-3261c6014449","authorName":" Phyllis Houston, MSOL ","authorCompany":"AmerisourceBergen","date":"June 2018","description":"Medication adherence matters for pharmacies and patients. Learn how can pharmacies connect with their non-adherent patients and keep them on their medication regimen.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/the-value-of-medication-adherence","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"The Value of Medication Adherence"},"categories":["medication adherence","medication therapy management","good neighbor pharmacy","patient care"],"segments":["pharmacies"],"timestamp":636658853570000000,"title":"the value of medication adherence"},{"card":{"key":"ffd5f740-3924-4b15-ac1c-54787f9a381d","authorName":"David Hardman, MBA 340B ACE; Jason Atlas, RPh, MBA, 340B ACE","authorCompany":"AmerisourceBergen","date":"May 2021","description":"Perhaps you’ve heard of the benefits of 340B from a friend, colleague, or pharmacy association. Maybe you’ve been trying to find a potential 340B partnership. How to become a 340B contract pharmacy is one of the most common questions our 340B Advisory Team receives. And although there isn’t an easy answer, our road map will help you understand whether 340B makes sense for your pharmacy. From there, you can identify, evaluate, and engage with the right covered entity partner. ","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/roadmap_magenta.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/feeling-left-out-of-340b","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Feeling left out of 340B?"},"categories":["340b","pharmacy operations"],"segments":["pharmacies"],"timestamp":637556681950000000,"title":"feeling left out of 340b?"},{"card":{"key":"ca19be24-cc9c-495f-8b68-8bedc0f0e0de","authorName":"George Rafferty","authorCompany":"AmerisourceBergen","date":"August 2020","description":"The Corporate Partnerships team at AmerisourceBergen services 20 of AmerisourceBergen’s largest and most strategic customers, including Express Scripts, Costco, Walgreens, Kaiser Permanente and Humana to name a few. Learn how the team has evolved its strategy and service model to better serve these customers.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/stories/ndcstagingarea117257.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/spotlight-on-the-corporate-partnerships-model","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Spotlight: The corporate partnerships model"},"categories":["large retail pharmacy","covid-19","distribution","our role in healthcare"],"segments":["pharmacies"],"timestamp":637324226160000000,"title":"spotlight: the corporate partnerships model"},{"card":{"key":"9c8355c1-02be-406c-9836-3910c5281910","authorName":"US Bioservices","authorCompany":null,"date":"June 2018","description":"Our experts explain how specialty pharmacy can emerge as the centerpiece of clinically-integrated, patient-centered care that minimizes obstacles and optimizes outcomes.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/why-specialty-pharmacy-is-key-to-collaborative-care","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Physician Practices","headline":"Why Specialty Pharmacy is Key to Collaborative Care"},"categories":["specialty pharmacy","medication adherence","medication therapy management","population health management","readmissions","transitional care"],"segments":["physician practices"],"timestamp":636639813270000000,"title":"why specialty pharmacy is key to collaborative care"},{"card":{"key":"6cbb66a7-250e-4307-a27d-2103f2b7f9a9","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2017","description":"Thinking about retirement? Explore five considerations to preserve the legacy of independent pharmacy for future generations. ","img":{"alt":"Pharmacist superhero flying","src":"-/media/assets/gnp/images/gnp-insights-guardians-of-the-pharmacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/guardians-of-the-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Guardians of the Pharmacy"},"categories":["pharmacy ownership"],"segments":["pharmacies"],"timestamp":636492834000000000,"title":"guardians of the pharmacy"},{"card":{"key":"6b458e14-4f2d-437d-80f0-b33781615328","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2019","description":"Political advocacy can be intimidating, but it doesn’t need to be. Here are a few tips to help you get started. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/eight-impact-making-advocacy-tips-for-pharmacists","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Eight Impact Making Advocacy Tips for Pharmacists"},"categories":["dir fees","legislation","policy","advocacy"],"segments":["pharmacies"],"timestamp":636995926800000000,"title":"eight impact making advocacy tips for pharmacists"},{"card":{"key":"602e5f39-da4b-4dff-aef0-ff7aa58c6bd4","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"January 2018","description":"Learn how immunizations present an opportunity for additional pharmacy revenue and enhanced patient care.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/pharmacy/shutterstock_572712955.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/diversification-through-immunization","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Diversification through Immunization"},"categories":["immunizations"],"segments":["pharmacies"],"timestamp":636519050310000000,"title":"diversification through immunization"},{"card":{"key":"c51ce046-694a-4da2-b6c6-32842b1e9eb2","authorName":"Jim McCaslin","authorCompany":"AmerisourceBergen","date":"December 2016","description":"Ways independent pharmacies can ensure their patients maintain their medication regimens.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/nine-tips-for-medication-adherence","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Nine Tips for Improving Medication Adherence"},"categories":["medication adherence"],"segments":["pharmacies"],"timestamp":636166395000000000,"title":"nine tips for improving medication adherence"},{"card":{"key":"3e7ecb95-0f06-4e13-8f4f-bdcb40e16280","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2018","description":"Take our quiz to find out what superpower lies behind the white coat.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-pharmacy-superhero-are-you-quiz","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"QUIZ: What Pharmacy Superhero Are You?"},"categories":["patient care"],"segments":["pharmacies"],"timestamp":636760702040000000,"title":"quiz: what pharmacy superhero are you?"},{"card":{"key":"1084aad2-f260-4cfd-a9f4-628c42ea2760","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"August 2021","description":"The facts on Medicare Open Enrollment, a helpful guide for pharmacists and their patients. ","img":{"alt":"Pharmacy consultation","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ab-pharmacy-front-consult-1_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/medicare-part-d-open-enrollment","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Medicare Part D open enrollment: What your patients need to know"},"categories":["open enrollment","patient care","good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":637649104800000000,"title":"medicare part d open enrollment: what your patients need to know"},{"card":{"key":"9a44fa8c-5c70-486c-a05c-d3b600bdfdfb","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2018","description":"The Good Neighbor Pharmacy of the Year Award recognizes a pharmacy that exemplifies what it means to be a pillar in their community. Beyond filling prescriptions, they display excellence in patient care, community outreach and innovative pharmacy practice.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/best-practices-from-our-2018-good-neighbor-pharmacy-of-the-year-award-nominees","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Best Practices From our 2018 Good Neighbor Pharmacy of the Year Award Nominees"},"categories":["good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":636664863980000000,"title":"best practices from our 2018 good neighbor pharmacy of the year award nominees"},{"card":{"key":"38bae145-c765-4a4d-90d4-6ee9a32df5a6","authorName":"George Rafferty","authorCompany":"AmerisourceBergen","date":"June 2021","description":"A good healthcare distributor is more than just a middleman. Pharmacies can only dream big if they have a distributor who will dream big with them, embracing and living out a larger purpose and applying that to how they partner with their pharmacy customers. These are a few of the ways in which a distributor should dream big on behalf of its large retail pharmacy customers.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_a-frame_bottles_011.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/five-ways-distributors-should-dream-big-for-pharmacy-partners","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Five ways distributors should dream big for pharmacy partners"},"categories":["covid-19","distribution","health equity","innovation","large retail pharmacy","our role in healthcare","product access"],"segments":["pharmacies"],"timestamp":637587815710000000,"title":"five ways distributors should dream big for pharmacy partners"},{"card":{"key":"8a6e4f7e-f4f7-43ec-97e0-a0a752973de0","authorName":" Phyllis Houston, MSOL ; Gold Eneyo, PharmD","authorCompany":"AmerisourceBergen","date":"March 2022","description":"Offering patient care services can increase your pharmacy's revenue stream and improve your community's health. Here's how to get started.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-pharmacist-with-elderly-female-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/using-unique-patient-care-services-to-drive-traffic-and-outcomes","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Using unique patient care services to drive traffic and outcomes"},"categories":["covid-19","good neighbor pharmacy","immunizations","in-store experience","packaging","patient care"],"segments":["pharmacies"],"timestamp":637829683450000000,"title":"using unique patient care services to drive traffic and outcomes"},{"card":{"key":"f2e6d945-ced9-4c99-bb70-c6f1d8f6c3aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"“We found a model that worked, and it has allowed us to grow rapidly. The impetus was to do what the bigger guys do, but better.”","img":{"alt":"Product injectable","src":"-/media/assets/amerisourcebergen/product/product_injectable_syringes_2011-2012_002.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/specialty-pharmacy-customer-spotlight-encompass-rx","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Specialty Pharmacy Customer Spotlight: Encompass RX"},"categories":["specialty pharmacy"],"segments":["pharmacies"],"timestamp":636513034720000000,"title":"specialty pharmacy customer spotlight: encompass rx"},{"card":{"key":"0a54f46a-53f9-4677-8c12-41741db1725d","authorName":"Marc Johnson","authorCompany":"AmerisourceBergen","date":"August 2020","description":"As essential healthcare providers to the most vulnerable populations, it's critical that long-term care pharmacies have a plan in case an employee tests positive for COVID-19. These five steps will help ensure your LTC pharmacy keeps employees and patients healthy and safe.","img":{"alt":"pharmacist in mask","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ltc-pharmacist-in-mask.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/covid-19-and-long-term-care","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"COVID-19 and long-term care: An action plan for responding to a positive coronavirus test"},"categories":["covid-19","long term care"],"segments":["pharmacies"],"timestamp":637320817220000000,"title":"covid-19 and long-term care: an action plan for responding to a positive coronavirus test"},{"card":{"key":"fcc03d2b-e8f6-4d1a-9126-b10f64eac40a","authorName":"Danny Nelson","authorCompany":"AmerisourceBergen","date":"August 2017","description":"Tips for community pharmacies looking to keep inventory at the optimal level.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/taking-stock-inventory-management-best-practices-for-community-pharmacies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Taking Stock: Inventory Management Best Practices for Community Pharmacies"},"categories":["inventory management"],"segments":["pharmacies"],"timestamp":636396359400000000,"title":"taking stock: inventory management best practices for community pharmacies"},{"card":{"key":"0456511c-eae6-49b5-bfaf-1117766564a8","authorName":"Charlie Le Bon","authorCompany":"AmerisourceBergen","date":"September 2017","description":"How strong is your community pharmacy’s financial picture?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-community-pharmacy-owners-can-avoid-serious-financial-mistakes","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Avoidable Financial Mistakes: A Must Read for Community Pharmacy Owners"},"categories":["financial management","pharmacy operations"],"segments":["pharmacies"],"timestamp":636409186800000000,"title":"avoidable financial mistakes: a must read for community pharmacy owners"},{"card":{"key":"8b7efb49-a57c-436d-bfcd-a6269a67ceae","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2020","description":"Long-term care (LTC) pharmacies have not only been on the front lines of the COVID-19 pandemic, but they're also finding ways to thrive. Liberty Drug in Murray, Utah, is just one example. Owner Jenna Merchant shares how the store opened in the midst of the pandemic and has managed to grow faster than they ever expected.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/libertydrug/ld1.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/ltc-customer-spotlight-liberty-drug","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"LTC customer spotlight: Liberty Drug"},"categories":["long term care"],"segments":["pharmacies"],"timestamp":637340691700000000,"title":"ltc customer spotlight: liberty drug"},{"card":{"key":"a37f200a-24c8-4fcb-a862-a796d0974fa0","authorName":"Jeff Puetz","authorCompany":"Good Neighbor Pharmacy","date":"August 2021","description":"Building a profitable independent pharmacy practice in today's environment goes well beyond ramping up your prescription volume. Learn how to mitigate declining reimbursement by diversifying your pharmacy business.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-pharmacist-with-elderly-female-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/translating-business-diversification-into-dollar-signs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Translating business diversification into dollar signs"},"categories":["business performance","covid-19","good neighbor pharmacy","in-store experience","marketing","medication adherence","patient care"],"segments":["pharmacies"],"timestamp":637636940850000000,"title":"translating business diversification into dollar signs"},{"card":{"key":"bfa9efcf-5805-4020-9b35-ef78c929deb4","authorName":"Gold Eneyo, PharmD; Phyllis Houston, MSOL ; Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"March 2022","description":"Innovative PSAOs are helping independent pharmacies evolve for the future, allowing them to compete and thrive in a dynamic market. Here's how.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1077578340.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/5-benefits-of-an-innovative-psao","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Five benefits of an innovative PSAO"},"categories":["business performance","dir fees","good neighbor pharmacy","immunizations","innovation","pharmacy operations","reimbursement"],"segments":["pharmacies"],"timestamp":637841751850000000,"title":"five benefits of an innovative psao"},{"card":{"key":"9996b3c1-130e-4ba5-8f51-3912889e1596","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2018","description":"By promoting health and wellness, pharmacists play a crucial role in their communities. Explore three examples of how pharmacists can positively impact the lives of the people they serve.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/promoting-health-and-wellness-in-the-community","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Promoting Health and Wellness in the Community"},"categories":["patient care","good neighbor pharmacy"],"segments":["pharmacies"],"timestamp":636657231540000000,"title":"promoting health and wellness in the community"},{"card":{"key":"7ffc3914-b3e0-4fde-a86b-8a67c6589247","authorName":"Tanya Mericle","authorCompany":"AmerisourceBergen","date":"June 2018","description":"When it comes to diabetes care, community pharmacies have an opportunity to be the leading resource for patients. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/caring-for-the-patient-with-diabetes","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Caring for the Patient with Diabetes"},"categories":["good neighbor pharmacy","patient care","medication adherence","medication therapy management","in-store experience"],"segments":["pharmacies"],"timestamp":636656249180000000,"title":"caring for the patient with diabetes"},{"card":{"key":"9b32de53-bbb4-46b4-8fb2-1d105ac662e3","authorName":"Marc Johnson","authorCompany":"AmerisourceBergen","date":"April 2020","description":"Technology can save time and encourage more efficient relationships and workflows. Consider these priorities when investing in a high-tech solution for your LTC pharmacy.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/oralpillsblisterpackloading11160003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/should-technology-be-a-priority-for-your-ltc-pharmacy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Should Technology Be a Priority for Your LTC Pharmacy?"},"categories":["long term care","technology"],"segments":["pharmacies"],"timestamp":637224772200000000,"title":"should technology be a priority for your ltc pharmacy?"},{"card":{"key":"9f2b612a-15fc-4942-a48a-6de3421547d1","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"Access to experienced coaches who offer innovative ideas for solving pharmacy challenges is the hallmark of Good Neighbor Pharmacy business coaching. Learn about some of the expert guidance a few of our business coaches have provided pharmacies. ","img":{"alt":"","src":"-/media/assets/amerisourcebergen/pharmacy/ip_frontstore_pharm_abcrep_003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/insights-from-our-business-coaches","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Pharmacies","headline":"Expert Guidance: A Spotlight on Business Coaches"},"categories":["good neighbor pharmacy","pharmacy operations","in-store experience","pharmacy ownership","inventory management"],"segments":["pharmacies"],"timestamp":636510289120000000,"title":"expert guidance: a spotlight on business coaches"},{"card":{"key":"40d0064c-d696-4fff-9777-3cf224d1cca8","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/adobestock_336406836.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/minimizing-the-impact-of-covid-19-on-practice-operations-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: Minimizing the impact of COVID-19 on practice operations "},"categories":["advocacy","covid-19","practice management"],"segments":["physician practices"],"timestamp":637236852600000000,"title":"roundtable: minimizing the impact of covid-19 on practice operations "},{"card":{"key":"0ffe5aff-d981-486e-93bf-37f1a05ca392","authorName":"Featured article","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"","src":"-/media/assets/intrinsiq/images/istock-1166115050.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/how-covid-19-is-altering-telehealth","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How COVID-19 is Altering Telehealth"},"categories":["managed care","patient care","practice management","regulatory"],"segments":["physician practices"],"timestamp":637214339940000000,"title":"how covid-19 is altering telehealth"},{"card":{"key":"a572bacb-fc0c-4432-823a-e465af81c19e","authorName":"Tim Navin","authorCompany":"","date":"April 2021","description":"Pre-ordering is a critical component of the flu distribution model. A phased approach sends product to as many sites of care as possible early in the flu season so they can start to vaccinate patients.","img":{"alt":"Woman getting vaccine","src":"-/media/assets/besse/images/general/woman-getting-vaccine.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/supporting-flu-vaccine-access","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Supporting flu vaccine access"},"categories":["distribution","immunizations"],"segments":["physician practices"],"timestamp":637552139420000000,"title":"supporting flu vaccine access"},{"card":{"key":"2ec09251-1b6f-4f89-a70d-d2db9fb794b4","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"Doctor looking at iPad","src":"-/media/assets/intrinsiq/images/istock-1035963640_crop.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/working-together-in-response-to-covid-19-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: Working together in response to COVID-19"},"categories":["covid-19","practice management","advocacy"],"segments":["physician practices"],"timestamp":637213824000000000,"title":"roundtable: working together in response to covid-19"},{"card":{"key":"ba76dd46-c502-4a79-a1f9-2a2378efefb5","authorName":"Rita Norton","authorCompany":"","date":"June 2022","description":"","img":{"alt":"doctors with ipad","src":"-/media/assets/besse/images/general/docs-ipad-thumb.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/q-and-a-with-the-amerisourcebergen-office-of-government-affairs-and-public-policy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Q&A with the AmerisourceBergen Office of Government Affairs and Public Policy (AB GA&P)"},"categories":[],"segments":["physician practices"],"timestamp":637904623510000000,"title":"q&a with the amerisourcebergen office of government affairs and public policy (ab ga&p)"},{"card":{"key":"00ba62fe-a060-46c1-89a8-20511ce9434d","authorName":"Rita Norton","authorCompany":"","date":"December 2021","description":"Specialty physician practices are facing up to a 9.75 percent cut in their Medicare reimbursement next year.","img":{"alt":"Consultant and doctor with tablet computer","src":"-/media/assets/besse/images/general/consultant-tablet-doctor.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-dangers-of-pending-medicare-cuts-and-what-practices-can-expect-in-2022","linkText":"Read the Q&A","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Q&A: The dangers of pending Medicare cuts and what practices can expect in 2022"},"categories":[],"segments":["physician practices"],"timestamp":637744698000000000,"title":"q&a: the dangers of pending medicare cuts and what practices can expect in 2022"},{"card":{"key":"460fec10-62ab-494f-ba01-46e77826eac2","authorName":"Alana Vaughn","authorCompany":"ION Solutions","date":"November 2016","description":"Like a slowly dripping faucet or an improperly insulated window, gaps and inefficiencies in a business allow profits to seep out over time. Even one leak—while seemingly small—can have damaging effects on a company’s financial health. Oncology practices are no different.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/physician-practices/plugging-profit-leaks","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Physician Practices","headline":"Plugging Profit Leaks"},"categories":["financial management","practice management","reimbursement","oncology"],"segments":["physician practices"],"timestamp":636137974200000000,"title":"plugging profit leaks"},{"card":{"key":"05fdaac1-af1b-4194-a5d4-52976b3f52c2","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2020","description":"","img":{"alt":"","src":"-/media/assets/intrinsiq/images/istock-1072311118.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-importance-of-marketing-and-communications-for-community-practices","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: The importance of marketing and communications for community practices"},"categories":["covid-19","marketing","practice management"],"segments":["physician practices"],"timestamp":637280352000000000,"title":"roundtable: the importance of marketing and communications for community practices"},{"card":{"key":"540260ea-a4cc-4cb0-954c-9f5aeb2a704e","authorName":"IntrinsiQ Specialty Solutions","authorCompany":"","date":"August 2020","description":"","img":{"alt":"Doctor looks at laptop and takes notes","src":"-/media/assets/intrinsiq/images/istock-996290796.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/billing-and-payer-reimbursement-for-telemedicine","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How to thrive with telemedicine"},"categories":["covid-19","technology","reimbursement"],"segments":["physician practices"],"timestamp":637327512000000000,"title":"how to thrive with telemedicine"},{"card":{"key":"dd833902-075a-4621-8862-a03009c4971d","authorName":"Sean McGowan","authorCompany":"AmerisourceBergen","date":"December 2021","description":"Answering specialty physicians basic questions about this drug class","img":{"alt":"woman infusion","src":"-/media/assets/besse/images/general/infusion-woman.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/seven-questions-about-biosimilars","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Seven questions about biosimilars"},"categories":[],"segments":["physician practices"],"timestamp":637744710000000000,"title":"seven questions about biosimilars"},{"card":{"key":"7fa42280-7a9c-4e62-a231-9ef3eff74eec","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2020","description":"","img":{"alt":"Doctor on video call with colleagues","src":"-/media/assets/intrinsiq/images/iqss_blog_commpract.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/practice-innovations-in-covid","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"How Community and Specialty Physician Practices Are Confronting COVID-19 Challenges"},"categories":["covid-19","distribution","practice management"],"segments":["physician practices"],"timestamp":637275790620000000,"title":"how community and specialty physician practices are confronting covid-19 challenges"},{"card":{"key":"6124a682-764e-4bce-a0af-43767bedf5ad","authorName":"Rick Lozano and Susan Weidner; Susan Weidner","authorCompany":"","date":"June 2020","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/masked-healthcare-professional-watching-computer.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/data-analysis-for-smart-business-decisions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"The now normal, part 1: Data analysis for smart business decisions"},"categories":["analytics","practice management","practice data"],"segments":["physician practices"],"timestamp":637284509520000000,"title":"the now normal, part 1: data analysis for smart business decisions"},{"card":{"key":"159d1988-8b0b-44b9-bb7c-f297058c745a","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2016","description":"New England Cancer Specialists demonstrates why staying the same simply isn't an option when it comes to cancer care.","img":{"alt":"Female patient with Doctor","src":"-/media/assets/amerisourcebergen/patient-care_physicians/examconsultdrmpatientf1116010.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-metamorphosis-of-a-community-oncology-practice","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Physician Practices","headline":"The Metamorphosis of a Community Oncology Practice"},"categories":["practice management","oncology"],"segments":["physician practices"],"timestamp":636132761400000000,"title":"the metamorphosis of a community oncology practice"},{"card":{"key":"e77bfc68-4d30-4cb1-9201-5e0d1afe8add","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2020","description":"","img":{"alt":"","src":"-/media/assets/intrinsiq/images/istock-995485400blur.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/cybersecurity-and-working-virtually-during-the-pandemic","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Cybersecurity and Working Virtually During the Pandemic"},"categories":["technology","regulatory"],"segments":["physician practices"],"timestamp":637208506800000000,"title":"cybersecurity and working virtually during the pandemic"},{"card":{"key":"70d5ca1e-6301-4427-9166-e81604d23250","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2020","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/virtual-training_female.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/the-early-impact-of-covid-19-on-community-practices","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Roundtable: The early impact of COVID-19 on community practices"},"categories":["covid-19","patient care","practice management"],"segments":["physician practices"],"timestamp":637315546560000000,"title":"roundtable: the early impact of covid-19 on community practices"},{"card":{"key":"f0c4d727-a284-4620-99df-358d0e381659","authorName":"Featured article","authorCompany":null,"date":"April 2020","description":"","img":{"alt":"","src":"-/media/assets/intrinsiq/images/iqss_blog_practicetips.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/tips-for-practices-to-keep-patients-and-staff-healthy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Tips for Practices to Keep Patients and Staff Healthy"},"categories":["covid-19","patient safety","practice management"],"segments":["physician practices"],"timestamp":637218033180000000,"title":"tips for practices to keep patients and staff healthy"},{"card":{"key":"002d41d3-eced-445a-91d1-2c107c3d238d","authorName":"Lisa Harrison","authorCompany":"","date":"June 2022","description":"","img":{"alt":"doctor with patient","src":"-/media/assets/besse/images/what-matters-patient-doc.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/what-matters-series-volume-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Evolving with our customers: Putting patients first through specialty distribution"},"categories":[],"segments":["physician practices"],"timestamp":637904656040000000,"title":"evolving with our customers: putting patients first through specialty distribution"},{"card":{"key":"5671e462-f97a-4f5c-8036-374ac2b9ddb0","authorName":"Besse Medical","authorCompany":"","date":"June 2021","description":"Picking a medication delivery platform that easily integrates with other technologies allows you to streamline inventory processes while improving both the provider and the patient experience.","img":{"alt":"","src":"-/media/assets/intrinsiq/images/istock-1069859094.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/streamline-the-infusion-inventory-process-with-technology","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Streamline the infusion inventory process with technology"},"categories":["practice management","technology","inventory management"],"segments":["physician practices"],"timestamp":637592811000000000,"title":"streamline the infusion inventory process with technology"},{"card":{"key":"cadff82a-6dab-41ff-9a4f-cf27f05a8f69","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"IntrinsiQ Specialty Solutions COVID19 Virtual Roundtable Resources and Webinar recordings","img":{"alt":"","src":"-/media/assets/intrinsiq/images/covid-19-virtual-round-table-carousel_iqss.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/covid-19-roundtable","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"COVID-19 Resources"},"categories":["covid-19","patient care","practice management","regulatory"],"segments":["physician practices"],"timestamp":637238594810000000,"title":"covid-19 resources"},{"card":{"key":"6a2c6d81-3bf7-47bc-8563-4dc5dbe800d0","authorName":"Jennifer Sherak","authorCompany":"","date":"December 2021","description":"Our reach into all facets of the healthcare industry means AmerisourceBergen can rely on collective resources to meet the goal of narrowing cancer care disparities.","img":{"alt":"Elderly Black man with community oncology doctor","src":"-/media/assets/ion/images/elderly-black-man-with-doctor.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/community-oncology-practices-build-more-equitable-access-and-outcomes","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Physician Practices","headline":"Community oncology practices build more equitable access and outcomes"},"categories":[],"segments":["physician practices"],"timestamp":637744662000000000,"title":"community oncology practices build more equitable access and outcomes"},{"card":{"key":"041a8277-66aa-4b3d-aeff-131dbaddfc28","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2019","description":"When it comes to unit dose packaging, is it time for health systems to re-evaluate how they acquire UD products? Is it more efficient to outsource or repackage in house? AHP goes beyond cost per dose to help health systems evaluate every option.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/rethink-unit-dose-product-acquisition","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Rethink: Unit Dose Product Acquisition"},"categories":["packaging","pharmacy operations"],"segments":["health systems"],"timestamp":636843877760000000,"title":"rethink: unit dose product acquisition"},{"card":{"key":"3146d057-943c-4371-ae3b-3e962bdd412e","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2018","description":"Explore what is in store for the future of ambulatory pharmacy. Download the Ambulatory Pharmacy Outlook for Health Systems 2018 report to discover opportunities for health system leaders to fully leverage ambulatory pharmacy to improve revenue and enhance the patient experience. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/ambulatory-pharmacy-outlook","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Ambulatory Pharmacy Outlook for Health Systems 2018"},"categories":["ambulatory pharmacy"],"segments":["health systems"],"timestamp":636791815400000000,"title":"ambulatory pharmacy outlook for health systems 2018"},{"card":{"key":"6699d19a-2d57-43fb-b260-2ab567799c96","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"Matt Wolf, Group Vice President, Consulting Practice at Pharmacy Healthcare Solutions, shares how pharmacy can help the health system generate revenue and contain costs.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/leveraging-the-health-system-pharmacy-as-a-strategic-asset","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Leveraging the Health System Pharmacy as a Strategic Asset"},"categories":[],"segments":["health systems"],"timestamp":636590743200000000,"title":"leveraging the health system pharmacy as a strategic asset"},{"card":{"key":"8039bfa8-68c9-4b9e-8bf4-266d2c2922d7","authorName":"Kristin Chambers","authorCompany":"AmerisourceBergen","date":"April 2018","description":"What challenges does the increased demand for care coordination create for health system specialty pharmacies and what opportunities does it present for demonstrating value?
","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/caring-for-the-whole-patient","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Caring for the Whole Patient"},"categories":["specialty pharmacy","patient care","oncology"],"segments":["health systems","manufacturers"],"timestamp":636591383130000000,"title":"caring for the whole patient"},{"card":{"key":"7894ff79-fd0e-4a11-822b-ba7ad057185f","authorName":"Darin Thornburgh","authorCompany":"AmerisourceBergen","date":"March 2020","description":"The end of 2019 brought new guidelines for the handling of hazardous drugs under the USP <800> ruling. What do health systems and hospitals need to know about changes to the ordering and distribution of hazardous drugs? What do health systems need to know about changes to the ordering and distribution of hazardous drugs?","img":{"alt":"Pharmacist looks at medication. ","src":"-/media/assets/phs/images/pharmacy/hs_ippharm_rec_area_totes_fms_013.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/health-systems/usp-800-compliance","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Health Systems","headline":"Partnering With Your Distributor for USP 800 Compliance"},"categories":["patient safety","regulatory"],"segments":["health systems"],"timestamp":637195508520000000,"title":"partnering with your distributor for usp 800 compliance"},{"card":{"key":"7c249967-0a7c-4fee-8466-164a161e20da","authorName":"Kevin Ban; Jenni Zilka","authorCompany":"","date":"June 2022","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/patients-lose-if-we-dont-continue-to-expand-pharmacy-based-clinical-care-in-the-us","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"Patients lose if we don't continue to expand pharmacy-based clinical care in the U.S."},"categories":["good neighbor pharmacy","patient care","regulatory"],"segments":[],"timestamp":637902139980000000,"title":"patients lose if we don't continue to expand pharmacy-based clinical care in the u.s."},{"card":{"key":"daeaaab1-ca23-4b36-87c8-f9077be13650","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2021","description":"In an industry that seems designed to lock the little guy out, Blue Sky Specialty Pharmacy is thriving. One thing we love about this small specialty pharmacy is the leadership team’s ability to think big, whether they’re confronting the challenges of today’s healthcare environment or preparing for tomorrow. For their partnership with AmerisourceBergen, that means the Blue Sky team is nimble and ready to get creative when it comes to trying new solutions and exploring new ideas together.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/blue_sky.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/customer-spotlight-blue-sky-part-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Customer spotlight: Blue Sky Specialty Pharmacy, Part 1 "},"categories":["innovation","our role in healthcare","patient care","product access","specialty pharmacy","technology"],"segments":["pharmacies","manufacturers"],"timestamp":637590294000000000,"title":"customer spotlight: blue sky specialty pharmacy, part 1 "},{"card":{"key":"cf126efe-a880-4efe-86b2-7a2239eb1b16","authorName":"Kristin Chambers","authorCompany":"AmerisourceBergen","date":"April 2018","description":"How drug manufacturers, health systems and payers can collaborate more closely in the new world of patient-centered care.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/upping-the-game","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Upping the Game"},"categories":["patient care","transitional care","readmissions","product access"],"segments":["manufacturers"],"timestamp":636592288840000000,"title":"upping the game"},{"card":{"key":"402b4c81-d5dd-431c-8e20-6232985db6ea","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2021","description":"In an industry that seems designed to lock the little guy out, Blue Sky Specialty Pharmacy is thriving. One thing we love about this small specialty pharmacy is the leadership team’s ability to think big, whether they’re confronting the challenges of today’s healthcare environment or preparing for tomorrow. For their partnership with AmerisourceBergen, that means the Blue Sky team is nimble and ready to get creative when it comes to trying new solutions and exploring new ideas together.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/blue-sky-thumbs-up-trans.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/customer-spotlight-blue-sky-part-2","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Customer spotlight: Blue Sky Specialty Pharmacy, Part 2"},"categories":["innovation","our role in healthcare","patient care","product access","specialty pharmacy","technology"],"segments":["pharmacies","manufacturers"],"timestamp":637590294000000000,"title":"customer spotlight: blue sky specialty pharmacy, part 2"},{"card":{"key":"354a7528-9d2d-4749-9ba8-33e000d876fe","authorName":"Brian McMillan","authorCompany":" American Health Packaging","date":"May 2018","description":"While suppliers are making fewer pre-packaged unit dose treatments available, health system pharmacies still have options for acquiring them. Learn which is best.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/commercially-available-unit-dose-products","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Commercially Available Unit Dose Products: Enhancing Access to Treatments and Promoting Pharmacy Efficiency"},"categories":["packaging","patient care","pharmaceutical storage and transport management","pharmacy operations","product access","distribution"],"segments":["health systems"],"timestamp":636626991940000000,"title":"commercially available unit dose products: enhancing access to treatments and promoting pharmacy efficiency"},{"card":{"key":"57f8a759-6b27-4e1a-9d1c-47f3291de717","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"October 2021","description":"Does your PSAO prioritize you (and not just prescription volume)? How can you tell? Learn the three priorities of the right partner.","img":{"alt":"Pharmacist examining a pill bottle behind the pharmacy counter","src":"-/media/assets/gnp/images/gnp-elevate-pha.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-the-right-psao-protects-patient-access-and-pharmacy-viability","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How the right PSAO protects patient access and pharmacy viability"},"categories":["advocacy","business performance","cash flow management","dir fees","good neighbor pharmacy","managed care","our role in healthcare","product access"],"segments":["pharmacies"],"timestamp":637704390100000000,"title":"how the right psao protects patient access and pharmacy viability"},{"card":{"key":"3f858da9-d985-40f4-a77e-e78adf50a56f","authorName":"Carla Frehn","authorCompany":"AmerisourceBergen ","date":"March 2019","description":"Google is the first place people go when they want to find a pharmacy, so it’s absolutely vital to have a robust Google listing with up-to-date business , but having a great listing isn’t enough though. Learn what an independent pharmacy needs to do to ensure their business appears in the search results.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/pharmacies/convert-from-search-turn-online-traffic-into-foot-traffic","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Pharmacies","headline":"Convert from Search: Turn Online Traffic into Foot Traffic"},"categories":["marketing","good neighbor pharmacy","pharmacy operations"],"segments":["pharmacies"],"timestamp":636892954430000000,"title":"convert from search: turn online traffic into foot traffic"},{"card":{"key":"ad844a5b-3939-41b0-8750-37624c92e753","authorName":"Xcenda","authorCompany":null,"date":"October 2020","description":"","img":{"alt":"Republican Democrat Healthcare","src":"-/media/assets/xcenda/english/images/insights/rep_dem_election_healthcare.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/lets-ditch-2020-and-plan-for-2021-election-what-ifs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Let's Ditch 2020 and Plan for 2021: Election What-Ifs"},"categories":["legislation","managed care","policy","regulatory"],"segments":[],"timestamp":637390602000000000,"title":"let's ditch 2020 and plan for 2021: election what-ifs"},{"card":{"key":"3bfa83be-96cb-4b5e-8743-cbde9ba04ce8","authorName":"Amanda Riedell","authorCompany":"","date":"June 2022","description":"The SUPPORT for Patients and Communities Act, passed in 2018 to help combat the nationwide opioid crisis, originally mandated that Medicare Part D prescribers use electronic prescribing for controlled substances (EPCS) technology by Jan. 1 ,2021. ","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/worldcourier_2_3-card-05-min.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/e-prescribing-ramps-up-through-federal-and-state-mandates","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"E-prescribing ramps up through federal and state mandates"},"categories":["pharmacy operations","pharmacy ownership","patient care"],"segments":["pharmacies"],"timestamp":637920100190000000,"title":"e-prescribing ramps up through federal and state mandates"},{"card":{"key":"15bb7713-2d53-4a3a-a332-a02bebe72f10","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"Partnership spotlight: How OrderInsite and AmerisourceBergen are making inventory management easier for pharmacies","img":{"alt":"Pharmacist stocking bottles","src":"-/media/assets/amerisourcebergen/pharmacy/ip_backstore_pharm_stock_bottles_002.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/making-inventory-management-easier-for-pharmacies","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Partnership spotlight: How OrderInsite and AmerisourceBergen are making inventory management easier for pharmacies"},"categories":[],"segments":["pharmacies"],"timestamp":637876842000000000,"title":"partnership spotlight: how orderinsite and amerisourcebergen are making inventory management easier for pharmacies"},{"card":{"key":"83bdba9f-0032-4b04-b50c-5b6a7183f6e7","authorName":"David Hardman, MBA 340B ACE; Jason Atlas, RPh, MBA, 340B ACE","authorCompany":"AmerisourceBergen","date":"August 2022","description":"In an effort to accurately exclude 340B claims from commercial rebate collection, Pharmacy Benefit Managers (PBMs) are requiring mandatory identification of 340B dispenses. Let’s review a pharmacy’s billing requirements, (the different) claim identification approaches, potential PBM usage of data, and newly proposed state legislation to combat PBM efforts.","img":{"alt":"Doctor on computer","src":"-/media/assets/worldcourier/english/images/gettyimages-875949032_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/what-you-need-to-know-about-adjudicating-340b-claims","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"What you need to know about adjudicating 340B claims"},"categories":["340b","pharmacy operations"],"segments":["pharmacies"],"timestamp":637967808070000000,"title":"what you need to know about adjudicating 340b claims"},{"card":{"key":"3d3ee039-cc5c-40b4-b9d1-e93ebf6d3355","authorName":"Peter Kounelis; Beth Lea; Shaun Henry; Tracy Armstrong","authorCompany":"AmerisourceBergen","date":"August 2022","description":"","img":{"alt":"Cropped shot of a pharmacist using a digital tablet in a chemist","src":"-/media/assets/gnp/images/gettyimages-1135377819_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/elevate-provider-network-fights-to-prohibit-ger-ber-and-dir-recoupments","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Elevate Provider Network fights to prohibit GER, BER, and DIR Recoupments"},"categories":["business performance","cash flow management","dir fees","financial management","good neighbor pharmacy","managed care","reimbursement"],"segments":[],"timestamp":637969481290000000,"title":"elevate provider network fights to prohibit ger, ber, and dir recoupments"},{"card":{"key":"9a98a510-37e6-46be-a9ad-24dee2443564","authorName":"Mark Pilkington, MS, RPh","authorCompany":"AmerisourceBergen","date":"May 2022","description":"How pharmacies can make medication disposal easy for their communities","img":{"alt":"How to properly dispose of medication","src":"-/media/assets/amerisourcebergen/pharmacy/pharmacy_backofstore.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/how-to-properly-dispose-of-medication","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How to properly dispose of medication"},"categories":["pharmacy ownership","pharmacy operations"],"segments":["pharmacies"],"timestamp":637874220120000000,"title":"how to properly dispose of medication"},{"card":{"key":"19405f9c-501d-485c-a2a9-3d813760144b","authorName":"Jordan Cupo","authorCompany":"Good Neighbor Pharmacy","date":"May 2022","description":"Improving your search ranking will drive additional customers to your pharmacy and help boost your bottom line.","img":{"alt":"An older male pharmacist educating a younger female pharmacist while holding up a pill bottle","src":"-/media/assets/gnp/images/gnp-insights-preserving-the-legacy.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/tips-for-ranking-higher-on-google","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"How can independent pharmacies rank higher in Google search?"},"categories":["marketing","pharmacy operations","good neighbor pharmacy"],"segments":[],"timestamp":637872648200000000,"title":"how can independent pharmacies rank higher in google search?"},{"card":{"key":"7767e356-3d32-4877-a1db-c9b30e007843","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2019","description":"Explore what is in store for the future of ambulatory pharmacy. Download the Ambulatory Pharmacy Outlook for Health Systems 2019 report to discover opportunities for health system leaders to fully leverage ambulatory pharmacy to improve revenue and enhance the patient experience. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/health-systems/ambulatory-pharmacy-outlook-2019","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Ambulatory Pharmacy Outlook for Health Systems 2019"},"categories":["ambulatory pharmacy"],"segments":["health systems"],"timestamp":637108632000000000,"title":"ambulatory pharmacy outlook for health systems 2019"},{"card":{"key":"e292b7e8-9dbf-41a8-a0bc-c740e65c4e7e","authorName":"AmerisourceBergen","authorCompany":"","date":"October 2022","description":"An indicator of a rapidly changing healthcare landscape, innovative payer-manufacturer contracts aim to reduce costs while improving outcomes amid a crowded market of emerging and perceivably unproven therapies.","img":{"alt":"vaccines on top of US dollars","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-summer-2021/htaq_vaccines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improve-outcomes-and-reduce-costs-for-emerging-therapies","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Improve outcomes and reduce costs for emerging therapies"},"categories":["affordability","reimbursement","value-based care"],"segments":["manufacturers"],"timestamp":638006776060000000,"title":"improve outcomes and reduce costs for emerging therapies"},{"card":{"key":"2c705a80-78f4-44aa-b369-39cb1fc7e9e5","authorName":"Christie Smith","authorCompany":"","date":"September 2022","description":"Introducing the potential benefits of an integrated oncolytic dispensing model. ","img":{"alt":"Doctors examining notes","src":"-/media/assets/oncologysupply/images/general/doctors-examining-notes.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/clinically-integrated-oncolytic-dispensing","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Clinically integrated oncolytic dispensing: The next frontier in cancer care "},"categories":["oncology","specialty pharmacy","patient care"],"segments":[],"timestamp":637987169130000000,"title":"clinically integrated oncolytic dispensing: the next frontier in cancer care "},{"card":{"key":"88d3dc3c-43a4-4436-8387-a5a40e89f3c5","authorName":"Amanda OHora","authorCompany":"","date":"July 2022","description":"Cell and gene-based therapies (CGTs) have captured our imagination for their potential to cure disease after a single course of therapy but have also raised eyebrows for their astronomical price tags.","img":{"alt":"Business meeting","src":"-/media/assets/gnp/images/01-home-page-new-images/home-page-service-images/business-meeting.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/navigating-reimbursement-and-access-challenges-for-novel-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Navigating reimbursement and access challenges for novel cell and gene therapies"},"categories":["cell and gene therapy","reimbursement"],"segments":["manufacturers"],"timestamp":637934028190000000,"title":"navigating reimbursement and access challenges for novel cell and gene therapies"},{"card":{"key":"b30dbf63-9cea-41c5-8bf7-781b9df3bb8b","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2020","description":"Manufacturers today have more options than ever for electronic benefit verification. What type of eBV solution is best for you?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-evaluate-an-ebv-product","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Insight","headline":"How to Evaluate an eBV Product"},"categories":[],"segments":[],"timestamp":637142249930000000,"title":"how to evaluate an ebv product"},{"card":{"key":"581d0467-58c2-4de5-b1db-dd2531218399","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2019","description":"100+ physicians shared their perspectives on biosimilar utilization, cost and barriers to adoption in a recent survey. Get a quick glimpse at the results in this infographic.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/biosims_micro.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/infographic-physician-perspectives-on-biosimilars","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Infographic: Physician Perspectives on Biosimilars"},"categories":["biosimilars","commercialization"],"segments":["manufacturers","physician practices"],"timestamp":637123686110000000,"title":"infographic: physician perspectives on biosimilars"},{"card":{"key":"77c0e470-59fa-4097-8511-b3f898aa5156","authorName":"Xcenda","authorCompany":null,"date":"March 2022","description":"","img":{"alt":"","src":"-/media/assets/xcenda/english/images/insights/debunking-pie-misperceptions.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/debunking-common-pie-misperceptions-webinar","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar: Debunking common PIE misperceptions to enhance your PIE strategy and tactics"},"categories":["regulatory","market access","policy","product access"],"segments":[],"timestamp":637836457980000000,"title":"webinar: debunking common pie misperceptions to enhance your pie strategy and tactics"},{"card":{"key":"c18c730e-2076-43ad-b58c-5f62e4e87608","authorName":"Xcenda","authorCompany":null,"date":"September 2020","description":"What information do payers want from pharma? How can manufacturers deliver it in today's virtual world?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pie.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/is-your-pie-incomplete","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Is your PIE incomplete?"},"categories":["commercialization","data","market access"],"segments":["manufacturers"],"timestamp":637358705760000000,"title":"is your pie incomplete?"},{"card":{"key":"5cf45b48-7220-42ea-9cf6-f1560cc0e60e","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2019","description":"Behind every successful patient medication adherence program is a team of experts who work toward one goal: helping the patient start and stay on prescribed therapy. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/lash-group-tech-enabled-webinar","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"Webinar: Achieve Better Patient Outcomes with Clinically Supported, Tech-Enabled Adherence Programs"},"categories":[],"segments":[],"timestamp":637026873000000000,"title":"webinar: achieve better patient outcomes with clinically supported, tech-enabled adherence programs"},{"card":{"key":"32e3ba6c-24f6-4c62-86b0-799781bd2216","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Download our latest infographic that outlines the latest on copay accumulators, the industry action, and what steps you can take now to prepare for 2023. ","img":{"alt":"Hand giving copay card to pharmacist","src":"-/media/assets/xcenda/english/images/insights/copay_pharmacy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/preparing-for-2023-piloting-copay-assistance-through-strong-headwinds","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Preparing for 2023: piloting copay assistance through strong headwinds"},"categories":[],"segments":[],"timestamp":637782143230000000,"title":"preparing for 2023: piloting copay assistance through strong headwinds"},{"card":{"key":"d6510267-35cc-45a4-82ce-ca7967547fb5","authorName":"Rich Tremonte","authorCompany":"AmerisourceBergen","date":"August 2017","description":"Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.
","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improving-customer-experience-and-driving-long-term-value-for-manufacturers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Improving Customer Experience and Driving Long-Term Value for Manufacturers"},"categories":["biosimilars","distribution"],"segments":["manufacturers"],"timestamp":636384237600000000,"title":"improving customer experience and driving long-term value for manufacturers"},{"card":{"key":"1843cdbd-5a30-4956-b28c-f39b97052138","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"","img":{"alt":"medication ","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/ab_2_3_card_01.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/hub-spp-2021-webinar-optimize-program-performance","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar: How to continuously optimize program performance: Using innovation to solve for change"},"categories":["patient support services","innovation","technology"],"segments":[],"timestamp":637544624280000000,"title":"webinar: how to continuously optimize program performance: using innovation to solve for change"},{"card":{"key":"19c89499-902c-43a1-8894-3b7eda923837","authorName":"Ana Stojanovska","authorCompany":"Biopharma Services","date":"June 2018","description":"An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-navigate-cell-and-gene-therapy-reimbursement-part-one","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How to Navigate Cell and Gene Therapy Reimbursement: Part One"},"categories":["cell and gene therapy","commercialization","financial management","market access","oncology","orphan drugs","policy","reimbursement"],"segments":["manufacturers"],"timestamp":636658819860000000,"title":"how to navigate cell and gene therapy reimbursement: part one"},{"card":{"key":"d5989732-51e5-4f15-8b32-418db1a88036","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2022","description":"","img":{"alt":"policy impacts on pharma","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/policy-impacts-on-pharma.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/policy-and-its-impact-on-the-pharmaceutical-industry","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Roundtable: Policy and its impact on the pharmaceutical industry"},"categories":["advocacy","affordability","legislation","our role in healthcare","policy"],"segments":["manufacturers"],"timestamp":637921067360000000,"title":"roundtable: policy and its impact on the pharmaceutical industry"},{"card":{"key":"bec3cad1-f252-4b4b-bbe2-6a9079994cba","authorName":"Ana Stojanovska","authorCompany":"Biopharma Services","date":"June 2018","description":"An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-navigate-cell-and-gene-therapy-reimbursement-part-two","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How to Navigate Cell and Gene Therapy Reimbursement: Part Two"},"categories":["cell and gene therapy","commercialization","financial management","market access","oncology","orphan drugs","policy","reimbursement"],"segments":["manufacturers"],"timestamp":636658819860000000,"title":"how to navigate cell and gene therapy reimbursement: part two"},{"card":{"key":"106d115b-a8c6-4c4b-8b78-3d953dab6d05","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2022","description":"Cell and gene therapies are currently at the forefront of scientific innovation. They hold great promise for patients suffering from a range of serious ailments. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercializing-cell-and-gene-therapies-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Commercializing cell and gene therapies in Canada"},"categories":["commercialization","patient support services","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637804260000000000,"title":"commercializing cell and gene therapies in canada"},{"card":{"key":"e9cb6786-fbd3-4179-b336-531619cc13ab","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"","img":{"alt":"pharma marketing promotional programs","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pharma-marketing-promotional-programs.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-reach-customers-and-cut-through-the-noise-webinar","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: How to reach customers and cut through the noise"},"categories":["business performance","data","marketing"],"segments":["manufacturers"],"timestamp":637891690320000000,"title":"webinar: how to reach customers and cut through the noise"},{"card":{"key":"e26d6499-7ca3-4dc4-9e0a-f383b9584bf2","authorName":"Xcenda","authorCompany":null,"date":"July 2021","description":"Over the past few years, there has been an increased focus on drug pricing, including some proposals for direct government involvement in negotiating or even setting drug prices. While none of the policies have been implemented, regulation of drug prices by the federal government would likely impact a variety of stakeholders, particularly those purchasing and managing drugs.

To evaluate the impact of government-mandated price reductions on coverage and patient affordability and access, Xcenda surveyed advisors from health plans, integrated delivery networks (IDNs), and pharmacy benefit managers (PBMs) and asked questions about the impact of government price regulation on access, including cost-sharing and benefit design. Federal price action could trigger some payers to modify formulary benefit design, shifting coverage and use of utilization management tools.","img":{"alt":"abstract lines ","src":"-/media/assets/xcenda/english/images/insights/ab-colors-abstract-lines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/affordability-is-about-more-than-drug-prices","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Affordability is about more than drug prices"},"categories":["affordability","commercialization","legislation","managed care","patient care","patient support services","policy","regulatory","research"],"segments":[],"timestamp":637624007400000000,"title":"affordability is about more than drug prices"},{"card":{"key":"a8105a53-2162-4565-a842-39daecf821da","authorName":"Innomar Strategies","authorCompany":null,"date":"August 2021","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/digital-innovation-in-patient-support","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Digital innovation in patient support"},"categories":["commercialization","patient support services","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637636953850000000,"title":"digital innovation in patient support"},{"card":{"key":"67fdcf2f-ffa4-498f-ac9d-830d5a146783","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2021","description":"With the advance of technology and increasing needs of an aging population, telehealth has been playing an important role in transforming the delivery of healthcare. The ongoing coronavirus disease (COVID-19) pandemic and the expansion of value-based care (VBC) models have also contributed to its rapid adoption in the US. Telehealth can facilitate data-driven decision making and has great potential to assist providers, biopharmaceutical companies, and medical device manufacturers in reducing uncertainty in demonstrating the value of their products.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-winter-2021-telehealth-value-based-care-us","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"Telehealth through the lens of value-based care in the US"},"categories":["value-based care","commercialization","covid-19","managed care","patient care","data"],"segments":[],"timestamp":637725132530000000,"title":"telehealth through the lens of value-based care in the us"},{"card":{"key":"ac03642d-5be9-4ae5-8865-dc254d3e025d","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2020","description":"As pharmaceutical manufacturers navigate new and looming legislation related to drug pricing and other policies, distributors can help them adapt and thrive.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-policy-flag-stethoscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/infographic-navigating-health-policy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Infographic: navigating health policy"},"categories":["distribution","policy","our role in healthcare"],"segments":["manufacturers"],"timestamp":637378605010000000,"title":"infographic: navigating health policy"},{"card":{"key":"0f8fa7b7-1771-4794-824e-bc2d934b2804","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"","img":{"alt":"innovative agreements","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/1000x150-tlc-fierce-biopharma-services.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innovative-agreements-exploring-alternative-payment-models","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innovative agreements: Exploring alternative payment models"},"categories":["value-based care","reimbursement","product access","market access"],"segments":["manufacturers"],"timestamp":637940279410000000,"title":"innovative agreements: exploring alternative payment models"},{"card":{"key":"0a75e007-a760-49cf-8077-524764bdfe3b","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"What information do payers and providers want from pharma?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/information-exchange-with-payers-and-providers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Information Exchange With Payers and Providers"},"categories":["commercialization","data","analytics","reimbursement","engagement"],"segments":["manufacturers"],"timestamp":636516438730000000,"title":"information exchange with payers and providers"},{"card":{"key":"b90dfa44-74f9-4eec-97c5-db00efad4241","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"","img":{"alt":"Woman looks at pill bottle and her phone","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1299286865-200dpi.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/5-steps-to-improved-medication-adherence","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"5 steps to improved medication adherence"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637939221510000000,"title":"5 steps to improved medication adherence"},{"card":{"key":"81c679a6-ebf6-46aa-8320-be8de994cfa5","authorName":"Innomar Strategies","authorCompany":null,"date":"December 2019","description":"A recap of InnomarLive 2019, including highlights from speakers and panel discussions on key considerations for commercializing pharmaceutical products in Canada.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innomarlive-2019-summary-commercializing-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"InnomarLive 2019: Commercializing in Canada"},"categories":["commercialization","product access","market access","regulatory"],"segments":["manufacturers"],"timestamp":637118653800000000,"title":"innomarlive 2019: commercializing in canada"},{"card":{"key":"0b6f1e87-0a24-46a5-966f-735448331179","authorName":"MWI Animal Health","authorCompany":"","date":"June 2022","description":"Aligning on single-source vendors like MWI Office Supply with the associated price savings benefits practices. ","img":{"alt":"","src":"-/media/assets/mwianimalhealth/images/insights-images/business-planning-couple.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/how-destination-pet-redefined-practice-autonomy","linkText":"Read the case study","hasImage":true,"isImageMode":true,"label":"Animal Health","headline":"How Destination Pet redefined practice autonomy for its financial benefit"},"categories":["veterinary practices","distribution","inventory management"],"segments":["animal health"],"timestamp":637913691520000000,"title":"how destination pet redefined practice autonomy for its financial benefit"},{"card":{"key":"7177e7f9-10fa-479d-8e13-dd50f7e88577","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2022","description":"","img":{"alt":"GPOconnect","src":"-/media/assets/amerisourcebergen/manufacturer/gpoconnect.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-reach-customers-and-cut-through-the-noise-pdf","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to reach customers in the new world of work"},"categories":["commercialization","marketing","data"],"segments":["manufacturers"],"timestamp":637910083200000000,"title":"how to reach customers in the new world of work"},{"card":{"key":"408e944e-92e0-4150-91e2-88d26c0af950","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"A partner who understands the clinical development journey is key to unlocking product potential","img":{"alt":"Black female nurse uses stethoscope on older Black female patient","src":"-/media/assets/intrinsiqanalytics/images/gettyimages-950886826_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innovative-clinical-trial-design","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innovative clinical trial design"},"categories":["clinical trial logistics","research","advocacy"],"segments":["manufacturers"],"timestamp":637981623050000000,"title":"innovative clinical trial design"},{"card":{"key":"344efa7e-f47e-4473-8337-71818eb9f062","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2017","description":"How can data-driven service design improve patient support programs and outcomes? ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/improving-patient-services-and-outcomes-with-data-driven-design","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Improving Patient Services and Outcomes With Data-Driven Design"},"categories":["patient support services","data","technology"],"segments":["manufacturers"],"timestamp":636423060000000000,"title":"improving patient services and outcomes with data-driven design"},{"card":{"key":"35be6fc0-c457-486e-b8e8-a510b3740399","authorName":"Innomar Strategies","authorCompany":null,"date":"May 2018","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/insight-series-value-of-patient-support-programs","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Insight Series: Value of Patient Support Programs for Specialty Medications in Canada"},"categories":["patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":636621818470000000,"title":"insight series: value of patient support programs for specialty medications in canada"},{"card":{"key":"6ab57d52-c806-4759-bd37-08c1bc189ed1","authorName":"Innomar Strategies","authorCompany":null,"date":"June 2021","description":"What started as a three-person huddle in 2001 became a modern fixture in Canadian healthcare. Here's how Innomar Strategies went from a small team with big dreams to the largest COVID-19 vaccine distribution vendor in Canada's history.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/innomar-strategies---20-years-of-innovative-market-access-solutions","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Innomar Strategies: 20 years of innovative market access solutions"},"categories":["covid-19","distribution","market access"],"segments":["manufacturers"],"timestamp":637586208000000000,"title":"innomar strategies: 20 years of innovative market access solutions"},{"card":{"key":"25b6add5-0910-4614-b24f-eb1cdab2079e","authorName":"Mike Sweeney; Kim McLeod, MPH","authorCompany":"World Courier","date":"September 2020","description":"Executive Q&A: COVID-19 has made more and more trial and provider sites inaccessible. How can manufacturers and trial sponsors adapt?","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/direct-to-patient/patients/insights-cta-dtp-image.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/is-a-contact-free-clinical-trial-possible","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Is a contact-free clinical trial possible?"},"categories":["clinical trial logistics","direct-to-patient","market access"],"segments":["manufacturers"],"timestamp":637365668170000000,"title":"is a contact-free clinical trial possible?"},{"card":{"key":"0196c431-f913-44d6-a3d9-178e0ff80323","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2017","description":"How are payers thinking about apps, wearables and other digital health technologies?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-do-payers-think-about-digital-health-technologies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"What Do Payers Think About Digital Health Technologies"},"categories":["reimbursement","technology","market access"],"segments":["manufacturers"],"timestamp":636419638800000000,"title":"what do payers think about digital health technologies"},{"card":{"key":"1eefad8f-0a7e-450f-812a-5c3df8ab0e30","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2017","description":"In supply chain decisions, a wholly new type of product demands a wholly new definition for supply chain expertise and effective support.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/logistics-decisions-will-impact-the-success-of-new-cell-and-gene-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Logistics Decisions Will Impact the Success of New Cell and Gene Therapies"},"categories":["cell and gene therapy","commercialization","third party logistics"],"segments":["manufacturers"],"timestamp":636359181000000000,"title":"logistics decisions will impact the success of new cell and gene therapies"},{"card":{"key":"48c9c784-7ae2-47c6-ac61-7e128ee09ed1","authorName":"Donna Gilbert","authorCompany":"Biopharma Services","date":"April 2017","description":"Learn the unintended consequences of channel strategy decisions and the impact on patients and providers.","img":{"alt":"Fridgeration distribution center","src":"-/media/assets/amerisourcebergen/distribution/louisville_distribution_drug_refridgeration_003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/changing-channels","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"Changing Channels"},"categories":["product access","distribution","commercialization"],"segments":["manufacturers"],"timestamp":636274381800000000,"title":"changing channels"},{"card":{"key":"40ee2b9c-96a9-4063-a931-71fc25067e63","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Amid an evolving policy landscape, legacy copay programs need a reimagined approach. By incorporating financial wellness platforms into patient support services, biopharma companies can ready their programs for the uncertainty to come.","img":{"alt":"","src":"-/media/assets/firstview/images/proxe360-platform/fv-ab-webheader10.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/maintain-an-agile-copay-program-in-a-changing-policy-environment","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Maintain an agile copay program in a changing policy environment"},"categories":["affordability","legislation","reimbursement"],"segments":["manufacturers"],"timestamp":637993637990000000,"title":"maintain an agile copay program in a changing policy environment"},{"card":{"key":"eab4edcf-423a-47b5-8404-d52080de7ac6","authorName":"Dave Picard; Brian Ansay","authorCompany":"AmerisourceBergen","date":"September 2017","description":"What should biosimilar manufacturers focus on for commercialization success?","img":{"alt":"Female researcher with test tube","src":"-/media/assets/amerisourcebergen/lab/lab_testtube_rsrch_fm_003.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-growth-of-biosimilars-in-the-oncology-pipeline","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"The Growth of Biosimilars in the Oncology Pipeline"},"categories":["biosimilars","commercialization","oncology"],"segments":["manufacturers"],"timestamp":636420538080000000,"title":"the growth of biosimilars in the oncology pipeline"},{"card":{"key":"bb4aa6a5-695c-4960-82a2-c482ca05a2bb","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2020","description":"With the future of face-to-face field sales uncertain for a while, how can pharma ensure product messaging reaches the right healthcare audiences and, ultimately, patients) — now and in the new era of healthcare delivery?","img":{"alt":"Manufacturer’s guide to omnichannel marketing","src":"-/media/assets/lash/images/approach/pagedesign_groupcomputer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/manufacturers-guide-to-omnichannel-marketing","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Manufacturer's Guide to Omnichannel Marketing"},"categories":["marketing"],"segments":["manufacturers"],"timestamp":637358662800000000,"title":"manufacturer's guide to omnichannel marketing"},{"card":{"key":"9cbb4503-21b3-414f-9b86-bccf31c7903d","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2017","description":"What does the future of benefit verification look like for manufacturer patient support programs?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/physician-practices/headset.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-the-future-of-benefit-verification","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"Rethink: The Future of Benefit Verification"},"categories":["commercialization","patient support services","affordability"],"segments":["manufacturers"],"timestamp":636420520460000000,"title":"rethink: the future of benefit verification"},{"card":{"key":"dd477116-a204-4905-8c23-08ffd2631d1a","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Learn more about the benefits of working with a single commercialization services partner in this Q&A with one of AmerisourceBergen's pharmaceutical manufacturer partners.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/ab-new-brand-magenta-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/mcs-qa","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The hidden value of integrated commercialization services: A manufacturer’s perspective"},"categories":["commercialization","distribution","market access","product access","third party logistics"],"segments":["manufacturers"],"timestamp":637544563500000000,"title":"the hidden value of integrated commercialization services: a manufacturer’s perspective"},{"card":{"key":"261ff1ab-b4d7-419a-984d-e10e39c8fc39","authorName":"Xcenda","authorCompany":null,"date":"August 2020","description":"By the numbers: Field reimbursement and access support for pharmaceutical products in the new normal of COVID-19.","img":{"alt":"Male doctor speaking to patient on a tablet","src":"-/media/assets/xcenda/english/images/insights/telehealth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/solving-access-reimbursement-and-pap-awareness-problems","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Solving access, reimbursement, and PAP awareness problems"},"categories":["reimbursement","patient support services","covid-19","product access","market access"],"segments":["manufacturers"],"timestamp":637338783070000000,"title":"solving access, reimbursement, and pap awareness problems"},{"card":{"key":"63f75c3f-5031-4632-98ee-d826251b2f02","authorName":"Xcenda","authorCompany":null,"date":"February 2021","description":"Melissa Muchahey, Vice President of Field Services Business Development and Strategy at Xcenda, discusses how field services teams have been able to innovate and adapt to the challenges of COVID-19.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-with-mask-at-computer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/launching-field-services-in-the-midst-of-covid-19","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Launching field services in the midst of COVID-19"},"categories":["commercialization","reimbursement","product access","covid-19","patient support services"],"segments":["manufacturers"],"timestamp":637479766110000000,"title":"launching field services in the midst of covid-19"},{"card":{"key":"b6a4e356-3d36-4403-ae06-f674c14e2d33","authorName":"Corey Ford, MHA","authorCompany":"Xcenda","date":"March 2019","description":"Over the past two years, pharmacy benefit managers (PBMs) and commercial health plans have launched copay accumulator adjustment programs, an insurance design with potential adverse impacts on patients’ adherence to prescribed therapy regimens. Copay accumulator adjustment programs exclude the use of manufacturer-sponsored commercial copay assistance from a patient’s accrual of out-of-pocket (OOP) expenses throughout a plan benefit year. In this issue brief, Xcenda and the Lash Group explore recent trends around copay accumulators, the impact on patients, and solutions for consideration.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rolling-back-the-tide-consultative-approach-tackle-expansion-of-copay-accumulators","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Managing the Growing Expansion of Copay Accumulators"},"categories":["affordability","commercialization","legislation","patient support services","policy","reimbursement"],"segments":["manufacturers"],"timestamp":636874103300000000,"title":"managing the growing expansion of copay accumulators"},{"card":{"key":"e3d66f96-082c-491f-bd68-8ae81116bb2e","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Patients and pharmacists face a lot of choice. They have limited time to focus on product selection and limited resources to solve financial barriers. Learn how targeted marketing programs like AmerisourceBergen's BRx Catalog and CustomConnect can integrate tailored messages seamlessly into pharmacy customers’ workflow where they are engaged and ready to act.","img":{"alt":"Connecting your brand message with the healthcare providers","src":"-/media/assets/amerisourcebergen/manufacturer/targeted-marketing-programs.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/maximize-your-brands-visibility-case-studies","linkText":"Download case studies","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case studies: Maximize your brand's visibility"},"categories":["commercialization","marketing","data"],"segments":["manufacturers"],"timestamp":637776131090000000,"title":"case studies: maximize your brand's visibility"},{"card":{"key":"cb39e59e-62c0-44c8-a37f-ebc7efa57816","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Xcenda and FormularyDecisions joined AMCP for a live webinar on January 19, 2022 titled, “Bridging the HCEI Divide – Insights on an Effective Healthcare Economic Information (HCEI) Exchange.”","img":{"alt":"","src":"-/media/assets/sustainability/images/ab-business-meeting-2_rgb_card.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/bridging-the-hcei-divide-webinar","linkText":"Download slides","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Bridging the HCEI Divide – Insights on an Effective Healthcare Economic Information (HCEI) Exchange"},"categories":[],"segments":["manufacturers"],"timestamp":637781981400000000,"title":"webinar: bridging the hcei divide – insights on an effective healthcare economic information (hcei) exchange"},{"card":{"key":"696cef00-a2bd-4574-80b8-a2364dbb690f","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"Data can be powerful when it's paired with actionable insights. Is your patient support provider telling you what you need to know?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/data.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/next-level-analytics-part-1","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Next-level analytics part 1: Eight insights to expect from your patient support provider"},"categories":["analytics","data","affordability","patient support services","medication adherence","product access"],"segments":["manufacturers"],"timestamp":637224946200000000,"title":"next-level analytics part 1: eight insights to expect from your patient support provider"},{"card":{"key":"054cf79c-26d1-4317-a20d-98d9c12e8a9f","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2021","description":"Xcenda and FormularyDecisions joined AMCP for a live webinar on June 9, 2021 titled, “The Rise in Digital Information Dissemination: Communication Trends in Managed Care.”","img":{"alt":"","src":"-/media/assets/sustainability/images/ab-business-meeting-2_rgb_card.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-rise-of-digital-information-dissemination-communication-trends-in-managed-care","linkText":"Download slides","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: the rise of digital information dissemination: communication trends in managed care"},"categories":[],"segments":["manufacturers"],"timestamp":637590173480000000,"title":"webinar: the rise of digital information dissemination: communication trends in managed care"},{"card":{"key":"4f0c9339-b2b3-4469-980b-a6cd89e04433","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2020","description":"With the future of face-to-face field sales uncertain for a while, how can pharma ensure product messaging reaches the right healthcare audiences (and ultimately, patients) -- now and in the new era of healthcare delivery?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ip_backstore_pharm_stock_bottles_010.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/on-demand-webinar-virtual-marketing","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: virtual marketing do's and don'ts"},"categories":["affordability","covid-19","marketing","our role in healthcare","product access"],"segments":["manufacturers"],"timestamp":637344952520000000,"title":"on-demand webinar: virtual marketing do's and don'ts"},{"card":{"key":"f8d71c5a-a4df-467f-bd2d-0808fa4e2499","authorName":"Innomar Strategies","authorCompany":null,"date":"September 2017","description":"Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-route-to-market-access-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Route to Market Access in Canada"},"categories":["market access","reimbursement"],"segments":["manufacturers"],"timestamp":636413640000000000,"title":"the route to market access in canada"},{"card":{"key":"009bc3f8-8968-41cd-9b64-fc8067f06635","authorName":"Xcenda","authorCompany":null,"date":"January 2019","description":"What does Medicare claims data reveal about physician-administered drugs? An Xcenda survey reveals whether physicians choose treatment based on how much they're reimbursed.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/medicare-part-b-infographic","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Medicare Part B: Do Providers Choose Treatment Based on Payment?"},"categories":["policy","reimbursement"],"segments":["manufacturers"],"timestamp":636831781040000000,"title":"medicare part b: do providers choose treatment based on payment?"},{"card":{"key":"c5d69830-4114-46c1-a9b6-f96cb111962f","authorName":"Kim McLeod, MPH","authorCompany":"Xcenda","date":"February 2020","description":"New ways manufacturers are gathering data that supports their product value story, both pre- and post-launch.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/mindthegap.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/mind-the-evidence-gap","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Mind the (Evidence) Gap"},"categories":["commercialization","data","legislation","market access","orphan drugs","policy","regulatory","technology"],"segments":["manufacturers"],"timestamp":637163352000000000,"title":"mind the (evidence) gap"},{"card":{"key":"af08bf50-d11b-464d-b2cc-743422c074f8","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2019","description":"Executive Q&A: How shifting coverage for some drugs from Medicare Part B to Part D could impact access and affordability for patients.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/moving-medicare-coverage","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Moving Medicare Coverage"},"categories":["affordability","advocacy","legislation","policy","product access"],"segments":["manufacturers","physician practices"],"timestamp":636857686750000000,"title":"moving medicare coverage"},{"card":{"key":"2d411185-885b-4f26-9ce4-039571b2a192","authorName":"Lash Group","authorCompany":null,"date":"June 2020","description":"With the right data, manufacturers can pivot their patient support services in response to real-time trends. Learn the three data-driven decisions you can make when you work with the right partner.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/data.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/next-level-analytics-part-2","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Next-level analytics part 2: Is your patient support program data actionable?"},"categories":["data","analytics","patient support services"],"segments":["manufacturers"],"timestamp":637274896030000000,"title":"next-level analytics part 2: is your patient support program data actionable?"},{"card":{"key":"fbc49006-8536-464a-bd37-5eca3ee1d35c","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2022","description":"","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1251485261_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nine-questions-about-rare-and-orphan-drug-commercialization","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Nine questions about rare and orphan drug commercialization"},"categories":["orphan drugs","commercialization","distribution"],"segments":["manufacturers"],"timestamp":637811347780000000,"title":"nine questions about rare and orphan drug commercialization"},{"card":{"key":"99676027-aaf2-4ee2-a205-41f94f08850f","authorName":"Lash Group","authorCompany":null,"date":"November 2019","description":"How do nurses make a difference when it comes to patient-centric adherence programs? A Lash Group nurse shares how she offers personal support for rare disease patients.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-amy","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Nurse Stories: Amy"},"categories":["commercialization","engagement","medication adherence","patient care","patient support services"],"segments":["manufacturers"],"timestamp":637091946070000000,"title":"nurse stories: amy"},{"card":{"key":"6874677e-3489-40b3-9128-6c39a3ab9273","authorName":"Lash Group","authorCompany":null,"date":"December 2019","description":"For Angela, a nurse navigator with Lash Group, every phone call is an opportunity to help a cancer patient, and sometimes solve problems they didn't even know they had.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-angela","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Nurse Stories: Angela"},"categories":["medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637122945170000000,"title":"nurse stories: angela"},{"card":{"key":"e448e70c-4712-4f4e-a3ef-abde645eef5e","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"Jessica, a Lash Group nurse educator, shares why building rapport with patients is rewarding for the person on both ends of the phone.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/telehealth_phone_steth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-jessica","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Nurse Stories: Jessica"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637160652000000000,"title":"nurse stories: jessica"},{"card":{"key":"2752693b-2b1e-485a-8efc-21c60adfbb99","authorName":"Brenda Agnew","authorCompany":"","date":"April 2022","description":"Caregivers play a critical role in Canadian healthcare. In a survey conducted by The Ontario Caregiver Association, 35 percent of the workforce provides unpaid care to a family member or friend. This number has gone up 22 percent as a result of COVID-19, and 52 percent of Canada’s 7.8 million caregivers say balancing work and caregiving is more challenging due to the pandemic.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-caregivers-story--how-to-support-caregiving-employees-and-their-families","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"A caregiver's story: How to support caregiving employees and their families"},"categories":["advocacy","engagement","patient care","patient support services","technology"],"segments":[],"timestamp":637866790230000000,"title":"a caregiver's story: how to support caregiving employees and their families"},{"card":{"key":"87081eb4-f9c4-4957-8b53-38a8e719800f","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"Nurse navigators work tirelessly to help patients start and stay on specialty medications. Here's how becoming one has not only changed Polly's life, but the lives of many more people with rare and chronic diseases.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/rn_polly.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/nurse-stories-polly","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Nurse Stories: Polly"},"categories":["affordability","patient support services","patient care","product access"],"segments":["manufacturers"],"timestamp":637148023160000000,"title":"nurse stories: polly"},{"card":{"key":"ff1744b5-6e8a-49d6-a8b1-af86b19994b6","authorName":"Xcenda","authorCompany":null,"date":"November 2020","description":"An advocate working on behalf of oral and infusion specialty therapies, Ashley helps cancer patients start and stay on lifesaving medications.","img":{"alt":"Doctor talking to patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor-talking-to-patient.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-ashley","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Ashley's story"},"categories":["affordability","commercialization","market access","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637405442760000000,"title":"pharma in the field: ashley's story"},{"card":{"key":"6d1a07ee-2bf8-46ff-9fea-71dba6dae027","authorName":"Xcenda","authorCompany":null,"date":"March 2021","description":"A look at how Xcenda's field reimbursement and access team leads help fuel patient access and better outcomes.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/thinklive-web-hero-background-1200x800.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-barrett","linkText":"Meet Barrett","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Barrett's story"},"categories":["affordability","commercialization","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637504929760000000,"title":"pharma in the field: barrett's story"},{"card":{"key":"bb8d97bd-cbb3-42bf-9f2c-2d1bf2aa9275","authorName":"Xcenda","authorCompany":null,"date":"December 2020","description":"As a field reimbursement and access specialist (FRAS) at Xcenda, Heather spends her days helping healthcare providers get to the bottom of any issue that might prevent patients from being able to access the therapy they need.","img":{"alt":"Doctor talking to patient","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor-talking-to-patient.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-heather","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Heather's story"},"categories":["affordability","commercialization","patient support services","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637432200110000000,"title":"pharma in the field: heather's story"},{"card":{"key":"29198465-258d-4749-897a-abe5a5ac8817","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2020","description":"Leverage our expertise and network of retail and physician customers to promote your brand through the BRx Catalog and CustomConnect®.

Our highly targeted marketing programs leverage our proximity to the customer, connecting your brand message with the healthcare providers who influence your brand’s performance. Your tailored messages are integrated into our customers’ existing workflow so your communication stands out and gets recognized.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/manufacturer/gettyimages-1222500485-rev.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/promote-your-brand-through-the-brx-catalog-and-customconnect","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case studies: The power of multichannel marketing"},"categories":["affordability"],"segments":["manufacturers"],"timestamp":637327681800000000,"title":"case studies: the power of multichannel marketing"},{"card":{"key":"46685f42-6c52-46cd-8728-99dde1e48b9c","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2018","description":"How manufacturers can benefit from provider-led care coordination to improve patient outcomes.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-channel-strategy-for-oral-oncolytics","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Rethink: Channel Strategy for Oral Oncolytics"},"categories":["commercialization","distribution","data","medication adherence","oncology","specialty pharmacy","product access"],"segments":["manufacturers"],"timestamp":636632080780000000,"title":"rethink: channel strategy for oral oncolytics"},{"card":{"key":"579b0fbe-5dd9-4e01-8183-29f52a4fe998","authorName":"Xcenda","authorCompany":null,"date":"August 2020","description":"What are the myths that could be impacting access to your products, and how could the right field services partner help?","img":{"alt":"female_doctor_virtual_visit","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/doctor_female_telehealth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-field-services","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Rethink field services: Three myths keeping access barriers in front of your product"},"categories":["commercialization","covid-19","market access","patient support services","product access"],"segments":["manufacturers"],"timestamp":637341528710000000,"title":"rethink field services: three myths keeping access barriers in front of your product"},{"card":{"key":"28f8d2b9-8e4f-4741-b290-bc1e562ec732","authorName":"Dale Hanna","authorCompany":"Lash Group","date":"November 2020","description":"Executive Q&A: Dale Hanna, Product Director, and Andrea Windich, Director of Nursing, discuss how Lash Group is adapting patient support programs to address the medication adherence barriers patients are facing during the COVID-19 pandemic.","img":{"alt":"stethoscope medication adherence","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/telehealth_phone_steth.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/overcoming-medication-adherence-barriers-during-the-covid-19-pandemic","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Overcoming medication adherence barriers during the covid-19 pandemic"},"categories":["medication adherence","patient support services","covid-19"],"segments":["manufacturers"],"timestamp":637415006400000000,"title":"overcoming medication adherence barriers during the covid-19 pandemic"},{"card":{"key":"722c6f00-a33b-4b8c-a92d-e2bdf9786bdd","authorName":"Lash Group","authorCompany":null,"date":"July 2020","description":"Pharmaceutical manufacturers are assessing how they can adjust their patient assistance programs to meet emerging needs during the COVID-19 pandemic. How can patient support flex to ensure access to needed medications?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/covid-piggy-bank.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/patient-support-in-the-time-of-covid-19","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support in the time of COVID-19: Five ways to adapt"},"categories":["affordability","covid-19","patient support services","medication adherence","product access"],"segments":["manufacturers"],"timestamp":637305286510000000,"title":"patient support in the time of covid-19: five ways to adapt"},{"card":{"key":"883ead32-384c-4ae4-9984-699a269da7ea","authorName":"Lash Group","authorCompany":null,"date":"December 2020","description":"Entering a crowded marketplace with a new therapy comes with challenges, but manufacturers can find success with the right patient support program launch plan. Learn how to outperform competitive products and deliver value from day one with this essential guide from Lash Group.","img":{"alt":"","src":"-/media/assets/xcenda/english/images/formularydecisions/formularydecisions-body1-504x504x2.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/patient-support-launch-guide-competitive-markets","linkText":"Get the guide","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support launch guide: competitive markets"},"categories":["medication adherence","patient support services","product access"],"segments":["manufacturers"],"timestamp":637439180400000000,"title":"patient support launch guide: competitive markets"},{"card":{"key":"0d88a470-1dde-442d-b85c-be1598f8a040","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"Insights from managed care executives on the future of coverage and outcomes evaluation.","img":{"alt":"Rethink: Payer Strategies for Commercializing Cell and Gene Therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/lab_microscope_rsrch_007.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/payer-strategies-for-commercializing-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Rethink: Payer Strategies for Commercializing Cell and Gene Therapies"},"categories":["cell and gene therapy","reimbursement","commercialization"],"segments":["manufacturers"],"timestamp":636590666680000000,"title":"rethink: payer strategies for commercializing cell and gene therapies"},{"card":{"key":"c15f4059-9a42-4586-bf03-2506d9c91b0f","authorName":"Karen Rice","authorCompany":"Lash Group","date":"May 2020","description":"Executive Q&A: How to help employees navigate change while working for the good of patients during times of crisis. Lash Group's Karen Rice shares her insights.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/karenrice.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/people-first-helping-employees-navigate-work-change-and-patient-support","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"People First: Helping Employees Navigate Work, Change and Patient Support"},"categories":["covid-19","engagement","patient support services"],"segments":["manufacturers"],"timestamp":637254175430000000,"title":"people first: helping employees navigate work, change and patient support"},{"card":{"key":"9602a29f-5a75-41a5-8e09-54e73fafd177","authorName":"Xcenda","authorCompany":null,"date":"July 2020","description":"How the field reimbursement specialist (FRS) differs from the sales rep — and where outsourced field teams can supplement sales teams to ensure patients and providers receive the support they need.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/medical-staff-wearing-masks-talking-at-laptop.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Sales reps vs. reimbursement and access specialists"},"categories":["covid-19","commercialization","market access","patient support services","product access"],"segments":["manufacturers"],"timestamp":637309537050000000,"title":"pharma in the field: sales reps vs. reimbursement and access specialists"},{"card":{"key":"22358fe9-2dfd-4266-9d29-cb6fb80bb037","authorName":"Xcenda","authorCompany":null,"date":"November 2020","description":"An in-depth look into the work of the pharma industry's field access manager — from relationships with sales reps and providers to the extra steps they take to improve patient access.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pharma-in-the-field-tierra","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pharma in the field: Tierra's story"},"categories":["affordability","commercialization","market access","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637405393790000000,"title":"pharma in the field: tierra's story"},{"card":{"key":"6113059b-0b36-4c93-921e-d5bea578a13f","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"What should your commercialization partner be
focused on post-launch? Effective partners optimize
programs and solutions as needed to remove access
and adherence barriers and ensure products reach
their full potential.","img":{"alt":"Post-launch checklist","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/post-launch-checklist.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/post-launch-checklist","linkText":"Download checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Post-launch checklist: What to look for in a commercialization partner"},"categories":["business performance","commercialization","commercial supply chain","data","distribution","medication adherence"],"segments":["manufacturers"],"timestamp":637540949250000000,"title":"post-launch checklist: what to look for in a commercialization partner"},{"card":{"key":"0f827788-0bf9-4684-8f49-53246609c3e9","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2021","description":"What makes a good commercialization partner? How do you find the right match? A checklist for manufacturers, starting with pre-launch needs.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/ab-lab-and-science-female_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pre-launch-check-list","linkText":"See checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Pre-launch checklist: What to look for in a commercialization partner"},"categories":["commercialization","innovation","market access","medication adherence","patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":637493409120000000,"title":"pre-launch checklist: what to look for in a commercialization partner"},{"card":{"key":"5375e011-ef6f-4a8f-b9fa-4fc0ff463242","authorName":"Matt Sample","authorCompany":"AmerisourceBergen","date":"May 2019","description":"Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/preparing-for-dscsa-interoperability","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Preparing for DSCSA Interoperability"},"categories":["distribution","legislation","secure supply chain","technology"],"segments":["manufacturers","pharmacies","health systems"],"timestamp":636934550300000000,"title":"preparing for dscsa interoperability"},{"card":{"key":"74dbcb78-a9c0-4828-ad4b-983364300d9e","authorName":"Lash Group","authorCompany":null,"date":"November 2018","description":"Open enrollment for Health Insurance Marketplace plans is here. Do PAP patients know their coverage options?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/preparing-patients-for-open-enrollment","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Preparing Patients for Open Enrollment"},"categories":["affordability","patient support services","policy","product access","medication adherence"],"segments":["manufacturers"],"timestamp":636772063300000000,"title":"preparing patients for open enrollment"},{"card":{"key":"2d19ecef-8bf1-455b-9429-2ffb8e8ff1e4","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2020","description":"Ideas that matter from PAP 2020: As the larger healthcare system looks for ways to alleviate challenges brought on by the coronavirus, patient support providers are shifting how they work with manufacturers to increase impact and provide ongoing support for patients.","img":{"alt":"blue face masks on yellow background tiled","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/face-masks-tiled.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/pap-2020-panel-recap-navigating-covid-19","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"PAP 2020 panel recap: Navigating COVID-19"},"categories":["affordability","covid-19","commercialization","product access"],"segments":["manufacturers"],"timestamp":637387221350000000,"title":"pap 2020 panel recap: navigating covid-19"},{"card":{"key":"9e15ca31-9c7a-4d72-9257-215a8279630d","authorName":"Lash Group","authorCompany":null,"date":"July 2020","description":"Executive Q&A: Troy Ward, Chief Operations Officer at Lash Group, shares how his team sustains operational excellence during times of uncertainty, such as the current COVID-19 pandemic.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/callcenter-remote-female.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/patient-support-program-operations","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support program operations: A peek behind the curtain"},"categories":["patient support services"],"segments":["manufacturers"],"timestamp":637318102760000000,"title":"patient support program operations: a peek behind the curtain"},{"card":{"key":"b6e5e5e5-56ad-4a57-a50b-76a1227e866d","authorName":"Barbara Whitten","authorCompany":"Lash Group","date":"December 2019","description":"Executive Q&A: How to make the annual benefits reverification process as smooth as possible for patients and key stakeholders.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/scaling-up-for-annual-reverification","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Scaling Up for Annual Reverification"},"categories":["affordability","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637110875760000000,"title":"scaling up for annual reverification"},{"card":{"key":"e9b96d0c-79e8-4207-8eb4-ccb9bfa9f2ee","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Launching a new pharmaceutical product is a complex endeavor, involving a web of interrelated activities from clinical trials through market maturity. How can manufacturers avoid common pitfalls on the journey toward product success? Strategic Partnerships for Unlocking Product Potential explores how manufacturers can benefit from integrated commercialization solutions. Learn how a partner with the right combination of solutions, perspectives, and scale can help manufacturers unlock product potential by optimizing everything from clinical trials and payer engagement to patient support and field solutions.","img":{"alt":"Strategic partnerships for unlocking product potential ebook","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/strategic-partnerships-for-unlocking-product-potential.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/strategic-partnerships-for-unlocking-product-potential","linkText":"Download ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Ebook: Strategic partnerships for unlocking product potential"},"categories":["clinical trial logistics","commercialization","data","distribution","innovation","market access","patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":637540018110000000,"title":"ebook: strategic partnerships for unlocking product potential"},{"card":{"key":"92b69e38-5ce0-46d9-a791-fb5b9f5b027f","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2015","description":"Successful commercialization demands that manufacturers address three critical areas of opportunity — evidence, access and adherence. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-fundamentals-of-commercialization-strategy","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Fundamentals of Commercialization Strategy"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":635585847600000000,"title":"the fundamentals of commercialization strategy"},{"card":{"key":"d98baa17-9a49-432b-b586-f43aa0642f30","authorName":"Donna Gilbert; Nancy Hoak","authorCompany":"Biopharma Services","date":"September 2021","description":"Watch on demand to rethink commercialization strategy and the role of the right partner. From drug development through post-launch, see how commercialization solutions can be reimagined and integrated at every step of a drug’s journey to market. Learn how to rethink logistics and deliver clinical trial meds direct to patients. Reimagine field and patient services to remove access barriers even when patients are getting virtual care. Explore market-moving channel strategies and innovative logistics. And hear about it all from the team that designs and delivers commercialization strategies and solutions for our manufacturer partners every day.","img":{"alt":"Manufacturer commercialization Services","src":"-/media/assets/amerisourcebergen/manufacturer/manufacturer-commercialization-services.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethink-your-commercialization-strategy","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Rethink your commercialization strategy"},"categories":["commercialization","data","distribution","innovation"],"segments":["manufacturers"],"timestamp":637679129130000000,"title":"webinar: rethink your commercialization strategy"},{"card":{"key":"85b215f9-509c-40ee-838a-9b076e1cc22a","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2018","description":"How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/rethinking-reimbursement-and-patient-support-following-medical-innovation","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Rethinking Reimbursement and Patient Support Following Medical Innovation"},"categories":["commercialization","cell and gene therapy","patient support services","reimbursement","affordability"],"segments":["manufacturers"],"timestamp":636519837600000000,"title":"rethinking reimbursement and patient support following medical innovation"},{"card":{"key":"f42cdb83-d305-43bc-85b2-564ba490ade0","authorName":"Lash Group","authorCompany":null,"date":"November 2020","description":"Why is incorporating pharmacy benefits into eBV essential? As technology continues to advance with automation, new opportunities emerge to deliver more detail for real-time pharmacy benefits.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/provider-at-computer-from-back.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/speeding-access-to-therapy-with-pharmacy-ebv","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Speeding access to therapy with pharmacy eBV"},"categories":["affordability","patient support services","product access"],"segments":["manufacturers"],"timestamp":637399312010000000,"title":"speeding access to therapy with pharmacy ebv"},{"card":{"key":"927e18ab-a4d9-4dad-9c85-79c67ca98866","authorName":"Corey Ford, MHA; Dale Hanna","authorCompany":"Xcenda","date":"March 2021","description":"Experts from Xcenda and Lash Group discuss copay accumulators, the impact of the new CMS regulations, and operational solutions for manufacturers.","img":{"alt":"copay accumulator piggy bank","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pink-piggy-bank-and-stethoscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/strategies-for-addressing-copay-accumulators","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Strategies for addressing copay accumulators: What manufacturers need to know"},"categories":["affordability","commercialization","market access","patient support services","policy","regulatory"],"segments":["manufacturers"],"timestamp":637508352790000000,"title":"strategies for addressing copay accumulators: what manufacturers need to know"},{"card":{"key":"75eb36df-8d9d-4edd-ad24-7ccede937599","authorName":"Lash Group","authorCompany":null,"date":"November 2018","description":"How combining the PAM survey with individual care planning can improve patient activation and adherence.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-part-three","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Insight","headline":"The Power of Patient Activation: Part Three"},"categories":["medication adherence","patient support services"],"segments":[],"timestamp":636770338690000000,"title":"the power of patient activation: part three"},{"card":{"key":"2cf339cc-8ee1-49ff-9268-c5e00b80376b","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2020","description":"What will it take to bring a treatment for COVID-19 to market? What have we learned from efforts to ensure supply chain stability at the height of the coronavirus pandemic? Leaders from AmerisourceBergen's Strategic Global Sourcing team share their perspective on how we'll make sure the right pieces are in place as manufacturers seek to commercialize new therapies.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/covid_masks_texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-road-to-a-covid-19-treatment-launch","linkText":"Read the Q&A","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The road to a COVID-19 treatment launch"},"categories":["covid-19","distribution","commercialization","secure supply chain"],"segments":["manufacturers"],"timestamp":637390702800000000,"title":"the road to a covid-19 treatment launch"},{"card":{"key":"9793c2b6-391c-4f28-bd66-dbd7ab0211aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2018","description":"","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-road-to-commercialization-in-canada","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Insight","headline":"Infographic: The Road to Commercialization in Canada"},"categories":["commercialization","market access","third party logistics","legislation"],"segments":[],"timestamp":636608804290000000,"title":"infographic: the road to commercialization in canada"},{"card":{"key":"418625b1-0d22-46a7-9810-bdc1f767b486","authorName":"Matt Sarnes, PharmD; Allen Lising","authorCompany":"Biopharma Services","date":"June 2020","description":"Payers and IDNs representing more than 275 million lives routinely use FormularyDecisions to access product information. How can manufacturers connect with payers and other healthcare decision makers where they are to deliver pre-, peri- and post-approval product information in the digital space?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/tech_blue_laptop.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-future-of-payer-engagement-how-pharma-can-break-through","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The Future of Payer Engagement: How Pharma Can Break Through"},"categories":["market access","analytics","commercialization","data","technology"],"segments":["manufacturers"],"timestamp":637280084440000000,"title":"the future of payer engagement: how pharma can break through"},{"card":{"key":"faea71af-fdfe-4c5b-90a0-006725697177","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2020","description":"Three major challenges must be prepared for: constantly shifting travel restrictions, maintaining shipment integrity in the face of those restrictions, and ensuring trial data can be relied upon.","img":{"alt":"Shipments","src":"-/media/assets/worldcourier/english/images/article-images/180321_wc-2199.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-impact-of-lockdown-and-restrictions-on-covid-19-treatment-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Article: The Impact of Lockdown and Restrictions on COVID-19 Treatment Trials"},"categories":["covid-19","pharmaceutical storage and transport management"],"segments":[],"timestamp":637350837000000000,"title":"article: the impact of lockdown and restrictions on covid-19 treatment trials"},{"card":{"key":"f5d0ddf4-e73a-4fac-a888-bd81be7b0662","authorName":"HTA Quarterly","authorCompany":"","date":"August 2022","description":"The new 2022 European Union (EU) health technology assessment (HTA) regulation is intended to streamline assessment of clinical data across the EU and minimize duplication of effort, for both health technology developers and HTA bodies.","img":{"alt":"EU Flag HTA Assessments","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-fall-2022/shutterstock_388372504-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-fall-2022-eu-regulation-and-health-technology-assessment","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The new EU regulation on health technology assessment: Major change or minor adjustment?"},"categories":[],"segments":["manufacturers"],"timestamp":637975507800000000,"title":"the new eu regulation on health technology assessment: major change or minor adjustment?"},{"card":{"key":"05c689e8-b78f-4c98-b696-d09babac3fa0","authorName":"World Courier","authorCompany":null,"date":"September 2020","description":"Based on World Courier’s experience of maintaining supply channels during times of public health crises and transport disruption, we’ve outlined key logistics considerations that apply to COVID-19 vaccine development and distribution.","img":{"alt":"Trials","src":"-/media/assets/worldcourier/english/images/article-images/patient_needs.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-logistics-of-covid-19-vaccine-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Article: The Logistics of COVID-19 Vaccine Trials"},"categories":["covid-19","secure supply chain"],"segments":["manufacturers"],"timestamp":637350738600000000,"title":"article: the logistics of covid-19 vaccine trials"},{"card":{"key":"6d0c1e19-a7e7-435a-b23a-3371f1bfe39a","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"Whilst Orphan diseases individually are rare, collectively they are not; population prevalence of rare diseases is put at 5% to 10%. Whilst developers look for high prices to cover their costs, can payers afford them? A review of the “lock” system in the Netherlands suggests maybe not.","img":{"alt":"Panama Canal Orphan Drug Lock Article Image","src":"-/media/assets/xcenda/english/images/hta-quarterly-images/htaq-lock.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/htaq-summer-2022-orphan-drugs-trapped-in-the-lock","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Orphan drugs: trapped in the lock? A review of the lock system in the Netherlands"},"categories":["market access","orphan drugs"],"segments":[],"timestamp":637883097600000000,"title":"orphan drugs: trapped in the lock? a review of the lock system in the netherlands"},{"card":{"key":"a7fc1511-e3c7-4264-be76-a271a02aea9c","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2021","description":"How your commercialization partner can deliver data-driven insights to propel product success","img":{"alt":"The power of data across your product journey","src":"-/media/assets/amerisourcebergen/manufacturer/the-power-of-data-across-your-product-journey.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-data-across-your-product-journey","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: The power of data across your product journey"},"categories":["analytics","business performance","commercialization","data","financial management","inventory management","research","technology"],"segments":["manufacturers"],"timestamp":637523796600000000,"title":"on-demand webinar: the power of data across your product journey"},{"card":{"key":"4e232c6b-7180-4c67-90c6-f553f1b74a96","authorName":"Innomar Strategies","authorCompany":null,"date":"June 2021","description":"Put return-to-work fears at rest with an app that helps your employees prioritize what matters.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/overcoming-reentry-concerns-with-workplace-wellness-technology","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Insight","headline":"Overcoming reentry concerns with workplace wellness technology"},"categories":["advocacy","engagement","patient care","technology"],"segments":[],"timestamp":637593984000000000,"title":"overcoming reentry concerns with workplace wellness technology"},{"card":{"key":"ed516991-9296-47f3-8b9f-b17cd1a21a05","authorName":"Lash Group","authorCompany":null,"date":"November 2018","description":"What are the pitfalls of historic approaches to adherence? Learn how leading solutions combine both measurement and engagement for real results.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-ebook","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Power of Patient Activation: eBook"},"categories":["affordability","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636777219620000000,"title":"the power of patient activation: ebook"},{"card":{"key":"8f2faabf-6ec6-40b4-a141-0cfc7db23d13","authorName":"Lash Group","authorCompany":null,"date":"October 2018","description":"The evolving needs of the patient and historic approaches to non-adherence.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-part-one","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Power of Patient Activation: Part One"},"categories":["affordability","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636741887760000000,"title":"the power of patient activation: part one"},{"card":{"key":"23c076d8-cdb0-444c-988f-b5c96718e800","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Legislative updates to help practices prepare for 2023 and beyond. ","img":{"alt":"US capitol building","src":"-/media/assets/besse/images/general/capitol-building.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/physician-practices/policy-updates-from-the-inflation-reduction-act-to-the-enhancing-oncology-model","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Policy updates: From the Inflation Reduction Act to the Enhancing Oncology Model"},"categories":["policy","advocacy","legislation"],"segments":[],"timestamp":637986831170000000,"title":"policy updates: from the inflation reduction act to the enhancing oncology model"},{"card":{"key":"ede2fbcb-d443-42e9-8408-6a1a932336cb","authorName":"Lash Group","authorCompany":null,"date":"October 2018","description":"How leading patient support providers combine measurement with engagement to improve adherence.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-power-of-patient-activation-part-two","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Power of Patient Activation: Part Two"},"categories":["affordability","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636758273660000000,"title":"the power of patient activation: part two"},{"card":{"key":"c322aaee-ffc0-4497-a8f4-81435dc5547d","authorName":"Xcenda","authorCompany":null,"date":"July 2022","description":"Why FormularyDecisions is the right choice for enterprise biopharma payer engagement. The secure, online platform connects biopharma companies and payers to share information bi-directionally","img":{"alt":"formulary decisions enterprise man working on computer","src":"-/media/assets/xcenda/english/images/formularydecisions/formularydecisions-hero-3840x2194.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/formularydecisions-enterprise-biopharma-payer-engagement","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Why FormularyDecisions® is the right choice for enterprise biopharma payer engagement "},"categories":["commercialization","market access","technology"],"segments":["manufacturers"],"timestamp":637931438910000000,"title":"why formularydecisions® is the right choice for enterprise biopharma payer engagement "},{"card":{"key":"56c43df4-e90c-4016-85e6-92be2d585abd","authorName":"Ann Pham","authorCompany":"","date":"September 2018","description":"What are FTZs and why should pharma use them?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-role-of-foreign-trade-zones-in-pharmaceutical-manufacturing-success-part-one","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part One"},"categories":["commercialization","third party logistics"],"segments":["manufacturers"],"timestamp":636718635840000000,"title":"the role of foreign trade zones in pharmaceutical manufacturing success: part one"},{"card":{"key":"07e9f70b-70b7-4d8e-89e2-65309af77c41","authorName":"Ann Pham","authorCompany":"","date":"September 2018","description":"How can FTZs help with commercialization success? What should manufacturers consider when evaluating a FTZ and 3PL partner?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-role-of-foreign-trade-zones-in-pharmaceutical-manufacturing-success-part-two","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part Two"},"categories":["commercialization","third party logistics"],"segments":["manufacturers"],"timestamp":636719335750000000,"title":"the role of foreign trade zones in pharmaceutical manufacturing success: part two"},{"card":{"key":"ff0c67fa-11ab-4f95-9e1c-8cf9413fc794","authorName":"Tasmina Hydery","authorCompany":"","date":"June 2022","description":"Download the webinar slides from the Xcenda and FormularyDecisions discussion: “Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies.” ","img":{"alt":"abstract lines ","src":"-/media/assets/xcenda/english/images/insights/ab-colors-abstract-lines.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-slides-navigating-reimbursement-and-access-challenges-for-novel-cell-and-gene-therapies","linkText":"Download slides","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies"},"categories":["cell and gene therapy","commercialization","market access"],"segments":["manufacturers"],"timestamp":637914326220000000,"title":"webinar slides: navigating reimbursement and access challenges for novel cell and gene therapies"},{"card":{"key":"046dadef-e3cf-40dc-b556-c9897023ebe0","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2018","description":"Much of the complexity of the cell and gene supply chain comes from how dependent the commercialization phase is on the clinical phase. What does integration look like, and how can the right logistics partner help?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-supply-chain-redefined-cgt","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"The Supply Chain Redefined: Cell and Gene Therapies"},"categories":["cell and gene therapy","third party logistics","commercialization","commercial supply chain"],"segments":["manufacturers"],"timestamp":636686495650000000,"title":"the supply chain redefined: cell and gene therapies"},{"card":{"key":"41117729-a208-4482-9a49-3597d36d3194","authorName":"Shanna Barnes; Myra Reinhardt","authorCompany":"Lash Group","date":"May 2020","description":"","img":{"alt":"","src":"-/media/assets/lashgroup/images/9-news-events/screen-shot-20200501-at-25749-pm.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-webinar---part-2-leveraging-ai-within-ebv","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar Part 2: Leveraging AI within eBV to speed access to therapy"},"categories":["patient support services","affordability","product access","commercialization","technology"],"segments":["manufacturers"],"timestamp":637254036000000000,"title":"webinar part 2: leveraging ai within ebv to speed access to therapy"},{"card":{"key":"d9721eaf-ff66-42ad-8da8-8d456e806d7d","authorName":"AmerisourceBergen","authorCompany":"","date":"August 2022","description":"","img":{"alt":"Abstract image of Red Color Illuminated Fiber Optics Selective Focus on Blue Background.","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1179988450_rgb_large_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/three-reasons-why-early-planning-is-critical-for-hta-countries","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Market access abroad: Three reasons why early planning is critical for HTA countries"},"categories":["market access","regulatory"],"segments":["manufacturers"],"timestamp":637967963050000000,"title":"market access abroad: three reasons why early planning is critical for hta countries"},{"card":{"key":"3e5efdef-91de-483f-bee8-4bc4110e6ebb","authorName":"Lash Group","authorCompany":null,"date":"June 2019","description":"How adherence solutions are evolving -- with some high-tech help. Originally published on FiercePharma.com.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2019-hightech-trends-how-patient-adherence-and-engagement-solutions-are-evolving","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"High-Tech Trends: How Patient Adherence and Engagement Solutions Are Evolving"},"categories":["engagement","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636950863200000000,"title":"high-tech trends: how patient adherence and engagement solutions are evolving"},{"card":{"key":"85719e40-bd19-4fc1-83eb-4a644b30ad8f","authorName":"Dale Hanna","authorCompany":"Lash Group","date":"September 2022","description":"Why do patients struggle with medication adherence even when they know it will help them? In part one of a two-part article series from Lash Group, discover how the most advanced patient support programs use behavioral science to unlock adherence.","img":{"alt":"Physician discussing medication bedside","src":"-/media/assets/amerisourcebergen/patient-care_physicians/hs_patcare_bedside_fmphys_mpat_meds_006-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/uncommon-commonalities-part-one","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"Uncommon commonalities: Applying behavioral economics to medication adherence"},"categories":["medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637981693200000000,"title":"uncommon commonalities: applying behavioral economics to medication adherence"},{"card":{"key":"f5f20fd3-acd8-44c9-8884-5b09eb630e64","authorName":"Lash Group","authorCompany":null,"date":"May 2020","description":"Patient support providers are a vital link that enables the type of industry-wide collaboration that is needed to address access, affordability, and adherence issues now to make a substantial impact in the future. Hear from Tommy Bramley, PhD, on we can achieve better equilibrium across healthcare’s tension points and simplify the path to better outcomes.","img":{"alt":"","src":"-/media/assets/lashgroup/images/9-2-leadership-associates/lash-group-mk025-copy-(2)/lash-group-mk027-copy-(2).png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-simplifying-the-path-to-better-patient-outcomes---tommy-bramley","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Simplifying the Path to Better Patient Outcomes"},"categories":["commercialization","patient support services","affordability","product access","technology"],"segments":["manufacturers"],"timestamp":637244636400000000,"title":"simplifying the path to better patient outcomes"},{"card":{"key":"8697bdd7-33b7-45f9-8356-82de7c6825db","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2019","description":"Watch Volker Kirchner, Director of Temperature Control Solutions discuss how Cocoon is the industry's most dependable solution for transporting pallet-sized shipments of temperature-sensitive materials","img":{"alt":"A forklift loads a shipping container into a World Courier truck at a loading dock.","src":"-/media/assets/worldcourier/english/images/pharma-storage-and-distribution/storage/world-courier_delivery-truck_ny_074-(2).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/understand-the-innovation-behind-cocoon","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Video: Understand the Innovation Behind Cocoon"},"categories":["commercial supply chain","temperature control solutions","packaging"],"segments":[],"timestamp":636893703060000000,"title":"video: understand the innovation behind cocoon"},{"card":{"key":"88278f60-ff86-4b35-9ddf-27e9f6deb051","authorName":"Lash Group","authorCompany":null,"date":"May 2020","description":"","img":{"alt":"","src":"-/media/assets/lashgroup/images/9-2-leadership-associates/adobestock_313394356.jpeg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-webinar-patient-assistance-in-the-wake-of-covid19-lash-group-and-xcenda","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Patient Assistance in the Wake of COVID19"},"categories":["commercialization","covid-19","patient support services","affordability","product access"],"segments":["manufacturers"],"timestamp":637245396000000000,"title":"webinar: patient assistance in the wake of covid19"},{"card":{"key":"71534c9e-35cf-4494-9674-c79230e206a1","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2019","description":"Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/value-of-patient-and-provider-satisfaction","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Health Systems","headline":"Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies"},"categories":["analytics","specialty pharmacy","product access","market access"],"segments":["health systems","manufacturers"],"timestamp":636911312100000000,"title":"coordinated care: the value of patient and provider satisfaction within health system specialty pharmacies"},{"card":{"key":"29deffb4-2dd5-43c1-9576-440113cc9732","authorName":"Myra Reinhardt; Shanna Barnes","authorCompany":"Biopharma Services","date":"April 2020","description":"","img":{"alt":"","src":"-/media/assets/lashgroup/images/9-news-events/screen-shot-20200410-at-101907-am.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/2020-webinar--part-1-leveraging-ai-within-ebv-to-speed-access-to-therapy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar Part 1: Leveraging AI within eBV to speed access to therapy"},"categories":["patient support services"],"segments":["manufacturers"],"timestamp":637237917000000000,"title":"webinar part 1: leveraging ai within ebv to speed access to therapy"},{"card":{"key":"857292f2-cddf-4e55-98e4-65a07c9a0394","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2020","description":"What education and resources can manufacturers provide to build physician confidence in biosimilars? Learn what physicians want to know, what they need, and how you can help.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/biosims-video-thumb1.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/video-removing-barriers-for-biosimilars","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Video: Removing Barriers for Biosimilars"},"categories":["biosimilars","commercialization","reimbursement"],"segments":["manufacturers","physician practices"],"timestamp":637175633650000000,"title":"video: removing barriers for biosimilars"},{"card":{"key":"23882d83-5d2d-4425-989e-10c36bb6155e","authorName":"Innomar Strategies","authorCompany":null,"date":"April 2020","description":"Executive Q&A: Justin Evans, Director of Regulatory Operations at Innomar Strategies, discusses how his team works with clients to meet Health Canada's rigorous standards on the path to commercialization.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/3-questions-with---publishing-and-submissions","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Commercializing in Canada: Regulatory Publishing and Submissions"},"categories":["commercialization","regulatory"],"segments":["manufacturers"],"timestamp":637227180000000000,"title":"commercializing in canada: regulatory publishing and submissions"},{"card":{"key":"4e85c445-5c93-4f4c-aef0-66de35a167ff","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2020","description":"The success of a manufacturer’s product depends heavily on provider uptake, patient and provider access to the product, and demonstrating product value to payers. And while all these touchpoints may happen at various stages of the product life cycle, they’ve all been impacted by COVID-19. ","img":{"alt":"","src":"-/media/assets/amerisourcebergen/homepage/coronavirus_stock.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/virtual-drug-commercialization-ebook","linkText":"Download ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Ebook: Virtual drug commercialization"},"categories":["covid-19","commercialization","distribution","market access","marketing"],"segments":["manufacturers"],"timestamp":637398568800000000,"title":"ebook: virtual drug commercialization"},{"card":{"key":"22dfc1f5-ba3f-4244-b6a3-837931afc1b8","authorName":"Alex Guite","authorCompany":"World Courier","date":"June 2020","description":"","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/direct-to-patient/shutterstock_1259963869-lr.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-on-demand---dtp-the-future-of-clinical-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Webinar on-demand: DtP - The Future of Clinical Trials?"},"categories":["direct-to-patient","clinical trial logistics","patient care","patient support services"],"segments":[],"timestamp":637291351200000000,"title":"webinar on-demand: dtp - the future of clinical trials?"},{"card":{"key":"b3a857a3-8006-4988-b7eb-a6ac8c6c41b8","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2022","description":"","img":{"alt":"Cell and gene therapy Alternate payer engagement models","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/alternate-payer-engagement-models.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/alternate-payer-engagement-models-are-changing-the-landscape","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Alternate payer engagement models are changing the landscape"},"categories":["cell and gene therapy","commercialization","innovation","value-based care"],"segments":["manufacturers"],"timestamp":637950527700000000,"title":"alternate payer engagement models are changing the landscape"},{"card":{"key":"4cc160ac-b318-4f5f-9eb4-8f9f83a0fcc6","authorName":"Innomar Strategies","authorCompany":null,"date":"April 2021","description":"Now more than ever, Canadian payers and regulators find value in outcomes-based evidence beyond randomized controlled trials in regulatory and reimbursement decision-making. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-value-of-rwe-in-canadian-drug-commercialization-part-2","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2"},"categories":["market access","regulatory","commercialization","data"],"segments":["manufacturers"],"timestamp":637533936000000000,"title":"the value of real-world evidence in canadian drug commercialization: part 2"},{"card":{"key":"439159b8-a3a8-4422-8595-2b84792e8889","authorName":"Tasmina Hydery; Sara Linnerooth","authorCompany":"","date":"March 2022","description":"Discussing the transition of going from platform users to employees of FormularyDecisions with the power to affect change.","img":{"alt":"Coworkers at meeting","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1179568324_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/6-insights-driving-formularydecisions-evolution","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Six insights driving the evolution of FormularyDecisions®"},"categories":["market access","product access","technology"],"segments":["manufacturers"],"timestamp":637843252400000000,"title":"six insights driving the evolution of formularydecisions®"},{"card":{"key":"4629da30-a2c3-4988-b64c-aafd73d4495f","authorName":"Bre Penzner; Nancy Young","authorCompany":"Xcenda","date":"May 2020","description":"How Xcenda's VIP 2.0 platform allowed a gene therapy manufacturer to conduct an all-virtual payer value messaging workshop during the COVID-19 pandemic.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/megaphone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/the-value-of-virtual","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving"},"categories":["commercialization","covid-19","market access","technology"],"segments":["manufacturers"],"timestamp":637263676780000000,"title":"the value of virtual: how remote workshops can keep market access efforts moving"},{"card":{"key":"b12ce289-cd07-4d04-a275-0c7fb497413a","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2018","description":"How is manufacturer thinking around channel strategy changing for oral oncolytics?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-new-approach-to-channel-strategy-for-oncology-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"A New Approach to Channel Strategy for Oncology Therapies"},"categories":["affordability","commercialization","distribution","product access","oncology"],"segments":["manufacturers"],"timestamp":636604430600000000,"title":"a new approach to channel strategy for oncology therapies"},{"card":{"key":"4fb71974-dd87-4f81-9fab-91fcf238c279","authorName":"Lash Group","authorCompany":null,"date":"December 2021","description":"What three things do manufacturers need to know as they build the copay solution of the future? Lash Group simplifies the complex future of copay.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/piggy-bank.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/three-considerations-for-patient-forward-copay-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient-forward copay solutions: Three considerations for building effective support"},"categories":["affordability","commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637751051050000000,"title":"patient-forward copay solutions: three considerations for building effective support"},{"card":{"key":"0ef97a4c-bc7e-4086-a00b-480011559add","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2021","description":"What does it take to deliver patient support that makes an impact on medication adherence? Lash Group shares tips for transforming your adherence program.","img":{"alt":"medication adherence services ebook","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-true-blue-waves.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/adherence-ebook","linkText":"Get the ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"eBook: Making an impact on medication adherence"},"categories":["commercialization","engagement","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637575732450000000,"title":"ebook: making an impact on medication adherence"},{"card":{"key":"355ff791-8954-40a3-8577-7c3dab8252a8","authorName":"Dale Hanna","authorCompany":"Lash Group","date":"August 2019","description":"What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/uncommon-commonalities-part-two","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Uncommon Commonalities: A Patient-Centric Strategy for Improving Medication Adherence"},"categories":["commercialization","data","engagement","medication adherence","patient support services","technology","analytics"],"segments":["manufacturers"],"timestamp":637027524000000000,"title":"uncommon commonalities: a patient-centric strategy for improving medication adherence"},{"card":{"key":"7fea2a0c-7722-4d71-a525-16f7276bae02","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2018","description":"Patients face a growing number of barriers that can impede medication access and adherence. How can manufacturers help address these hurdles? ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/understanding-and-addressing-critical-barriers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Understanding and Addressing Critical Barriers"},"categories":["medication adherence","patient support services","technology","affordability"],"segments":["manufacturers"],"timestamp":636673696430000000,"title":"understanding and addressing critical barriers"},{"card":{"key":"8149e3ca-0976-41b5-acc9-0dca9f6c1353","authorName":"Simon Ellison","authorCompany":"World Courier","date":"June 2019","description":"Should the clinical supply chain be the same as the commercial supply chain for advanced therapies? Find out here. ","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/article-images/woman-looking-through-microscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/advanced-therapies-commercial-supply-chain-lesson-for-clinical-trial-success","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Article: Advanced Therapy Commercial Supply Chain Lessons for Clinical Trial Success"},"categories":["clinical trial logistics","cell and gene therapy","commercial supply chain"],"segments":[],"timestamp":636965301160000000,"title":"article: advanced therapy commercial supply chain lessons for clinical trial success"},{"card":{"key":"e5f57fec-d90a-45b6-a7d4-36dd278ab588","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2017","description":"An interview with Matt George, patient advocate and survivor of paroxysmal nocturnal haemoglobinuria (PNH), a debilitating, rare and life-threatening disorder.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/understanding-the-rare-disease-journey","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Understanding the Rare Disease Journey"},"categories":["orphan drugs","patient support services"],"segments":["manufacturers"],"timestamp":636228799800000000,"title":"understanding the rare disease journey"},{"card":{"key":"fa576693-2e6d-44c4-819f-e66cd162b3b3","authorName":"Xcenda","authorCompany":null,"date":"January 2021","description":"Learn how Xcenda designed and launched a best-in-class field reimbursement and access program with a pharmaceutical manufacturer","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/an-innovative-field-reimbursement-program-expands-patient-access","linkText":"Read the case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: an innovative field reimbursement program expands patient access"},"categories":["market access","reimbursement","product access"],"segments":["manufacturers"],"timestamp":637456519200000000,"title":"case study: an innovative field reimbursement program expands patient access"},{"card":{"key":"9afae7d0-6b3c-4163-8608-53fa5f30fda7","authorName":"Corey Ford, MHA; Dale Hanna","authorCompany":"Xcenda","date":"December 2020","description":"Over the past four years, commercial health plans and pharmacy benefit managers have devised copay accumulator programs, which exclude the use of manufacturer-sponsored commercial copay assistance from a patient’s accrual of out-of-pocket (OOP) expenses throughout a plan benefit year. As the use of copay accumulators continues against pharmacy benefit drugs, commercial plans may explore new models targeting medical benefit products.","img":{"alt":"lash group copay accumulator program","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-the-growing-utilization-of-copay-accumulator-programs","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: the growing utilization of copay accumulator programs"},"categories":["affordability","commercialization","reimbursement","patient support services","policy"],"segments":["manufacturers"],"timestamp":637431252000000000,"title":"webinar: the growing utilization of copay accumulator programs"},{"card":{"key":"9feaec27-76e0-45b1-aaf5-37859c5c43fd","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Learn best practices on using HEOR in rare drug development

","img":{"alt":"Male and female coworker at conference table","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1180036737_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/answering-the-challenges-of-rare-disease-market-access-with-heor","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Answering the challenges of rare disease market access with HEOR"},"categories":["commercialization","market access","clinical trial logistics","research"],"segments":["manufacturers"],"timestamp":637976439000000000,"title":"answering the challenges of rare disease market access with heor"},{"card":{"key":"ae89d12e-dd9f-4f66-b29b-23a0e7be21f6","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Learn how Lash Group is leveraging mobile app engagement within patient support programs to improve medication adherence.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/man-wearing-pink-mask-using-mobile-phone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-is-a-digital-companion-and-how-is-it-changing-patient-support-for-the-better","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What is a digital companion, and how is it changing patient support for the better?"},"categories":["commercialization","medication adherence","innovation","technology"],"segments":["manufacturers"],"timestamp":637548013880000000,"title":"what is a digital companion, and how is it changing patient support for the better?"},{"card":{"key":"328f08c7-d81a-4d0c-9a26-3b052ec5c00b","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2019","description":"We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilar-physician-insights-survey","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars Check Up: Physician Survey Results"},"categories":["biosimilars"],"segments":["manufacturers","pharmacies"],"timestamp":637037227980000000,"title":"biosimilars check up: physician survey results"},{"card":{"key":"5362b8cb-2fe5-44cd-8834-8bf0db493b32","authorName":"AmerisourceBergen","authorCompany":"","date":"August 2022","description":"The annual reverification (AR) period is a time when the right combination of talent and technology can minimize disruptions in therapy for hundreds of thousands of patients. As a manufacturer, what do you need to know about annual reverification?","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/insurance-card-and-tablet.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-manufacturers-need-to-know-about-annual-reverification","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What biopharma companies need to know about annual reverification"},"categories":["affordability","commercialization","patient support services","product access","technology","innovation"],"segments":["manufacturers"],"timestamp":637970395800000000,"title":"what biopharma companies need to know about annual reverification"},{"card":{"key":"b34ae610-8989-4c33-932f-70def0f0071f","authorName":"Myra Reinhardt","authorCompany":"Biopharma Services","date":"March 2020","description":"Executive Q&A: Myra Reinhardt, Lash Group's Vice President of Product Innovation and Analytics, discusses why it's critical for even the most high-tech patient support providers to keep patients at the center of everything they do.","img":{"alt":"lightbulb w patient DNA strand","src":"-/media/assets/amerisourcebergen/tecnhology/technology/lighbulb_dna.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/a-patient-centric-approach-to-technology-and-analytics","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"A Patient-Centric Approach to Technology and Analytics"},"categories":["affordability","commercialization","medication adherence","patient support services","product access","technology","data","analytics"],"segments":["manufacturers"],"timestamp":637201472350000000,"title":"a patient-centric approach to technology and analytics"},{"card":{"key":"581c238c-c2dc-4148-bfd9-d46bce5aef7e","authorName":"Ana Stojanovska; Myra Reinhardt","authorCompany":"Biopharma Services","date":"July 2021","description":"In this Q&A with experts from Xcenda and Lash Group, learn the latest on reimbursement and patient support for innovative cell and gene therapies.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-brand-colors-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-manufacturers-need-to-know-about-reimbursement-and-patient-support-for-cell-and-gene-therapies","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What manufacturers need to know about reimbursement and patient support for cell and gene therapies"},"categories":["cell and gene therapy","commercialization","patient support services","reimbursement"],"segments":["manufacturers"],"timestamp":637617994870000000,"title":"what manufacturers need to know about reimbursement and patient support for cell and gene therapies"},{"card":{"key":"e0a17b38-f179-40f1-857d-71e1781b2312","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"The latest approaches to access support are removing barriers to therapy for patients","img":{"alt":"Accelerating access to therapy","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/accelerating-access-to-therapy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/accelerating-access-to-therapy-a-view-from-the-front-lines","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: Accelerating access to therapy (a view from the front lines)"},"categories":["commercialization","market access","patient support services","product access"],"segments":["manufacturers"],"timestamp":637546136900000000,"title":"on-demand webinar: accelerating access to therapy (a view from the front lines)"},{"card":{"key":"96dca497-f7d8-485e-9d31-bf4dd71d1dea","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"The future of eBV is here. How manufacturers can use AI to help patients start life-changing therapies faster than ever.","img":{"alt":"White paper beyond the promise of artificial intelligence in electronic benefit verification","src":"-/media/assets/lashgroup/images/white-paper---beyond-the-promise-of-artificial-intelligence-in-electronic-benefit-verification.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/white-paper---beyond-the-promise-of-artificial-intelligence-in-electronic-benefit-verification","linkText":"Learn more","hasImage":true,"isImageMode":false,"label":"Manufacturers","headline":"White paper: beyond the promise of artificial intelligence in electronic benefit verification"},"categories":["commercialization","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637153076400000000,"title":"white paper: beyond the promise of artificial intelligence in electronic benefit verification"},{"card":{"key":"fd624898-5fd5-4461-9ad2-abe1ce08f60b","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2019","description":"We asked 100 physicians to share their perspectives on biosimilar utilization, cost savings, and adoption barriers. See what they said and what it means for the market and manufacturers.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilar-adoption-in-the-united-states","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars Check Up: Part 2"},"categories":["biosimilars"],"segments":["manufacturers"],"timestamp":637131403800000000,"title":"biosimilars check up: part 2"},{"card":{"key":"befca0f9-41b7-45e8-9a37-1885820c5b3d","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2021","description":"Is field reimbursement and access support worth the investment? We asked an expert.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-speaking-to-medical-audience.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/work-worth-doing-field-solutions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Work worth doing: Innovative field solutions"},"categories":["commercialization","covid-19","data","innovation","market access","reimbursement","product access"],"segments":["manufacturers"],"timestamp":637593898800000000,"title":"work worth doing: innovative field solutions"},{"card":{"key":"fc60944d-23de-4d5e-837d-981f62e7adbb","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. To date, there have been 34 approvals and 22 launches in the U.S. biosimilar market. As this market matures, its pipeline continues to grow. This reference guide is a useful tool for visualizing the current product landscape and potential future of this emerging market.","img":{"alt":"Biosimilar_2020_Pipeline","src":"-/media/assets/worldcourier/english/images/worldcourier_2_3-card-05-min.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilar-pipeline-report","linkText":"Download report","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Biosimilars pipeline report: A guide for understanding the growing market"},"categories":["biosimilars","our role in healthcare"],"segments":["manufacturers"],"timestamp":637922682000000000,"title":"biosimilars pipeline report: a guide for understanding the growing market"},{"card":{"key":"ed322e44-2856-404d-a2b9-fb5cd9879c00","authorName":"Laurie Fazio","authorCompany":"Xcenda","date":"May 2021","description":"Laurie Fazio, Head of FormularyDecisions Market Access Solutions & Growth Strategies at Xcenda, covers why the information exchange platform is worth a pharmaceutical manufacture's investment of time and resources.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-blues-tech.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/work-worth-doing-formularydecisions","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Work worth doing: FormularyDecisions"},"categories":["commercialization","covid-19","data","innovation","market access","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637577372200000000,"title":"work worth doing: formularydecisions"},{"card":{"key":"9771a472-192a-457c-989f-ff05d562593f","authorName":"Xcenda","authorCompany":null,"date":"September 2019","description":"How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilars-launch-insights-from-the-field","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars: Launch Insights From the Field"},"categories":["biosimilars","commercialization","market access"],"segments":["manufacturers"],"timestamp":637044504690000000,"title":"biosimilars: launch insights from the field"},{"card":{"key":"12687964-8515-46e9-8be3-e8ee824664c0","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2021","description":"Biosimilars have made great strides since the first US launch, but there still appears to be room for growth in their uptake. Download these slides to learn more about how payer decision-making is affecting overall adoption of biosimilars, cost reduction and ultimately impact on patients.
","img":{"alt":"Market access professionals","src":"-/media/assets/xcenda/english/images/solutions/marketaccessleaders.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/webinar-uptake-or-heartbreak-with-biosimilars-progress-and-perspectives","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: uptake or heartbreak with biosimilars? Progress and perspectives"},"categories":["biosimilars","reimbursement","market access"],"segments":["manufacturers"],"timestamp":637497760150000000,"title":"webinar: uptake or heartbreak with biosimilars? progress and perspectives"},{"card":{"key":"bf54b080-77de-419c-afa5-e10a1cd99deb","authorName":"Innomar Strategies","authorCompany":null,"date":"April 2020","description":"Executive Q&A: Quality Assurance expert Stuart du Kamp talks about the need for QA to adapt to new industry trends, the benefits of a long-term quality improvement plan, and what manufacturers can gain from integrated solutions. ","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/3-questions-with---quality-assurance-and-gmp-services","linkText":"Learn more","hasImage":false,"isImageMode":true,"label":"Manufacturers","headline":"Commercializing in Canada: Quality Assurance and GMP Services"},"categories":["commercialization","regulatory"],"segments":["manufacturers"],"timestamp":637227216000000000,"title":"commercializing in canada: quality assurance and gmp services"},{"card":{"key":"2ec87069-3afa-40c8-9c7d-29e7fbf11265","authorName":"Bill Smith","authorCompany":"Biopharma Services","date":"August 2020","description":"Executive Q&A: Lash Group's Bill Smith explains how a patient support provider's operational makeup impacts the manufacturer and patient experience.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/whiteboard.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-a-unified-approach-to-business-excellence-means-for-patient-support-program-success","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What a unified approach to business excellence means for patient support program success"},"categories":["commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637329453720000000,"title":"what a unified approach to business excellence means for patient support program success"},{"card":{"key":"84636f6c-7e87-4af5-b56f-a64b64a18b24","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2022","description":"","img":{"alt":"Channel strategy for a rare disease product","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/channel-strategy-for-a-rare-disease-product.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/what-to-consider-when-building-a-channel-strategy-for-a-rare-disease-product","linkText":"Download checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"What to consider when building a channel strategy for a rare disease product"},"categories":["commercial supply chain","commercialization","distribution","orphan drugs"],"segments":["manufacturers"],"timestamp":637958312630000000,"title":"what to consider when building a channel strategy for a rare disease product"},{"card":{"key":"e70732e1-44dd-467d-b5f2-20137808b530","authorName":"Dawn Herren, RN, MSN","authorCompany":"Lash Group","date":"December 2018","description":"Why is accreditation important for patient support program providers?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/why-accreditation-matters-for-patient-support-providers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Why Accreditation Matters for Patient Support Providers"},"categories":["medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":636796267730000000,"title":"why accreditation matters for patient support providers"},{"card":{"key":"622d0d5a-2fab-40dc-947b-6f91629fccb7","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2022","description":"","img":{"alt":"barriers to biosimilar adoption","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/barriers-to-biosimilar-adoption.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/why-biopharma-companies-must-understand-barriers-to-biosimilar-adoption","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Why biopharma companies must understand barriers to biosimilar adoption"},"categories":["biosimilars","product access"],"segments":["manufacturers"],"timestamp":637874519320000000,"title":"why biopharma companies must understand barriers to biosimilar adoption"},{"card":{"key":"bdacd407-6cfb-43c5-a87d-64ea5ce89cfb","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2021","description":"How two AmerisourceBergen companies are partnering to deliver an innovative clinical trial solution during the COVID-19 pandemic and beyond.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/nurse-and-patient-in-home.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/adding-nursing-support-to-at-home-clinical-trials","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Innovation spotlight: Adding nursing support to at-home clinical trials"},"categories":["clinical trial logistics","covid-19","direct-to-patient","medication adherence","innovation"],"segments":["manufacturers"],"timestamp":637515970580000000,"title":"innovation spotlight: adding nursing support to at-home clinical trials"},{"card":{"key":"dbefd793-5bbe-4820-808b-62c165aade20","authorName":"Tanya Mericle","authorCompany":"AmerisourceBergen","date":"May 2022","description":"Happy employees go above and beyond for customers","img":{"alt":"A customer laughing joyfully as a pharmacist helps her find the medication she needs","src":"-/media/assets/gnp/images/gnp-insights-patient-satisfaction.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/keeping-patients-satisfied-when-your-pharmacy-is-short-staffed","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Keeping patients satisfied when your pharmacy is short staffed"},"categories":["good neighbor pharmacy","pharmacy operations","patient care"],"segments":[],"timestamp":637879437940000000,"title":"keeping patients satisfied when your pharmacy is short staffed"},{"card":{"key":"3a48e668-d468-4c82-be8a-6a4e37cd59d9","authorName":"Shemeka Johnson","authorCompany":"Lash Group","date":"March 2021","description":"Shemeka Johnson, Senior Director of Operations at Lash Group, discusses how social determinants of health impact patient access to medication and explains why it's important for manufacturers to develop a deep understanding of the patients they serve.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-at-desk.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/addressing-health-disparities-through-understanding","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Addressing health disparities through understanding"},"categories":["affordability","patient support services","health equity","product access"],"segments":["manufacturers"],"timestamp":637526343540000000,"title":"addressing health disparities through understanding"},{"card":{"key":"b8d6f7fd-9758-4e64-886a-983e92faeb26","authorName":"Jeff Buck","authorCompany":"Biopharma Services","date":"August 2021","description":"Jeff Buck, Vice President of Strategy & Market Development at Lash Group, shares his thoughts on what makes patient support services worth a manufacturer's investment and how these programs pay off in patient outcomes.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/callcenter-remote-female.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/work-worth-doing-patient-support-services","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Work worth doing: Patient support services"},"categories":["affordability","commercialization","innovation","medication adherence","patient support services","product access","technology"],"segments":["manufacturers"],"timestamp":637659317480000000,"title":"work worth doing: patient support services"},{"card":{"key":"5755c5d2-cdd5-4c3f-bef9-3f2806a05c86","authorName":"Lash Group","authorCompany":null,"date":"October 2021","description":"The manufacturer of a leading biologics therapy improved therapy initiation among targeted patient groups using an AI-powered patient support program.","img":{"alt":"Lash Group Artificial Intelligence Patient Support Program","src":"-/media/assets/lashgroup/images/ai_technology_innovation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/ai-case-study","linkText":"Get the case study","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: Improving therapy initiation with an AI-guided patient support program"},"categories":["commercialization","data","analytics","engagement","product access","patient support services","innovation","technology"],"segments":["manufacturers"],"timestamp":637699274250000000,"title":"case study: improving therapy initiation with an ai-guided patient support program"},{"card":{"key":"4c240c5d-c03b-4a65-b0b1-c150c6fb8cf5","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2021","description":"Collaboration has been at the epicenter of the world's response to COVID-19 and other imperatives across the healthcare ecosystem. But it's not just private-private alliances that get things done. Public-private collaborations are just as important.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-policy-flag-stethoscope.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/working-with-government-entities-to-advance-access-affordability-and-supply-chain-stability","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Working with government entities to advance access, affordability, and supply chain stability"},"categories":["advocacy","affordability","product access","distribution","policy","reimbursement"],"segments":["manufacturers"],"timestamp":637745870470000000,"title":"working with government entities to advance access, affordability, and supply chain stability"},{"card":{"key":"64d28c6e-027a-4c32-b37a-07c3aeaabb9a","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2021","description":"Melissa Mulchaney, Vice President of Field Services Client Engagement and Business Development at Xcenda, weighs in on the most important qualities to look for when building a field services team.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-insurance-claim-form.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/building-your-field-reimbursement-and-access-team","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Building your field reimbursement and access team: The translational experience and skills that matter most"},"categories":["affordability","commercialization","market access","reimbursement","product access"],"segments":["manufacturers"],"timestamp":637672436550000000,"title":"building your field reimbursement and access team: the translational experience and skills that matter most"},{"card":{"key":"43f4e1a9-024e-438a-80e5-c5aad4477d31","authorName":"Xcenda","authorCompany":null,"date":"September 2022","description":"","img":{"alt":"Patient support services","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/gettyimages-1055509742_srgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/youve-created-a-good-patient-support-program-now-make-it-great","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: You’ve created a good patient support program, now make it great"},"categories":["commercialization","marketing","patient support services"],"segments":["manufacturers"],"timestamp":638001437840000000,"title":"on-demand webinar: you’ve created a good patient support program, now make it great"},{"card":{"key":"2fa38be8-99e9-4b5c-b681-a66fbb34b47e","authorName":"Lash Group","authorCompany":null,"date":"April 2021","description":"The manufacturer of a leading biologic therapy used digital communications to improve medication adherence among targeted patient groups as they enrolled in a patient support program for the therapy.","img":{"alt":"digital companion medication adherence solutions","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ab-brand-abstract-swirls.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/case-study-improving-medication-adherence-with-a-digital-companion","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: Improving medication adherence with a digital companion"},"categories":["medication adherence","patient support services","innovation","commercialization"],"segments":["manufacturers"],"timestamp":637544736000000000,"title":"case study: improving medication adherence with a digital companion"},{"card":{"key":"7b294fc9-ca69-480e-9713-1b15d21a0798","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2021","description":"Novel cell and gene therapies require a different approach to the clinical supply chain. AmerisourceBergen and TrakCel experts will discuss key considerations for product owners during clinical development. Hear lessons learned from the latest cell and gene therapy clinical trials and insights on what you need to know about the clinical development journey.","img":{"alt":"optimal cell and gene therapy supply chain and tracking outcomes","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/cell-and-gene-therapies-clinical-supply-chain-considerations.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cell-and-gene-therapies-clinical-supply-chain-considerations","linkText":"Watch now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar | Cell and gene therapies: Clinical supply chain considerations"},"categories":["cell and gene therapy","clinical trial logistics","commercial supply chain","commercialization","distribution","secure supply chain"],"segments":["manufacturers"],"timestamp":637635945480000000,"title":"webinar | cell and gene therapies: clinical supply chain considerations"},{"card":{"key":"32653322-7820-46bc-a387-69161b4d80e5","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2021","description":"The journey from clinical to commercial for vein-to-vein autologous therapies can be challenging and complex. Manufacturers need to understand all of the key aspects of the value chain to ensure an effective transition. ","img":{"alt":"Autologous cell and gene therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/clinical-to-commercial-transition-for-autologous-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/clinical-to-commercial-transition-for-autologous-therapies","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Key insights on the clinical to commercial transition for autologous therapies"},"categories":["cell and gene therapy","clinical trial logistics","commercialization"],"segments":["manufacturers"],"timestamp":637673208120000000,"title":"webinar: key insights on the clinical to commercial transition for autologous therapies"},{"card":{"key":"29e1d842-e156-41c7-9991-672cabbb6d35","authorName":"AmerisourceBergen","authorCompany":null,"date":"August 2021","description":"The commercialization of novel cell and gene therapies requires smart strategy and integrated solutions. Hear from AmerisourceBergen and TrakCel experts as they discuss key elements to consider when preparing, designing, and implementing a plan for moving from clinical to commercial. ","img":{"alt":"Commercial supply chain strategies for cell and gene therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/cell-and-gene-therapies-clinical-supply-chain-considerations/commercial-supply-chain-strategies-for-cell-and-gene-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercial-supply-chain-strategies-for-cell-and-gene-therapies","linkText":"Watch on demand","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Commercial supply chain strategies for cell and gene therapies"},"categories":["cell and gene therapy","clinical trial logistics","commercial supply chain","commercialization","distribution","secure supply chain"],"segments":["manufacturers"],"timestamp":637642857000000000,"title":"webinar: commercial supply chain strategies for cell and gene therapies"},{"card":{"key":"d0a6c071-7c40-40d3-ac6d-8c4590fd471d","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Success factors for commercializing rare disease and orphan drugs ","img":{"alt":"Commercializing rare and orphan disease products","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/commercializing-rare-and-orphan-disease-products.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercializing-a-new-orphan-or-rare-disease-product","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On-demand webinar: Success factors for commercializing rare disease and orphan drugs"},"categories":["cell and gene therapy","commercialization","distribution","innovation","orphan drugs"],"segments":["manufacturers"],"timestamp":637550298000000000,"title":"on-demand webinar: success factors for commercializing rare disease and orphan drugs"},{"card":{"key":"ce11e0ef-c053-4013-9a31-ec26a8533801","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2019","description":"An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilars-shaping-a-moving-market","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars: Shaping a Moving Market"},"categories":["biosimilars","commercialization"],"segments":["manufacturers"],"timestamp":637043607390000000,"title":"biosimilars: shaping a moving market"},{"card":{"key":"6df65be6-2d53-4fb8-8f34-ba49404047da","authorName":"Lash Group","authorCompany":null,"date":"August 2021","description":"Lash Group experts share strategies for commercializing digital therapies and supporting patients who use them in this ebook developed in partnership with Pharmaceutical Executive.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-using-smartphone-on-yellow-couch.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/bringing-innovation-to-market-with-digital-therapeutics-ebook","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"eBook: Bringing innovation to market with digital therapeutics"},"categories":["affordability","commercialization","data","market access","medication adherence","patient support services","innovation","product access","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637655118740000000,"title":"ebook: bringing innovation to market with digital therapeutics"},{"card":{"key":"343fc1a6-b3fa-4862-ae9f-2a0bf5686950","authorName":"Shanna Barnes","authorCompany":"Lash Group","date":"April 2020","description":"Executive Q&A: How do you know you're working with a consultative patient support provider?","img":{"alt":"Six people at a conference table","src":"-/media/assets/amerisourcebergen/business-interactions/meetingconfroomgrouplarge11160082.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/building-partnerships-and-scaling-services-to-patient-needs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Building Partnerships and Scaling Services to Patient Needs"},"categories":["commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637221336770000000,"title":"building partnerships and scaling services to patient needs"},{"card":{"key":"3108a61a-e890-4277-94f0-7e6115e43008","authorName":"Lash Group","authorCompany":null,"date":"August 2019","description":"Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/case-study-improving-speed-to-therapy-with-provider-portals","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Case Study: Improving Speed to Therapy With Provider Portals"},"categories":["commercialization","patient support services","technology"],"segments":["manufacturers"],"timestamp":637027904170000000,"title":"case study: improving speed to therapy with provider portals"},{"card":{"key":"a214f039-0fe1-4314-a81e-f91b55762643","authorName":"Lash Group","authorCompany":null,"date":"January 2020","description":"Lash Group measured the impact of an adherence program on multiple myeloma patients. See the difference nurse navigators made on therapy adherence.","img":{"alt":"","src":"-/media/assets/lash/images/pagedesign_infusion.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/case-study-real-world-benefits-of-an-oncology-navigation-program","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Case study: real-world benefits of an oncology navigation program"},"categories":["commercialization","engagement","patient support services","medication adherence"],"segments":["manufacturers"],"timestamp":637157439930000000,"title":"case study: real-world benefits of an oncology navigation program"},{"card":{"key":"909e393a-afad-438b-8692-d975c2a3175c","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2020","description":"With the potential of 40+ groundbreaking cell and gene therapy products FDA-approved by 2024, manufacturers are looking for innovative ways to successfully bring these therapies to market. Join AmerisourceBergen experts as they discuss commercialization considerations that manufacturers should know.","img":{"alt":"Lab tech with DNA","src":"-/media/assets/xcenda/english/images/expertise/cgt-dna_bw.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/cell-and-gene-therapy-session","linkText":"Watch the webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Cell and gene therapies: bringing innovation to market"},"categories":["cell and gene therapy","commercialization","market access"],"segments":["manufacturers"],"timestamp":637432167000000000,"title":"cell and gene therapies: bringing innovation to market"},{"card":{"key":"7b9ba7be-1d46-4028-8121-b0e905501394","authorName":"Xcenda","authorCompany":null,"date":"February 2021","description":"More and more manufacturers recognize that the key to improving patient access and speed to therapy is to deploy an experienced field services team. Learn how Xcenda can help. ","img":{"alt":"xcenda field services working on project","src":"-/media/assets/xcenda/english/images/01-home-page-new-images/xcenda_1upcard_03.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/checklist-four-things-to-look-for-in-a-field-services-partner","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Checklist: Four things to look for in a field services partner"},"categories":["reimbursement","market access","commercialization"],"segments":["manufacturers"],"timestamp":637486886930000000,"title":"checklist: four things to look for in a field services partner"},{"card":{"key":"0e06d61e-f5da-402a-9ec4-7aa5e43872aa","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Experts from AmerisourceBergen and TrakCel recently participated in a webinar on commercial supply chain strategies for cell and gene therapies. In this webinar recap, you'll get highlights from the conversation and fast facts on optimizing the commercial supply chain. Think of it like Cliff's Notes for important ideas in the CGT space.","img":{"alt":"Cell and gene therapy cryogenic storage","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ics_brooks_3pl_cryogenic_088_rgb_rtchd_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/clinical-supply-chain-for-cell-and-gene-therapies","linkText":"Download PDF","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Managing clinical supply chain complexity for cell and gene therapies"},"categories":["cell and gene therapy","clinical trial logistics","direct-to-patient","technology","temperature control solutions"],"segments":["manufacturers"],"timestamp":637786523360000000,"title":"managing clinical supply chain complexity for cell and gene therapies"},{"card":{"key":"59a3cbc6-55c8-431d-be87-3931bd72f592","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Heightened collaboration among all stakeholders, including payers and biopharma companies, is critical to close the pre-approval information gaps and maximize the opportunities that PIE presents.","img":{"alt":"AB color abstract ","src":"-/media/assets/xcenda/english/images/01-home-page-new-images/gettyimages-1299992609-rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/closing-the-gap-in-preapproval-information-exchange","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Closing the gaps in pre-approval information exchange to accelerate product success and patient access"},"categories":["commercialization","data","policy","regulatory","market access"],"segments":["manufacturers"],"timestamp":637976490910000000,"title":"closing the gaps in pre-approval information exchange to accelerate product success and patient access"},{"card":{"key":"8d97f901-9efc-4c4d-85b6-09fbb12ecb4a","authorName":"Sean McGowan; Rick Lozano ","authorCompany":"AmerisourceBergen","date":"September 2019","description":"The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/biosimilars-market-insights-and-growth-factors","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Biosimilars: Market Insights and Growth Factors"},"categories":["biosimilars","commercialization","market access"],"segments":["manufacturers"],"timestamp":637045170800000000,"title":"biosimilars: market insights and growth factors"},{"card":{"key":"f8e801e0-5b07-4940-8fc4-5a7b496f9089","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2017","description":"Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/commercializing-cell-and-gene-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Commercializing Cell and Gene Therapies"},"categories":["cell and gene therapy","third party logistics","commercialization","reimbursement","commercialization","product access","affordability"],"segments":["manufacturers"],"timestamp":636348804000000000,"title":"commercializing cell and gene therapies"},{"card":{"key":"b17fbe7e-31df-4767-acde-688b0949e959","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2021","description":"What should cell and gene therapies manufacturers know about bringing these innovative treatments to market?","img":{"alt":"Considerations for the commercialization of cell and gene therapies","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/considerations-for-cell-and-gene-therapies.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/considerations-for-the-commercialization-of-cell-and-gene-therapies","linkText":"Watch webinar","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"On demand webinar: Considerations for the commercialization of cell and gene therapies"},"categories":["cell and gene therapy","commercialization","distribution","innovation","technology","temperature control solutions"],"segments":["manufacturers"],"timestamp":637521232770000000,"title":"on demand webinar: considerations for the commercialization of cell and gene therapies"},{"card":{"key":"b67421db-a6bb-4fcf-9cb2-fcfa5214f63a","authorName":"Corey Ford, MHA; Myra Reinhardt","authorCompany":"Xcenda","date":"July 2019","description":"Two experts in health economics and patient support team up to offer insight on how manufacturers can prepare for the impact of copay accumulators.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/copay-accumulators-are-your-patients-really-at-risk","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Copay Accumulators: Are Your Patients Really at Risk?"},"categories":["affordability","patient support services"],"segments":["manufacturers"],"timestamp":636995871930000000,"title":"copay accumulators: are your patients really at risk?"},{"card":{"key":"f3317fe3-12c9-4308-8530-87868e213144","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"AmerisourceBergen has the most diversified set of assets and businesses that can truly help biopharma companies successfully commercialize a product," says Tom Doyle, Senior Vice President of Sales, Chief Customer Officer, Biopharma Services.","img":{"alt":"Coworkers at meeting","src":"-/media/assets/xcenda/english/images/insights/gettyimages-1179568324_srgb_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/culture-people-and-an-investment-in-innovation-set-amerisourcebergen-apart","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Culture, people, and an investment in innovation set AmerisourceBergen apart"},"categories":["business performance","commercialization","our role in healthcare"],"segments":["manufacturers"],"timestamp":637938554430000000,"title":"culture, people, and an investment in innovation set amerisourcebergen apart"},{"card":{"key":"e385c07a-7873-4d3a-ab3c-369e44e9673b","authorName":"Lash Group","authorCompany":null,"date":"March 2020","description":"Benefits verification (BV) is built into the framework for physician-administered specialty therapies for good reason: it provides patients with both access to leading-edge care and clarity around out-of-pocket costs.","img":{"alt":"Access_to_therapy","src":"-/media/assets/xcenda/english/images/expertise/patientsmeds.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/data-analytics-enables-program-improvements-for-faster-therapy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Data Analytics Enables Program Improvements for Faster Access to Therapy"},"categories":["analytics","patient care","patient support services","product access","commercialization"],"segments":[],"timestamp":637194385800000000,"title":"data analytics enables program improvements for faster access to therapy"},{"card":{"key":"09570a88-b3df-433d-a1ba-67ff13266b30","authorName":"AmerisourceBergen","authorCompany":null,"date":"December 2019","description":"Learn how we are transporting the treatments that patients depend on every day worldwide ","img":{"alt":"","src":"-/media/assets/worldcourier/english/images/article-images/doctor-with-patient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/delivering-innovation-and-improving-lives","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"E-book: Delivering innovation, improving lives"},"categories":["clinical trial logistics","commercial supply chain","cell and gene therapy","commercialization","direct-to-patient","pharmaceutical storage and transport management"],"segments":[],"timestamp":637108978140000000,"title":"e-book: delivering innovation, improving lives"},{"card":{"key":"5c8d9534-e35f-48b1-af79-9297ee365a8e","authorName":"Xcenda","authorCompany":null,"date":"April 2022","description":"","img":{"alt":"Differentiate your product with FormularyDecisions","src":"-/media/assets/amerisourcebergen/manufacturer/differentiate-your-product-with-formularydecisions.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/differentiate-your-product-with-formularydecisions","linkText":"Watch video","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Differentiate your product with FormularyDecisions®"},"categories":["data","reimbursement","market access"],"segments":["manufacturers"],"timestamp":637864968600000000,"title":"differentiate your product with formularydecisions®"},{"card":{"key":"d4796d2c-63a5-44d8-b33f-b197f8e2ee12","authorName":"Xcenda","authorCompany":null,"date":"May 2020","description":"Virtual learning has become all the more relevant in a socially distanced world. Learn how manufacturers are transitioning training for field reimbursement teams out of the office.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/lightbulb-shatter.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/distant-but-engaged-transitioning-to-virtual-training","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Distant But Engaged: Transitioning to Virtual Training"},"categories":["commercialization","market access","reimbursement","covid-19"],"segments":["manufacturers"],"timestamp":637250701220000000,"title":"distant but engaged: transitioning to virtual training"},{"card":{"key":"a2c2be90-b2f6-4f2b-bcf5-6d3b778ababd","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2021","description":"Long before any therapy goes to market, manufacturers must make decisions that will ultimately influence commercial success. In the early days of drug development, manufacturers are navigating the near-term logistics of patient recruitment, clinical trial participation, compliance with regulatory requirements, and data collection.

With the right commercialization partner involved from the start, manufacturers can feel more confident that the drug development process establishes the best possible foundation for market entry—even when that may be months or years away.","img":{"alt":"Clinical Development Checklist","src":"-/media/assets/amerisourcebergen/manufacturer/clinical-development-checklist.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/drug-development-checklist","linkText":"Download checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Drug development checklist: What to look for in a commercialization partner"},"categories":["clinical trial logistics","commercialization","direct-to-patient","innovation","pharmaceutical storage and transport management","secure supply chain","temperature control solutions"],"segments":["manufacturers"],"timestamp":637535706700000000,"title":"drug development checklist: what to look for in a commercialization partner"},{"card":{"key":"bf89ba9a-7534-41c7-a9e5-d5ac405fbd04","authorName":"Lash Group","authorCompany":null,"date":"June 2021","description":"Patient support services are often tailored to pharmaceuticals. But they can also be beneficial in the emerging world of digital therapeutics. Here are a few ways to support patients in accessing new health technology.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/asian-woman-on-smartphone-at-home.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/dtx-critical-elements-for-building-effective-patient-support-programs","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Digital therapeutics: Critical elements for building effective patient support programs"},"categories":["affordability","commercialization","data","innovation","medication adherence","patient support services","technology"],"segments":["manufacturers"],"timestamp":637594752920000000,"title":"digital therapeutics: critical elements for building effective patient support programs"},{"card":{"key":"49c74168-067b-4d7a-9fb2-d1dd03ba3802","authorName":"Lash Group","authorCompany":null,"date":"June 2021","description":"Don't let a murky coverage landscape or a patient support program that can't keep pace hold your digital therapy back. Keep these do's and don'ts in mind as you commercialize your digital therapeutic.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/young-man-on-smartphone-pink-wall.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/dtx-dos-and-donts","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Patient support for digital therapeutics: Do's and don'ts for designing your program"},"categories":["affordability","commercialization","data","innovation","market access","patient support services","product access","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637595412680000000,"title":"patient support for digital therapeutics: do's and don'ts for designing your program"},{"card":{"key":"9ae4d205-b924-4ab4-b256-587cbb87ffef","authorName":"Lash Group","authorCompany":null,"date":"June 2021","description":"With the rapid growth of digital therapeutics, new products are entering a payer landscape that wasn't made for them. Here's how developers can adapt current payment models for emerging solutions.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/woman-on-smartphone-in-urban-setting.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/dtx-payer-landscape","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Navigating the payer landscape for digital therapeutics"},"categories":["affordability","data","commercialization","innovation","market access","medication adherence","patient support services","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637595437260000000,"title":"navigating the payer landscape for digital therapeutics"},{"card":{"key":"2ad36d44-e574-46bc-9f46-5fe466bfe0f1","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2021","description":"Distributors have become an essential source of market insights and customer connections, helping OTC healthcare products manufacturers reach consumers and raising the bar for what you should expect from a distribution partner.","img":{"alt":"stack of blue shopping baskets","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/consumer_shopping-baskets_stacked.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/ebook-the-evolution-of-the-otc-market","linkText":"Get the ebook","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"eBook: The evolution of the OTC market"},"categories":["consumer products"],"segments":["manufacturers"],"timestamp":637575664650000000,"title":"ebook: the evolution of the otc market"},{"card":{"key":"25ca12f5-f70b-47e3-8a7d-a4f68b9b9109","authorName":"Lash Group","authorCompany":null,"date":"September 2020","description":"The launch of a novel therapy can be simultaneously exciting and challenging. By following a phased approach, manufacturers can ensure their patient support program positions their therapy to improve outcomes for patients.","img":{"alt":"Man working on a laptop computer","src":"-/media/assets/xcenda/english/images/formularydecisions/formularydecisions-hero-3840x2194.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/essential-guide-launching-patient-support-for-a-novel-therapy","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Insight","headline":"Patient support launch guide: novel therapies "},"categories":["market access","marketing","medication adherence","patient support services","product access"],"segments":[],"timestamp":637362869400000000,"title":"patient support launch guide: novel therapies "},{"card":{"key":"0c324f6c-3ce3-4849-9593-43b1cf8144fb","authorName":"Lash Group","authorCompany":null,"date":"April 2021","description":"With multiple vendors vying to help you launch or optimize your patient support program, position yourself to make the biggest impact for patients by asking potential partners these questions.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/01-home-page-new-images/ab_textimage_01.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/five-questions-to-ask-a-potential-patient-support-partner","linkText":"Get the checklist","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Five questions to ask a potential patient support partner"},"categories":["affordability","commercialization","medication adherence","patient support services","product access","technology","innovation"],"segments":["manufacturers"],"timestamp":637534183330000000,"title":"five questions to ask a potential patient support partner"},{"card":{"key":"ce1434e2-5736-4bce-a565-70990a02b107","authorName":"Corey Ford, MHA","authorCompany":"Xcenda","date":"April 2020","description":"Executive Q&A: Patient assistance programs improve access to medication for today’s chronic, life-altering and difficult-to-manage diseases. Xcenda’s Corey Ford explains how COVID-19 could impact patient access and the programs supporting these patients.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/covid19/shutterstock_1620672310.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-covid-19-will-impact-patient-support","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How COVID-19 Will Impact Patient Support"},"categories":["covid-19","affordability","medication adherence","patient support services","product access"],"segments":["manufacturers"],"timestamp":637219767960000000,"title":"how covid-19 will impact patient support"},{"card":{"key":"a3420a29-6dbd-4334-b470-b9529f5491e4","authorName":"Xcenda","authorCompany":null,"date":"July 2019","description":"In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-digital-innovation-drives-improved-market-access-strategies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How Digital Innovation Drives Improved Market Access Strategies"},"categories":["affordability","analytics","commercialization","data","market access","patient support services","reimbursement","technology"],"segments":["manufacturers"],"timestamp":637000268110000000,"title":"how digital innovation drives improved market access strategies"},{"card":{"key":"fbe895ac-471e-45d2-be85-e9b4dc468805","authorName":"Lash Group","authorCompany":null,"date":"November 2019","description":"Lash Group's nurse educators offer empathy, experience and expertise to help patients navigate the complexities of today's specialty therapies. Learn how they add critical value to adherence programs.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-patient-support-program-nurse-educators-break-down-adherence-barriers","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How Patient Support Program Nurses Help Break Down Adherence Barriers"},"categories":["commercialization","medication adherence","patient support services"],"segments":["manufacturers"],"timestamp":637088308110000000,"title":"how patient support program nurses help break down adherence barriers"},{"card":{"key":"8c9668bc-4882-4980-8047-ba9825212a35","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2019","description":"Executive Q&A: The market trends and technology solutions impacting medication adherence today.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-tech-enabled-solutions-impact-adherence","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How Tech-Enabled Solutions Impact Adherence"},"categories":["medication adherence","patient support services","commercialization"],"segments":["manufacturers"],"timestamp":636924958740000000,"title":"how tech-enabled solutions impact adherence"},{"card":{"key":"aff87206-0cc8-4d26-a948-4aa9b6f1ee05","authorName":"AmerisourceBergen","authorCompany":null,"date":"November 2021","description":"Use this checklist to help you decide which skills are core, non-negotiable, translational attributes for a field reimbursement and access specialist -- and which ones can be learned in product-specific training.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/female-speaking-to-medical-audience.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/essential-skills-for-outsourced-field-solutions-teams","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Essential skills for outsourced field solutions teams"},"categories":["affordability","commercialization","innovation","market access","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637728582090000000,"title":"essential skills for outsourced field solutions teams"},{"card":{"key":"5ac79eee-996e-4f4a-8c18-5d07c5258429","authorName":"Xcenda","authorCompany":null,"date":"December 2020","description":"A look at the modern field reimbursement and access program. Why pharmaceutical manufacturers should rethink their approach in the face of COVID-19 and a changing healthcare landscape.","img":{"alt":"field-services-patient-access-meeting","src":"-/media/assets/xcenda/english/images/paid-media/circularmodule_typage_refresh.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/evaluating-the-modern-field-reimbursement-and-access-program-key-considerations","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Evaluating the modern field reimbursement and access program: key considerations"},"categories":["product access","reimbursement","covid-19"],"segments":["manufacturers"],"timestamp":637438559390000000,"title":"evaluating the modern field reimbursement and access program: key considerations"},{"card":{"key":"68f4072c-bc3c-40f5-95fa-909402517743","authorName":"Rod Bryant, MS; MarSha Lewers","authorCompany":"","date":"March 2021","description":"Whether buy-and-bill or self-administered, most specialty medications come with barriers to access and reimbursement. That's why manufacturers engage field support services to navigate the challenges. Xcenda's experts walk us through the difference in support for each model.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/pills-on-green-textured-background.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/field-services-for-buy-and-bill-vs-self-administered-products","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Buy-and-bill vs. self-administered: Field services remove barriers across access points"},"categories":["commercialization","patient support services","product access","reimbursement"],"segments":["manufacturers"],"timestamp":637511007890000000,"title":"buy-and-bill vs. self-administered: field services remove barriers across access points"},{"card":{"key":"ce64f028-8c96-4148-bc30-ad4edf845ab5","authorName":"Albert Cooksey","authorCompany":"","date":"July 2018","description":"How third-party logistics (3PL) solutions can help cell and gene therapy manufacturers manage the financial aspects of launching new therapies.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/financial-management-for-cell-and-gene-therapies","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"Financial Management for Cell and Gene Therapies"},"categories":["cell and gene therapy","commercialization","financial management"],"segments":["manufacturers"],"timestamp":636667627150000000,"title":"financial management for cell and gene therapies"},{"card":{"key":"e56bb7e1-5210-469e-b62c-34529af03126","authorName":"Lash Group","authorCompany":null,"date":"December 2021","description":"The eBV right solution isn't about having all the bells and whistles, it's about how it can scale with you. When looking for eBV tools that can quickly flex up from simple to sophisticated, consider these five factors.","img":{"alt":"electronic benefit verification article image","src":"-/media/assets/amerisourcebergen/insights/gettyimages-1139001612_rgb_large_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/finding-flexibility-five-important-features-of-pharmacy-ebv-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Finding flexibility: Five important features of pharmacy eBV solutions"},"categories":["affordability","commercialization","patient support services"],"segments":["manufacturers"],"timestamp":637745828080000000,"title":"finding flexibility: five important features of pharmacy ebv solutions"},{"card":{"key":"9fe616aa-1340-4f8d-965b-4b23d8d8aea3","authorName":"Jessica Donati","authorCompany":"Strategic Global Sourcing at AmerisourceBergen","date":"October 2020","description":"While it may seem that the role of distributors like AmerisourceBergen in helping over-the-counter (OTC) product manufacturers find commercial success is simply to make sure product gets from our warehouse to the pharmacy shelves, we’re actually instrumental in a lot more than that. In recent years, distributors have become an essential source of market insights and customer connections. ","img":{"alt":"consumer scanning products on smartphone in store","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/consumer-scanning-products-on-smartphone-in-store.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/five-growth-drivers-for-the-consumer-healthcare-products-market","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Five growth drivers for the consumer healthcare products market"},"categories":["commercialization","data","analytics","distribution","consumer products"],"segments":["manufacturers"],"timestamp":637384732090000000,"title":"five growth drivers for the consumer healthcare products market"},{"card":{"key":"b1f4f84e-df17-43ad-bd50-c5590411ee9c","authorName":"Xcenda","authorCompany":null,"date":"June 2020","description":"FormularyDecisions is a secure, online platform facilitating the bi-directional exchange of information between life sciences companies and over 2,100 qualified, active healthcare decision-makers. From pre-approval to post-launch, get unrivaled insight into what payers think of your product and those of your competitors, and gain feedback to better inform your market access strategies. ","img":{"alt":"","src":"-/media/assets/xcenda/english/images/paid-media/circularmodule_typage_refresh.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/formularydecisions-amcp-pie-webinar-june-3-2020","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Webinar: Effective Pre-Approval Communication With Payers"},"categories":[],"segments":["manufacturers"],"timestamp":637269601800000000,"title":"webinar: effective pre-approval communication with payers"},{"card":{"key":"ea67400d-8d87-4aa7-9d79-2c47a899d7d6","authorName":"AmerisourceBergen","authorCompany":null,"date":"June 2022","description":"","img":{"alt":"Cell and gene therapy commercialization","src":"-/media/assets/amerisourcebergen/manufacturer/advanced-therapies-week-2022.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/getting-the-right-drug-to-the-right-patient-at-the-right-place-at-the-right-time","linkText":"Read article","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Getting the right drug to the right patient at the right place at the right time"},"categories":["cell and gene therapy","commercialization","financial management","innovation"],"segments":["manufacturers"],"timestamp":637916031670000000,"title":"getting the right drug to the right patient at the right place at the right time"},{"card":{"key":"46774686-765c-4778-87e4-2926576a1411","authorName":"AmerisourceBergen","authorCompany":null,"date":"May 2021","description":"A manufacturer's launch guide for making the most of the drug commercialization process, including solutions you'll need at every step and checklists for finding the right commercialization partner.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/abstract-brand-colors-texture.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/guide-to-drug-commercialization","linkText":"Get the guide","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"The essential guide to drug commercialization"},"categories":["clinical trial logistics","commercialization","distribution","innovation","market access","medication adherence","patient support services","product access","reimbursement","technology","data"],"segments":["manufacturers"],"timestamp":637570511600000000,"title":"the essential guide to drug commercialization"},{"card":{"key":"727bb293-7010-4c1e-b1f8-21f9dfc6bb29","authorName":"Lash Group","authorCompany":null,"date":"March 2021","description":"Automating the benefits verification process is one of the most effective ways to speed access to therapy. Learn how to harness AI-powered digital assistant technology for real-time eBV.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ai_technology_innovation.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/harnessing-the-power-of-a-digital-assistant-to-accelerate-patient-access","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Harnessing the power of a digital assistant to accelerate patient access"},"categories":["affordability","patient support services","product access","technology","commercialization"],"segments":["manufacturers"],"timestamp":637521978000000000,"title":"harnessing the power of a digital assistant to accelerate patient access"},{"card":{"key":"433e299e-0844-4ccb-9f7e-99f26117a744","authorName":"Peter Kounelis, R.Ph.","authorCompany":"AmerisourceBergen","date":"January 2022","description":"How should the right PSAO be investing in and advocating for independent pharmacies? Peter Kounelis, Vice President of Elevate Provider Network at AmerisourceBergen, joins us to continue our discussion on the evolution of the PSAO.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/microphone.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/podcast-elevate-provider-network-part-2","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Podcast: Investing in independents"},"categories":["good neighbor pharmacy","innovation","managed care","patient care","our role in healthcare","pharmacy operations","reimbursement","dir fees"],"segments":["pharmacies"],"timestamp":637783062000000000,"title":"podcast: investing in independents"},{"card":{"key":"49e8eccf-c16a-47ec-9b3d-86c0747981e1","authorName":"AmerisourceBergen","authorCompany":null,"date":"October 2021","description":"Health policy experts discuss politics, policy, and the impact on manufacturers heading into 2022.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/health-policy-flag-stethoscope/ab-health-policy.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/health-policy-and-the-political-landscape","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Health policy and the political landscape"},"categories":["advocacy","affordability","policy","regulatory"],"segments":["manufacturers"],"timestamp":637705147390000000,"title":"health policy and the political landscape"},{"card":{"key":"b5f7bb71-be10-4966-975c-64565f8ff278","authorName":"AmerisourceBergen","authorCompany":null,"date":"April 2020","description":"AmerisourceBergen’s response to the COVID-19 pandemic: manufacturer questions answered.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/covid-19_masks-handsanitizer.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-the-pharma-supply-chain-is-responding-to-covid-19","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How the Pharma Supply Chain is Responding to COVID-19"},"categories":["covid-19","distribution","secure supply chain"],"segments":["manufacturers"],"timestamp":637214420920000000,"title":"how the pharma supply chain is responding to covid-19"},{"card":{"key":"488296e9-f372-4886-8ca5-d2d648928e9a","authorName":"Kashyap Patel, MD","authorCompany":"Carolina Blood and Cancer Care","date":"February 2020","description":"Physician Q&A: How manufacturers can realize the potential of biosimilars by improving education and utilization among oncologists.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/dna_blue_vial.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-boost-confidence-in-biosimilars","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Physician Q&A: How to Boost Confidence in Biosimilars"},"categories":["biosimilars","commercialization","oncology"],"segments":["manufacturers","physician practices"],"timestamp":637175700550000000,"title":"physician q&a: how to boost confidence in biosimilars"},{"card":{"key":"4a6a6d82-9bb9-4485-aff9-89bf92184d5a","authorName":"Todd Wells","authorCompany":"Biopharma Services","date":"November 2019","description":"Executive Q&A: best practices for a patient support program launch.","img":{"alt":"","src":""},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-launch-a-patient-support-program","linkText":"Learn more","hasImage":false,"isImageMode":false,"label":"Manufacturers","headline":"How to Launch a Patient Support Program"},"categories":["affordability","commercialization","medication adherence","product access"],"segments":["manufacturers"],"timestamp":637088419270000000,"title":"how to launch a patient support program"},{"card":{"key":"f8c10294-4f97-4573-826e-2839d4510d88","authorName":"AmerisourceBergen","authorCompany":null,"date":"March 2021","description":"Bringing a new therapy to market is no easy task, and making sure it's a commercial success is even harder. Manufacturers need to have the right commercialization services and partner at each stage of the commercialization process.","img":{"alt":"AmerisourceBergen manufacturer commercialization strategies","src":"-/media/assets/amerisourcebergen/insights/bright-tubes.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-make-the-most-of-integrated-commercialization-solutions","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to make the most of integrated commercialization solutions"},"categories":["commercialization","clinical trial logistics","distribution","innovation","market access","medication adherence","our role in healthcare","patient support services","pharmaceutical storage and transport management","product access","reimbursement","technology","third party logistics"],"segments":["manufacturers"],"timestamp":637517820100000000,"title":"how to make the most of integrated commercialization solutions"},{"card":{"key":"8580c622-65f9-4555-b2be-055d8aa78bb1","authorName":"AmerisourceBergen","authorCompany":null,"date":"February 2021","description":"The product life cycle solutions you need at every stage.","img":{"alt":"How to maximize your drug commercialization investments","src":"-/media/assets/amerisourcebergen/manufacturer/gettyimages-1179988450_rgb_large_jpg-(1).jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-maximize-your-drug-commercialization-investments","linkText":"View the guide","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to maximize your drug commercialization investments"},"categories":["commercialization"],"segments":["manufacturers"],"timestamp":637479994800000000,"title":"how to maximize your drug commercialization investments"},{"card":{"key":"48d6d622-43e9-4249-b149-22efc899d4db","authorName":"AmerisourceBergen","authorCompany":null,"date":"January 2022","description":"Experts from AmerisourceBergen and TrakCel recently participated in a webinar on commercial supply chain strategies for cell and gene therapies. In this webinar recap, you'll get highlights from the conversation and fast facts on optimizing the commercial supply chain. Think of it like Cliff's Notes for important ideas in the CGT space.","img":{"alt":"Cell and gene therapy cryo storage","src":"-/media/assets/amerisourcebergen/manufacturer/ics_brooks_3pl_ultra_low_freezer_063_rgb_jpg.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-to-optimize-the-commercial-supply-chain-for-cell-and-gene-therapies","linkText":"Download now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How to optimize the commercial supply chain for cell and gene therapies"},"categories":["cell and gene therapy","commercial supply chain","commercialization"],"segments":["manufacturers"],"timestamp":637783705190000000,"title":"how to optimize the commercial supply chain for cell and gene therapies"},{"card":{"key":"dd287477-7e69-492e-bd1e-c0abaa637b25","authorName":"AmerisourceBergen","authorCompany":null,"date":"July 2022","description":"","img":{"alt":"Biosimilars podcast ","src":"-/media/assets/amerisourcebergen/biosimilars-page/biosimilars-podcast-image.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/podcast-biosimilars-milestones-2022-looking-to-2023","linkText":"Listen now","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023"},"categories":["affordability","biosimilars","market access","product access","regulatory"],"segments":["manufacturers","pharmacies","health systems"],"timestamp":637944384600000000,"title":"podcast: milestones for biosimilars in 2022 and looking ahead to 2023"},{"card":{"key":"247447cd-68c3-44e6-9807-e9f6fc3742e2","authorName":"AmerisourceBergen","authorCompany":null,"date":"September 2022","description":"","img":{"alt":"Interchangeable biosimilars","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/podcast-interchangeable-biosimilars.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/podcast-conversations-around-interchangeability-and-biosimilar-entries-in-new-therapeutic-categories","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories"},"categories":["biosimilars","affordability","market access","regulatory"],"segments":["manufacturers"],"timestamp":637980984230000000,"title":"podcast: conversations around interchangeability and biosimilar entries in new therapeutic categories"},{"card":{"key":"29759932-6986-4341-8d22-32fe3afc4d64","authorName":"Heather Zenk, RPh, PharmD","authorCompany":"AmerisourceBergen","date":"April 2020","description":"What providers and pharmacies need to know about the distribution of high-demand inventory during the COVID-19 pandemic.","img":{"alt":"","src":"-/media/assets/amerisourcebergen/distribution/dist_drug_a-frame_bottles_016_grey.png?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-do-allocations-work-for-the-pharma-supply-chain","linkText":"Learn more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"How Do Allocations Work for the Pharma Supply Chain?"},"categories":["covid-19","distribution","inventory management","product access"],"segments":["pharmacies","health systems"],"timestamp":637226482110000000,"title":"how do allocations work for the pharma supply chain?"},{"card":{"key":"c44cdc04-cf15-4e83-823f-b4638e8aa995","authorName":"Mark Pilkington, MS, RPh; Robert Mosby, PharmD, JD, MBA","authorCompany":"AmerisourceBergen","date":"September 2022","description":"Local hospices and local pharmacies should join forces to enhance patient care. Pharmacy service managers can facilitate this and optimize operational processes that will further improve patient care, but not all pharmacy benefit managers offer processes that actually improve patient care. ","img":{"alt":"","src":"-/media/assets/amerisourcebergen/insights/images-for-insights/ab-brand-abstract-swirls.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/pharmacies/spread-pricing-for-hospice-prescription-drug-benefits","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Pharmacies","headline":"Spread pricing for hospice prescription drug benefits: What you need to know"},"categories":["managed care","patient care"],"segments":["pharmacies"],"timestamp":638001578520000000,"title":"spread pricing for hospice prescription drug benefits: what you need to know"},{"card":{"key":"b04c5174-3a9f-4b9d-ad83-c488bdb90034","authorName":"AmerisourceBergen","authorCompany":"","date":"September 2022","description":"Not all eBV solutions perform equally. Look for one that leveraging AR expertise to automate cases end-to-end.","img":{"alt":"","src":"-/media/assets/lash/images/pagedesign_maledoc_femalepatient.jpg?h=320&w=540"},"link":"https://www.amerisourcebergen.com/insights/manufacturers/how-an-automation-solution-helps-more-patients-stay-on-track-with-scheduled-therapies","linkText":"Read more","hasImage":true,"isImageMode":true,"label":"Manufacturers","headline":"How an automation solution helps more patients stay on track with scheduled therapies"},"categories":["analytics","patient support services","affordability"],"segments":["manufacturers"],"timestamp":638000549340000000,"title":"how an automation solution helps more patients stay on track with scheduled therapies"}]